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BisPMB (E, Z)-1,8-(Bis-p-methoxyphenyl)-2,3,7-trithiaocta-4-ene 7-oxide)  is a synthetic 
analogue of the garlic compound ajoene.  It is 12 times more active at inhibiting the growth 
of oesophageal squamous cell carcinoma WHCO1 cells and displays selectivity for cancer 
cells over normal cells. BisPMB is therefore attractive as a potential cancer therapeutic.  
In this study, bisPMB was found to inhibit WHCO1 cancer cell proliferation in a time 
and concentration dependent manner with 24 hour IC50’s between 6.7 – 8.1 µM against a 
range of oesophageal cancer cell lines including WHCO1, KYSE30 and WHCO6. The 
normal oesophageal epithelial cell line, HET1A was found to be five times less 
responsive to bisPMB. Furthermore, bisPMB was found to induce apoptosis and G2/M 
cell cycle arrest in WHCO1 cells. Gene expression data obtained from the microarray 
analysis showed that bisPMB primarily targets the unfolded protein response (UPR) in 
WHCO1 cells. We also found that bisPMB deregulated the ER stress genes involved in 
protein processing in the endoplasmic reticulum and also deregulated MAPK pathways 
in WHCO1 cells. At a protein level, bisPMB was found to induce an increase in protein 
ubiquitination and in the expression of ER stress and UPR genes ATF4, Grp78 and 
CHOP in WHCO1 cells. We also observed a decrease in ATF6 90 kDa protein and 
transient XBP-1 mRNA splicing. The activation of p38, JNK and ERK MAPK pathways 
in bisPMB treated WHCO1 cells was also observed. Furthermore siRNA mediated 
knock-down of CHOP abolished the anti-proliferative effect of bisPMB in WHCO1 
cells. However, inhibition of JNK and p38 MAPK by chemical inhibitors, SP600125 and 
SB 203580 respectively, had no effect on bisPMB antiproliferative activity against 
WHCO1 cells. On the other hand, inhibition of ERK1/2 MAPK by U0126 enhanced the 
anti-proliferative effect of bisPMB in WHCO1 cells. These results support the 
hypothesis that ER stress and MAPK signalling pathways are essential for bisPMB 





CHAPTER 1: LITERATURE REVIEW 
 
Oesophageal cancer (OC) presents a significant health burden in South Africa, being the third 
most prevalent cancer amongst black South African males. The average 5 year survival rate 
for these patients is reported to be less than 10% (Wong and Malthaner, 2000, Hendricks and 
Parker, 2002, Cotton et al., 2014, Dandara et al., 2015, Somdyala et al., 2015) and this is 
commonly attributed to late stage diagnosis of the disease. In addition, current OC treatment 
options have low success rates and poor prognosis (Barabas et al., 2008, Cohen and 
Leichman, 2015). Consequently, more effective and less toxic chemotherapeutic treatment 
options are needed. In this thesis, we investigate a new compound called bisPMB for OC 
therapeutic that has been developed based on the structure of the garlic compound ajoene. We 
present data on its cytotoxicity, its effect on gene transcription and the signalling pathways it 
modulates in WHCO1 oesophageal cancer cells. We also show that bisPMB induces its 
cytotoxic effects primarily via the ER stress and UPR pathway. 
1.1 Treatment of oesophageal cancer 
The treatment of OC is challenging because most patients present late for therapy and current 
treatment options result in low survival rates. For example, the 5 year survival rate for OC 
patients that have undergone surgery alone is 5 - 30% (Allum et al., 2009). Furthermore, this 
outcome is mainly applicable to patients diagnosed at the early stages of the OC disease 
development. 
Consequently, multimodal approaches are often used to improve the prognosis for OC 
patients, consisting of a combination of surgery, chemotherapy, radiotherapy, 
chemoradiotherapy, laser treatment, stent insertions and radiofrequency ablation (RFA) 
(Desai et al., 1989, Koshy et al., 2004, Tong and Law, 2009, Dandara et al., 2015). However 
the benefit of a multimodal treatment approaches is not clear with several clinical trials 
reporting conflicting outcomes (Bosset et al., 1997, Kelsen et al., 1998, Cooper et al., 1999, 
Urba et al., 2001, Stahl et al., 2005). Despite the inconclusive outcomes of the clinical trials, 
the most promising therapies are selected for treatment. The treatment options selected for 
therapy are dependent on multiple factors including the disease stage, as defined by the 
tumour node metastasis (TNM) system (Edge and Compton, 2010, Rice et al., 2010). Stage 0 
OC tumours are defined as non-invasive high grade dysplasia of the epithelial cells lining the 
oesophagus and are mainly treated by surgery alone (Rice et al., 2010).  In stage I, when the 
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cancer has grown into the submucosa layer of the oesophagus (Rice et al., 2010), 
combination of chemo-radiation followed by surgery or surgery alone is administered (figure 
1.1) (Mackay and Stefanou, 2006, Graham et al., 2007, Tong and Law, 2009). Late stage 
cancers (stage II and III) which invade all the oesophageal muscle layers and spread into the 
local lymph nodes (Rice et al., 2003, Rice et al., 2010) are usually treated with a combination 
of chemoradiotherapy and surgery or surgery alone or chemo-radiotherapy alone. The final 
stage IV cancer obstructs the oesophagus lumen and metastasizes to local and distant lymph 
nodes and possibly tissues (Rice et al., 2003). It is the stage that most patients are diagnosed 
in because OC patients typically present with dysphasia (Schlansky et al., 2006). For stage 
IV, the treatment options are primarily for palliative purposes and they include chemo 
radiation followed by surgery, stent insertions and chemotherapy (figure 1.1) (Tong and Law, 
2009, Kato and Nakajima, 2013). In most cases, OC treatment options (i.e. surgery, 
chemotherapy and radiotherapy) need to be improved with new and effective 
chemotherapeutic options 
 






                   
 
 
Figure 1.1 Standardized treatment options for each OC stage. Stage 0 non-invasive OC tumours are 
surgically removed. Stage I OC tumours are treated with chemoradiation in combination with surgical removal. 
Late metastatic stage II, III and IV OC tumours are subjected to palliative treatment including chemo radiation, 
surgery, stent insertions, radiation and chemotherapy. 
 
The chemotherapeutic drugs currently used in OC treatment are cisplatin, 5-fluorouracil (5-
FU), paclitaxel and docetaxel. These drugs targets different pathways in cancer cells. For 
• Surgery Stage 0 
• Chemoradiation followed by surgery 
• Surgery alone Stage I 
• Chemoradiation followed by surgery 
• Chemoradiation alone 
• Surgery alone 
Stage II 
• Cheloradiation  followed by surgery 
• Chemoradiation alone Stage III 
• Chemoradiation followed by surgery in stage IVA 
• Stents insertions 
• Radiation therapy with or with out intubation and 
dialation 





example, cisplatin exerts its cytotoxic effects by interacting with DNA, forming DNA 
adducts and inhibiting DNA synthesis and repair (Dasari and Tchounwou, 2014). 5-FU is 
metabolised to form fluorodeoxyuridine monophosphate (FdUMP) which inhibits the 
synthesis of deoxythymidine monophosphate (dTMP) by thymidilate synthase and thus 
blocks DNA repair and replication (Longley et al., 2003). Paclitaxel and docetaxel are anti-
mitotic agents which target microtubules by directly interacting with β-tubulin (Horwitz, 
1994, Stein, 1999). The net effect of the aforementioned chemotherapeutic drugs is inhibition 
of growth and induction of apoptosis in rapidly dividing cancer cells.   
Cisplatin is the most widely used chemotherapeutic drug for OC treatment, however   toxic 
side effects and drug resistance remain problematic (Barabas et al., 2008, Galluzzi et al., 
2012, Galluzzi et al., 2014). In order to reduce toxicity,  drug combination regimens with 
cisplatin have been developed which have enabled  reduction of the cisplatin dose (Ali and Al 
Moundhri, 2006). Cisplatin is commonly combined with 5-FU, docataxel or paclitaxel to 
result in  a synergistic outcome .  
The most widely used cisplatin based combination is cisplatin/5-FU. In a  phase II 
randomised trial, it was  reported that the outcome of patients treated with cisplatin/5-FU 
combinations compared to cisplatin alone displayed an overall survival rate of 35 % 
compared to 19 % with cisplatin alone although still with unwanted side effects (Bleiberg et 
al., 1997). This has led to the development of the cisplatin/5-FU/paclitaxel or 
cisplatin/paclitaxel combinations, which are reported to be active with tolerable side effects 
(Petrasch et al., 1998, Kim et al., 1999).  
Drug synergism arises in most cases from combinations that target multiple pathways such as 
the combination of a DNA binding compound (cisplatin) together with an anti-mitotic 
(Paclitaxel) (Jekunen et al., 1994, Cai et al., 2015). Furthermore, toxicity can be reduced in 
combination therapy due to a lowering of the effective drug concentration required for 
activity with drugs acting synergistically (Clark et al., 2010). Although drug combinations for 
the treatment of OC are currently acceptable, the survival rate is still low and the 





1.2  Plants as a source of anticancer drugs 
Plants contain reservoirs of compounds active both in cancer prevention and treatment. The 
potential of plants to yield compounds for cancer therapeutic development led to the 
establishment of the United States National Cancer Institute (US NCI), plant collection 
program, in the early 1960’s. 
During the period of 1967 – 1971, Hartwell and colleagues reported over 3000 plant species 
that possessed anti-cancer properties. To date over 275 000 structures of compounds have 
been recorded in the national cancer institute (NCI) database (Hartwell, 1969c, Hartwell, 
1969b, Hartwell, 1969a, Hartwell, 1971, Graham et al., 2000, Shiryaev et al., 2011). In 
addition, over 60 % of the newly approved anticancer drugs documented in Annual Reports 
of Medicinal Chemistry during the 1984 - 1995 originated from natural sources (Cragg et al., 
1997).  
Currently available plant derived anticancer drugs, either in clinical use or trials are 
categorised into vinca alkaloids, camptothecin derivatives, epipodophyllotoxins, 
anthracyclines and taxanes (Cragg and Newman, 2005, Nobili et al., 2009). Taxol is the 
success story of the NCI plant collection program. This  clinical anticancer drug was 
discovered from extracts of the bark of the Pacific Yew, Taxus brevifolia found in the Pacific 
Northwest of North America (Cragg, 1998).  
There are a number of plant based foods that contain  compounds (table 1.1) able to inhibit 
initiation and  progression of cancer (Surh, 2003). One of these compounds, ajoene; is 










Table 1.1 Dietary plant derived compounds with cytotoxic effects against cancer cell lines and in vivo  
Source Compound Structure Cancer Cell Lines Reference 
Turmeric Curcumin 
 
Skin,colon, myeloid leukaemia 




et al., 1999, 





Mouse skin tumour and human 
leukaemia cells, melanoma cells 
and Jurkat cells 





(Park et al., 
1998) 
Green tea Epigallocatechin-3-gallate 
 
Mouse epidermal keratinocytes 
JB6 cell line, human breast, head 
and neck cancer cell lines 
(Afaq et al., 
2003, Masuda 




Human breast, prostate cancer cell 
lines, hepatocarcinoma cells, 
alveolar epithelial carcinoma cells 
(Tacchini et al., 




Human mammary epithelial cells, 
Rat and human pancreatic 
carcinoma cells, human breast 
cancer cells, mouse epidermal bj6, 
HeLa cells. 
(Subbaramaiah 
et al., 1998, 
Subbaramaiah 
et al., 1999, 
Mouria et al., 
2002, Banerjee 
et al., 2002) 
Garlic Ajoene 
 
Human promyeloleukamia, Basal 
cell carcinoma 
(Dirsch et al., 
1998, 
Antlsperger et 
al., 2003, Tilli 
et al., 2003) 




1.3      The anti-cancer activity of garlic organosulfur compounds (OSC) 
1.3.1 The composition of OSC in a garlic clove  
A garlic clove contains an array of organosulfur compounds (OSC) which are proposedly 
responsible for its cancer preventative activity (Siegers et al., 1999, Bianchini and Vainio, 
2001, Nicastro et al., 2015). When an intact garlic clove is crushed, previously 
compartmentalised alliin and the enzyme alliinase come into contact followed by an 
enzymatic reaction which generates allicin, a diallyl thiosulfinate compound  (figure 1.2) 
(Block et al., 1986). Allicin then spontaneously decomposes into an array of water and oil 
soluble second generation OSC (figure 1.3) (Shukla and Kalra, 2007, Kaschula et al., 2010) 
of which the major constituents are diallyl sulphide (DAS), diallyl disulfide (DADS), diallyl 
trisulfide (DATS) and Ajoene ((E,Z)-4, 5, 9-thrithiadodeca-1, 6, 11-triene-9-oxide) (table 
1.2). The concentrations of these compounds in crushed garlic vary according to the type of 
extraction technique used  (table 1.3) (Block et al., 1992, Amagase et al., 2001, Lee et al., 
2003f, Kimbaris et al., 2006, Shukla and Kalra, 2007). Therefore different garlic preparations 
have different  concentrations of respective OSC compounds. 
 




                                                                                                                            
    
 
Figure 1.2 The enzymatic reaction between alliin and the enzyme alliinase in a crushed garlic clove. A 
Initial reaction between alliin and alliinase produce 2-propenesufenic acid. B Spontaneous condensation of two 









Figure 1.3. Chemical structures of allicin degradation products isolated from macerated garlic extracts. 
Allicin spontaneously degrades into an array of soluble OSCs including (1) 2.propensulphenic acid, (2) 2-
propenesulfinic acid, (3) propenesulphenic acid, (4) 1-propenesulfenic acid, (5) thioacrolein, (6a-c) 2-
(allylthiomethyl), 2-(allyldithiomethyl),  2-(allyltrithiomethyl)-3,4-dihydro-2H-thiopyran (7) 2-vinyl-2,4-
dihydro-1,3-dithiin, (8) 3-vinyl-3,4-dihydro-1,2-dithiin, (9a-c) 3-[(allylthiomethyl), (allyldithiomethyl),  
(allyltrithiomethyl)-] -3,4-dihydro-2H-thiopyran (10a-c) 5-methyl-4,7-dithiaundeca-1,9-diene for n 5 1,  E- and 
Z-4,5,9-trithiadodeca-1,6,11-triene 9-oxide (E- and Z-ajoene (11a-f)  diallyl sulfides,n 5 1–6, (12a-b)  dimethyl 
sulphides n 5 2–3, (13) 1-(methyldithio)propane, (14a-c)  allyl methyl sulphides (Kaschula et al., 2010). 
 
 
Table 1.2 Chemical structures of the garlic derived organosulfur compound DAS, DADS, DATS and ajoene. 
Garlic Organosulfur Compound Chemical Structure 
Diallyl sulphide (DAS)    
Diallyl disulphide (DADS)    
Diallyl trisulphide (DATS) 
   
Ajoene 




Table 1.3 Reported Concentrations of garlic derived OSCs prepared using different extraction methods 
Garlic Compound Method of extraction Concentration References 
Allicin Blended crushed garlic in water 2.5 to 3.1 mg/g 
(Block et al., 1986, Lawson et 
al., 1991, Lawson and 
Gardner, 2005) 
DAS 
simultaneous distillation extraction 
 Steam Distillation 
579µg/g 
898 µg/g 
(Munchberg et al., 2007) 
DADS 




(Munchberg et al., 2007) 
DATS 




(Munchberg et al., 2007) 
E-ajoene 
Fresh garlic in rice oil at 80  
Marketed garlic oil at 80  
172 µg/g 
127 µg/g 
(Shukla and Kalra, 2007, 
Naznin et al., 2008) 
Z-ajoene 
Fresh garlic in rice oil at 80   
Marketed garlic oil at 80   
476.3 µg/g 
170 µg/g 
(Shukla and Kalra, 2007, 
Naznin et al., 2008) 
 
1.3.2 The chemopreventitive activity of OSC 
Garlic (Allium sativum L), an Allium family member, has been used for centuries as a herbal 
remedy against a number of ailments. Epidemiological studies have demonstrated that garlic 
consumption reduces prevalence and cancer related death of oesophageal, gastric, skin, colon 
and lung cancer (Agarwal, 1996, Shukla and Kalra, 2007, Jin et al., 2013, Turati et al., 2015). 
In China, gastric cancer cases from regions that consume higher amounts of garlic (20 g/day) 
were found to have 12 times lower mortality rates from gastric cancer compared to the lower 
consumption regions and subsequent meta-analysis findings have illustrated this protective 
role (Agarwal, 1996, Kodali and Eslick, 2015). Moreover, the consumption of high amounts 
of Allium vegetables were found to associate with reduced risk of oesophageal and stomach 
cancer in Jiangsu province in China (Gao et al., 1999). On the other hand, the 
epidemiological reports on the protective role of garlic consumption against colorectal cancer 
have been inconsistent. Data from a meta-analysis study was found to demonstrate that high 
garlic consumption (>28 g/wk) has a protective role against colorectal and stomach cancer 
(Fleischauer et al., 2000). However, recent meta-analysis and prospective cohort studies have 
shown that garlic consumption or intake of garlic supplements is not associated with the 
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reduced risk of colorectal cancer (Meng et al., 2013, Zhu et al., 2014, Chiavarini et al., 2015). 
The variation in the meta-analysis reports have been attributed to the type of studies analysed, 
for example case-control studies seemingly found garlic to be protective against colorectal 
cancer while cohort studies did not (Chiavarini et al., 2015). Despite the somewhat 
conflicting evidence, the majority of epidemiological studies conducted suggest that garlic 
consumption has a protective role against different cancer types.  
1.3.3 Molecular mechanisms underlying OSC chemopreventitive activity  
 
Several reports have suggested that garlic extracts and more specifically, the OSC found in 
the garlic extracts may hinder cancer initiation by inhibiting mutagenesis and DNA adduct 
formation as well as altering the activity of xenobiotic metabolising enzymes and scavenging 
free radicals.  
Garlic extract is reported to inhibit the activation of the mutagens such as aflatoxin B1 and 4-
nitroquinoline-1-oxide in Salmonella typhimurium and Escherichia coli while ajoene inhibits 
the binding of aflatoxin B1 to calf thymus DNA in rat liver (Zhang et al., 1989, Tadi et al., 
1991, Soni et al., 1997). Furthermore, ajoene is reported to inhibit the activation of 
benzo[a]pyrene and 4-nitro-1, 2 phenylenediamine (NPD) in Salmonella typhimurium Strains 
(Tadi et al., 1991, Ishikawa et al., 1996). DAS is reported to delay the onset of polycyclic 
aromatic hydrocarbon (PAH) induced skin and lung carcinogenesis in mice (Singh and 
Shukla, 1998a, Singh and Shukla, 1998b, Yang et al., 2001). In addition, garlic powder and 
ajoene have been reported to inhibit 7, 12 dimethylbenzo[a]athracene (DMBA) - induced 
DNA adduct formation in rat liver and the mammary gland (Mehta et al., 1991, Liu et al., 
1992, Amagase and Milner, 1993).  
In addition to inactivation of mutagens and DNA adduct formation, garlic constituents are 
reported to modulate the activity of enzymes responsible for detoxifying carcinogens. For an 
example, garlic powder, DAS and DADS were found to enhance the activity of S-glutathione 
transferase (GST) and nicotinamide adenine dinucleotide phosphate (NADPH)-dependent 
oxidoreductase activity in rat liver (Reddy et al., 1993, Munday and Munday, 1999, Sheen et 
al., 1999). DAS was also found to decrease the activity of cytochrome P450  CYP2E1 in 
hepatic microsomes (Brady et al., 1988). Whereas garlic oil was found to enhance the activity 
of glutathione peroxidase, an enzyme that protects against free radicals, in epidermal cells 
(Perchellet et al., 1986). Furthermore, aged garlic extracts have been reported to exhibit 
antioxidant properties in the liver microsomal fractions (Imai et al., 1994). These 
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experimental reports suggest that garlic extracts and OSC may inhibit the initiation of 
mutagen and chemical induced cancer through similar mechanisms.  
1.3.4 Cytotoxicity of garlic extracts and OSCs in cancer cells 
 
Garlic extracts and OSC have been shown to prevent cancer progression through anti-
proliferative and apoptosis-inducing effects on growing tumour cells. Fresh garlic extracts 
and oil are reported to inhibit the growth of MCF-7 breast cancer, hepatoma HepG2, colon 
carcinoma Caco-2 and promyelocytic leukaemia HL-60 cells (Siegers et al., 1999, Seki et al., 
2000, Modem et al., 2012). DADS and DATS were found to inhibit prostate cancer PC-3 cell 
proliferation with 24 h 7 µM values of 35 µM and 22 µM respectively (Xiao et al., 2004). 
Furthermore, the 48 h 7 µM value of ajoene in human leukaemia HL-60, nasopharyngeal KB, 
cervical Bel-780, colon HCT, gastric BGC-823, breast MCF-7 gliobastoma cancer stem cells 
GBM CSC, hepatocellular Bel 7402, basal cell carcinoma TE354T, B cell lymphoma BJA-B 
and mouse melanoma cancer cells B16/BL6 (Scharfenberg et al., 1990, Dirsch et al., 1998, Li 
et al., 2002a, Tilli et al., 2003, Xu et al., 2004, Taylor et al., 2006, Jung et al., 2014) was 
found to lie in the range  5.2 - 26.1 µM (Li et al., 2002a). The 7 µM therefore does not appear 
to vary greatly with different cancer cell lines although a level of specificity has been 
reported for cancer over normal cell lines (see next section). DAS however is reported to 
have greatly reduced activity against the human SW-480 colon cancer and PC-3 prostate 
cancer cell lines with an 7 µM greater than 100 µM (Xiao et al., 2004).  
The anti-proliferative activity of garlic derived OSC has been associated with the induction of 
G2/M cell cycle arrest and apoptosis. Ajoene has been shown to induce a G2/M cell cycle 
arrest and apoptosis in human basal cell carcinoma BCC (Tilli et al., 2003), HT-29, 
leukaemia HL-60 (Dirsch et al., 2002, Li et al., 2002a) and Burkitt lymphoma BJA-B 
(Scharfenberg et al., 1990). DADS is reported to trigger G2/M cell cycle arrest in gastric 
cancer MGC803 cells (Ling et al., 2014) and oesophageal cancer cells (Yin et al., 2014). 
DATS is reported to induce G2/M cell cycle arrest and apoptosis in prostate DU145, basal 
cell carcinoma BCC, melanoma A375 and bladder cancer T24 cells (Herman-Antosiewicz et 
al., 2010, Wang et al., 2010a, Wang et al., 2010b). In addition to the in vitro studies, ajoene 
has been shown to have an inhibitory effect on the  growth of hepatocellular 22 and sarcoma 
180 tumour xenografts in Kunming mice and to reduce the tumour size of nodular or 
superficial basal cell carcinoma (BCC) in humans (Nakagawa et al., 2001, Li et al., 2002a, 
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Tilli et al., 2003). The reduction in the BCC tumour growth in human patients has been 
attributed to ajoene-induced apoptotic activity in these cells (Tilli et al., 2003). On the other 
hand, DADS and DATS were found to hinder leukaemia cell growth in a WEHI-3B mouse 
model by inducing apoptosis (Yang et al., 2006a, Hung et al., 2014). In summary, the garlic 
derived OSC compounds DADS, DATS and ajoene have been shown to counter cancer cell 
growth both in vitro and in vivo by inhibiting cell proliferation, and apoptosis. In addition 
garlic OSC also induced G2/M cell cycle arrest in various cancer cells.  
1.3.5 Selectivity of OSC for cancer cells 
As with many anticancer agents, the potential of OSC for selectivity against cancer rather 
than normal cells is a critical requirement. Data presented on the selectivity of garlic OSC for 
cancer cells is controversial. For example ajoene was found to have similar cytotoxicity 
against the normal HER2 immortalized mouse fibroblast NIH 3T3 cell line as against a panel 
of cancer cell lines including mouse melanoma BL6/B6 and  human colon HT-29, lung 
adenocarcinoma A549 and pancreatic adenocarcinoma PANC-1 cells (Taylor et al., 2006).  
However, marsupial Ptk2 cells, baby hamster kidney BHK21 and primary fibroblast FS4 cells 
were shown to be more resistant to ajoene than human leukemic HL60, Burkitt lymphoma 
BJA-B, breast MCF7, nasopharyngeal KB, hepatocellular Bel 7402, gastric BGC 823 and 
colon cancer HCT cells (Scharfenberg et al., 1990, Li et al., 2002o). Moreover, DADS was 
found to display increased toxicity against oesophageal squamous cell carcinoma ESCC than 
against the corresponding normal liver L02 cells (Yin et al., 2014). Generally, DATS has 
been reported to be more active in cancer than in normal cell lines. Melanoma A375, prostate 
cancer DU145 and PC-3 and breast cancer MCF-7 and MDA-MB-231 and human lung 
cancer H358 and H460 cells have been shown to be more sensitive to DATS induced 
apoptosis than normal melanocytes, prostate epithelial PrEC, human mammary MCF-10A 
and normal bronchial epithelial BEAS-2B cells (Xiao et al., 2005, Xiao et al., 2009, Murai et 
al., 2012, Chandra-Kuntal et al., 2013). Some of the most striking evidence comes from the 
complete selectivity of ajoene for normal peripheral mononuclear blood (PBMC) cells from 
healthy humans compared to leukemic cells collected from patients (Dirsch et al., 1998). In 
brief, the majority of reports suggest that garlic derived OSC are more active against cancer 
cells than their normal counter parts. The selectivity of anticancer agents for cancer cells is 
critical in cancer therapy as it reduces toxic side effects.  
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1.3.6 Signalling Pathways identified in OSC apoptotic activity against cancer cells  
The mechanism of action behind the cytotoxicity of garlic derived OSC in cancer cells is 
reported to be dependent on the activation of a number of signalling pathways. OSC induced 
apoptosis has been shown to proceed via the intrinsic pathway. Signalling pathways which 
may converge on this apoptotic pathway include activation of mitogen activated protein 
kinase (MAPK) pathways, intracellular calcium mobilization and the production of reactive 
oxygen species (ROS) 
DADS, DATS and ajoene have been found to induce apoptosis in a variety of cancer cells by 
triggering the mitochondrial dependent caspase cascade (Nakagawa et al., 2001, Dirsch et al., 
2002, Kwon et al., 2002, Tilli et al., 2003, Oommen et al., 2004, Xiao et al., 2004, Wang et 
al., 2010b, Chiu et al., 2013, Dasgupta and Bandyopadhyay, 2013, Shin et al., 2014). This 
involves activation of caspase 3, disruption of mitochondrial membrane potential, release of 
cytochrome c from the mitochondria into the cytosol and the down-regulation and 
phosphorylation of Bcl2 (Shi, 2001, Dirsch et al., 2002, Xiao et al., 2004, Wang et al., 2010b, 
Wang et al., 2012).  
Various studies have implicated MAPK activation by garlic OSC in cancer cells. The MAPK 
intracellular signalling pathways are activated in response to extracellular stimuli and are 
characterised into JNK, p38 and MEK/ERK MAPK (Yang et al., 2013). Activation of the 
JNK MAPK signalling pathway by stress stimuli promotes apoptosis (Pritchard and 
Hayward, 2013). The JNK signalling pathway mediates apoptosis induced by DATS in 
prostate cancer PC-3 and DU154 (Xiao et al., 2004) and in bladder cancer T24 cells (Shin et 
al., 2014). Moreover, DADS has been reported to induce apoptosis in prostate DU145 cancer 
cells by activating the JNK pathway (Shin et al., 2014, Shin et al., 2012). Although JNK is 
activated in ajoene treated human leukaemia HL60 (Antlsperger et al., 2003) and 3T3L-
adipocytes, it does not play a central role in ajoene induced apoptosis. The other stress 
activated MAPK is p38 and it also promotes apoptosis when activated (Obata et al., 2000). 
Garlic derived OSCs DAS and DADS trigger p38 induced apoptosis in glioblastoma T98G 
and U87MG (Das et al., 2007), colon cancer COLO 205 (Yang et al., 2009)  (Das et al., 2007, 
Yang et al., 2009, Wang et al., 2012). On the other hand, the MEK/ERK MAPK pathway is 
known to be activated by growth factors (Boulton et al., 1991). Once activated the ERK1/2 
pathway promotes cell proliferation and differentiation (Yang et al., 2013). The earliest report 
of ERK1/2 activation by DADS was reported in human colon cancer HCT cells (Knowles 
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and Milner, 2003). In addition, MEK1/2 inhibitors PD98059 and U0126 significantly 
enhanced ajoene and DADS induced apoptosis in human leukemic HL-60 and ESCC cancer 
cells respectively (Antlsperger et al., 2003, Xiao et al., 2004). Thus, all MAPK pathways are 
activated by different OSC, with the JNK pathway playing a major role in OSC induced 
apoptosis with the exception of ajoene. Furthermore, the p38 and MEK/ERK pathways are 
also activated by OSC, with the MEK/ ERK pathway negatively affecting ajoene induced 
apoptotic activity. The stress activated MAPK are sometimes activated by increased 
intracellular ROS levels  
ROS is produced as the by-product of metabolic reactions such as cellular respiration 
(Saybasili et al., 2001), with different  types including superoxide and hydrogen peroxide 
(Richter et al., 1995). Since cancer cells have high metabolic rates, ROS production is 
reported to be elevated in cancer cells (Behrend et al., 2003).  Consequently, production of 
ROS plays a major role in therapy cancer cell death (Benhar et al., 2002) and is reported to 
mediate OSC induced apoptosis in cancer cells. ROS mediates DADS induced apoptosis in 
mouse-rat hybrid ganglion cells (N18) (Lin et al., 2006) and lung A549 carcinoma cells (Wu 
et al., 2005), human glioblastoma T98G and U87MG (Das et al., 2007), leukaemia HL60 
cells (Kwon et al., 2002) and neuroblastoma SH-SY5Y (Filomeni et al., 2003). Furthermore, 
DATS is reported to enhance ROS levels in prostate cancer LNCaP cell line (Kim et al., 
2007), PC-3 and DU145 (Xiao et al., 2005). ROS production is key in ajoene induced 
apoptosis in human lymphoma U937 cells (Kelkel et al., 2012), leukaemia HL60 (Dirsch et 
al., 1998) and adipocytes 3T3-L1(Yang et al., 2006b). Thus, garlic derived OSC possibly 
promotes cancer cell oxidative stress condition caused by high ROS levels, to kill cancer 
cells.   
Garlic derived OSC have also been found to enhance intracellular calcium concentration. In 
this regard, DAS and DADS were found to increase intracellular calcium concentrations in 
SW480 colon cancer cells (Chen et al., 2012) and in human glioblastoma T98G and U87MG 
cells (Das et al., 2007). DADS was  found to inhibit the growth of human colon, lung and 
skin cancer by reducing the expression of calcium ATPase activity and consequently 
increasing intracellular calcium levels (Sundaram and Milner, 1996). Similarly, DADS and 
DATS were found to enhance intracellular calcium levels in lung A549 cancer cells 
(Sakamoto et al., 1997). The increase in intracellular calcium levels have been implicated in 
cellular processes such as ER stress (Pyrko et al., 2007a). 
15 
 
ER stress has not been as extensively studied as an OSC mechanism of action as the above 
mentioned intracellular events. However, Certain ER stress markers have been identified in 
garlic OSC treated cells. Increased expression of caspase 4 and Calpain has been observed in 
human glioblastoma T96G and U87MG cells treated with DAS and DADS (Das et al., 2007). 
Subsequently, C/EBP [CAAT/enhancer- binding protein]- homologous (CHOP), glucose 
regulated protein 78/ binding immunoglobulin protein (GRP78/BIP) and caspase 4 have been 
identified in human colon COLO 205 and basal cell carcinoma BCC cell treated with DADS 
(Yang et al., 2009, Wang et al., 2012). More recently, ajoene has been reported to increase 
GRP78/BIP in breast cancer MDA-MB-231 cells (Kaschula et al., 2015). These reports show 
that ER stress is activated by the garlic derived OSC in cancer cells. However none of them 
have demonstrated the role that it plays in OSC induced apoptosis. Furthermore, nothing is 
known about whether ER stress is a secondary or primary response to OSC treatment.  
Although various mechanisms of action have been cited, their relation to the chemical 
structure and intracellular target of garlic OSC is yet to be elucidated.  
1.4   Structure-activity relationships in garlic related OSC’s 
The cytotoxicity of garlic derived OSC in cancer cells is associated with the presence of a 
polysulphide or sulphide group. The potency of these OSC is related to the number of sulphur 
atoms in the backbone of the structure (Xiao et al., 2004) in which various studies have 
shown that the OSC from the least active to the most active against cancer cell growth  is of 
the order:  DAS < DADS < DATS  ajoene (table 1.2) (Scharfenberg et al., 1990, Sundaram 
and Milner, 1996, Sakamoto et al., 1997). Structure-activity studies conducted in our lab with 
ajoene analogues substituted with R1 end-groups demonstrated that the allyl end group is not 
critical in the anti-proliferative activity of ajoene against transformed fibroblast (CT-1), and 
WHCO1 cells (Hunter et al., 2008). In fact, some of the R1-substituted analogues were found 
to be more active than the parent ajoene with the most active analogue being that substituted 
with p-methoxybenzyl at both the R1 and R2 terminal ends (Hunter et al., 2008, Kaschula et 
al., 2011). This compound, designated bisPMB, was found to have enhanced anti-
proliferative activity against breast MDA-MB-231, cervical HeLa, oesophageal WHCO1 and 
Kyse520, and transformed fibroblast cancer CT1 cell lines by 2 - 12 fold relative to the 
natural product Z-ajoene (Kaschula et al., 2011).  
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In a follow up SAR study on bisPMB, the pharmacophore was found to be the disulfide with 
the vinyl group serving to further enhance the activity (see table 1.4) (Kaschula et al., 2012). 
Furthermore, stereoisomerism was found to be important in the cytotoxicity of ajoene with 
the E-stereoisomers being marginally less active than the corresponding Z-stereoisomers 
against WHCO1 or CT-1 cell proliferation (Hunter et al., 2008, Kaschula et al., 2011). 
Additionally, these reports suggest that the anticancer activity of ajoene and ajoene analogues 
may also be governed by certain stereospecific interactions such as in the interactions with 
proteins.  
Table 1.4 IC50 values of ajoene and structural analogues in WHCO1 oesophageal cancer cells.  
 
 
1.5 Mixed disulphide bond formation through OSC induced protein S-thiolation 
Disulfides are considered as thiol oxidising agents able to thiolate cysteine thiols in proteins 
through a mixed disulfide bond. There are specific reports in which garlic derived OSC S-
thiolate cysteine thiols to form mixed disulfides (Gallwitz et al., 1999).  DATS is reported to  
form a mixed disulfide with -tubulin at Cys12β and Cys354β in a cell free in vitro system 
(Hosono et al., 2005) and this is reported to be responsible for the inability of β-tubulin to 
Name Chemical Structure 
WHCO1 








25  2.8 











16  3.7 
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polymerise into microtubules (Li, Carcinogenesis 2002). In addition, ajoene has been shown 
to inhibit the activity of human gastric lipase, which contains a thiol, by forming a mixed 
disulfide bond with the enzyme (Gargouri et al., 1989). An X-ray crystallography study 
demonstrated that a reaction occurs  between the cysteine (Cys58) of glutathione reductase 
(GR) and the vinyl sulfur atom of E-ajoene, in a cell free system to form an S-thiolated 
protein product CH2=CH-CH2-SO2-CH2-CH=CH-S-Cys58-GR (Gallwitz et al., 1999). The 
proposed rationale for mixed disulfide bond formation between a protein and ajoene was 
demonstrated in a model reaction between N-Boc-L-cysteine ethyl ester and the ajoene 
analogue bisPMB (Kaschula et al., 2011). The product of the S-thiolation reaction 
demonstrated regioselectivity of the mixed disulfide reaction with the thiolate nucleophile 
attacking the allyl sulfur of the disulfide (figure 1.4) (Kaschula et al., 2011). The allyl sulfur 
is therefore transferred to the protein during thiolysis, producing alkylated proteins.  
 





Figure 1.4 Proposed rationale of S-thiolation between bisPMB and cellular protein thiols. Sulphur atom 
from a cysteine residue attacks the allyl sulphur of ajoene (demonstrated using bisPMB). The product of this 
reaction is a thiolated protein with the vinyl sulphur as the leaving group. 
 
A combination of both thiol/disulfide exchange reactions with protein cysteine residues in 
conjugation with single electron transfer (SET) processes of the disulfide with production of 
reactive oxygen species (figure 1.5) are proposed to contribute to the cytotoxicity of ajoene in 
cancer cells (Kaschula et al., 2011). 
 
 
                                                                                               
 
 











Until recently, the interaction of garlic derived OSC with prospective protein targets have 
only been illustrated in cell-free systems. In order to identify the intracellular ajoene targets, 
we have recently published data on fluorescently tagged ajoene analogues: dansyl tagged 
(DP) and flourescein tagged (FOX) which were designed & synthesized in our lab (figure 
1.6) and used to track the localization of ajoene within the human breast cancer cell line 
MDA-MB-231 (Kaschula et al., 2015). DP and FOX were found for the first time to localize 
to the endoplasmic reticulum (ER) in these cells (figure 1.7) Based on an S-thiolation 
reaction, ajoene was found to  S-thiolate multiple protein targets in MDA-MB-231 breast 
cancer cells and  this interaction was found to interfere with the folding of newly synthesized 
proteins (Kaschula et al., 2015). Protein aggregation and an increase in protein ubiquitination 
was also observed in MDA-MB-231 breast cancer cells treated with ajoene supporting 















Figure 1.7 Flourescein ajoene (FOX) localises to the ER in MDA-MB 231 breast cancer cells. A) FOX  
ajoene analogue in green transmitting light B) Phase contrast image of MDA MB 231 cells C) ER tracker in red 

















1.6   Endoplasmic Reticulum Stress and the Unfolded Protein Response 
The rough endoplasmic reticulum (ER) is an intracellular organelle and the site for the 
synthesis of secreted and membrane proteins. Newly synthesised polypeptides are targeted to 
the ER by signal sequences (Walter and Johnson, 1994). After entering the ER, post-
translational modification such as N-glycosylation and disulfide bond formation occur to 
stabilize the polypeptides. These polypeptides are then recognized by and bind to ER resident 
molecular chaperones such as protein disulphide isomerase (PDI), GRP78/BIP and glucose 
regulated protein 94 (GRP94) (Wang and Tsou, 1993, Griesemer et al., 2014, Halperin et al., 
2014). The molecular chaperones assist in the folding of polypeptides so that they can acquire 
their native/functional protein conformation. In addition to molecular chaperones, proteins 
are subjected to molecular foldases such as protein disulfide isomerase (PDI) and peptidyl-
prolyl cis-trans isomerase (PPI) (Schiene and Fischer, 2000, Hebert and Molinari, 2007) 
which catalyse the rate limiting reactions occurring during folding which include disulfide 
bond formation and isomerisation of the cis to trans conformation of proline residues in 
protein (Freedman et al., 1994, Schiene and Fischer, 2000). Only properly folded proteins are 
transported to the Golgi apparatus, en route to the extracellular environment and cell 














Figure 1.8 The route of transportation of secretory and membrane proteins from the rough ER to the cell 
membrane via the Golgi apparatus. Newly synthesized proteins in the rough ER are transported by COPII 
membrane vesicles “transport vesicles” to the cis face of the Golgi apparatus and exported through the Trans 
face in secretory vesicles towards the plasma membrane where they are secreted to the extracellular space in 
secretory vesicles. The Picture was taken from; http://en.wikipedia.org/wiki/Golgi_apparatus.  
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Approximately 30 % of newly synthesized proteins in normal eukaryotic cells undergo 
degradation mainly due to unsuccessful folding (Schubert et al., 2000, Goldberg, 2003). In 
the event of an abnormal accumulation of misfolded proteins in the ER, the formation of 
protein aggregates which are highly toxic to cells ensues (Bucciantini et al., 2002, Stefani and 
Dobson, 2003). Cells have evolved to cope with misfolded proteins through the unfolded 
protein response (UPR). The UPR reduces misfolded protein load by (i) attenuating 
translation by stopping protein production, (ii) increasing expression of the protein folding 
machinery to guide the re-folding of misfolded proteins (Takayanagi et al., 2013) and (iii) 
enhancing the degradation of terminally misfolded proteins through ER associated 
degradation (ERAD) (Meusser et al., 2005, Raasi and Wolf, 2007, Walter and Ron, 2011).  
The UPR is orchestrated by three ER transmembrane proteins namely: protein kinase like ER 
kinase (PERK), activating transcription factor 6 (ATF6) and Inositol requiring enzyme-1 
(IRE-1) (Ron and Walter, 2007, Walter and Ron, 2011). Once the ER transmembrane 
proteins are activated, they trigger a cascade of cellular reactions such as phosphorylation of 
eIF2- α resulting in selective translation of ATF4 and other reactions include ATF6 cleavage 
and XBP-1 mRNA splicing by IRE1 (figure 1.9). These molecular events lead to the 
localization of active transcription factors (ATF4, ATF6 and XBP-1s) to the nucleus to drive 
the transcription of molecular chaperones and genes involved in the ERAD process (figure 
1.9).  







Figure 1.9 The events that occur during the Unfolded Protein Response. UPR pathways (IRE1, PERK and 
ATF6) inhibit global protein translation, enhance the transcription of molecular chaperones and foldases and 




In addition, the activation of all UPR transmembrane proteins is regulated by GRP78/BIP 
binding to their ER luminal domain upon an accumulation of misfolded proteins (Shen et al., 
2002, Ron and Walter, 2007). Thus, an increase in GRP78/BIP expression commonly 
indicates ER stress and UPR induction. This increase in GRP78/BIP has been observed in 
garlic derived OSC treated cancer cells. For instance, the increase GRP78/BIP expression 
was reported in DADS treated human colon cancer COLO205 (Yang et al., 2009), DATS 
treated basal cell carcinoma BCC (Wang et al., 2012) and ajoene treated breast cancer MDA-
MB-231 cells (Kaschula et al., 2015).   
1.6.1 The protein kinase like – endoplasmic reticulum kinase (PERK) pathway  
 
PERK is a serine/ threonine kinase that serves as an ER stress sensor and UPR transducer. 
Following an increase in misfolded proteins, PERK undergoes dimerization, trans-
autophosphorylation and activation. Activated PERK phosphorylates and inactivates the 
eukaryotic translation initiation factor 2 alpha (eIF2α), which is required for polypeptide 
synthesis. This results in the attenuation of global protein synthesis (Koumenis et al., 2002). 
Interestingly, phosphorylated eIF2α selectively enhances the translation of several mRNAs 
including activating transcription factor 4 (ATF4) (figure 1.10). The garlic derived OSC 
DATTS was found to upregulate ATF4 expression in human colon HCT 116 cells (Saidu et 
al., 2013)  Genes that are downstream targets of ATF4 include Growth Arrest and DNA 
Damage 34 (GADD34), CAAT/ Enhancing binding protein homologous protein (CHOP), 
Activating Transcription Factor 3 (ATF3), Tribbles Pseudo-Kinase 3 (TRIB3), genes 
involved in protein folding and ERAD (Ma et al., 2002, Teske et al., 2011). The activation of 
these genes suggest that the PERK/ATF4 pathway is cytoprotective and primarily restores ER 
homeostasis through the reduction of ER misfolded protein load. On the other hand genes 
such as CHOP are implicated in ER stress induced apoptosis (Matsumoto et al., 2013). This 
suggested that the PERK/ATF4 pathway is also involved in ER stress induced apoptosis. The 
PERK/ATF4 pathway has also been implicated in crosstalks with other UPR pathways. The 
PERK/ATF4 arm of the UPR pathway has been shown to be essential for the transcription, 
and activation of ATF-6 in mouse embryonic fibroblast (MEF) cells (Teske et al., 2011). In 
contrast, the ATF6 pathway possibly lowers the expression of ATF4 through a negative 




1.6.2 Activating Transcription Factor 6 (ATF6) Pathway 
 
ATF6 is an ER transmembrane protein reported to have two isoforms ATF6α (90kDa) and 
ATF6β (110 kDa). In unstressed cells, the ATF6 protein is bound to GRP78/BIP, an ER 
resident chaperone. However, in response to ER stress, ATF6 dissociates from GRP78/BIP 
and translocates to the Golgi apparatus where it is sequentially cleaved by site 1 protease 
(S1P) and site 2 protease (S2P) (Ye et al., 2000, Shen et al., 2002). The cleaved products of 
ATF6α (50 kDa) or β (60kDa) are bZIP transcription factors that translocate to the nucleus 
and bind to the ATF/cAMP responsive element (CRE) and the ER responsive element 
(ERSE) (Guan et al., 2009, Yoshida et al., 2001g). The most active isoform is ATF6α and its 
activity is reportedly regulated by ATF6β. Glycosylated ATF6β represses the transcriptional 
activity of ATF6α possibly by competing for the promoter binding site (Guan et al., 2009). 
ATF6α has been shown to induce the transcription of GRP78/BIP, PDIA5, XBP-1, CHOP 
and GRP96 in MEF cells (Yamamoto et al., 2007).   
1.6.3 Inositol Requiring Enzyme 1 (IRE1) Pathway 
 
The IRE1 branch of the UPR is the most evolutionary conserved arm and has been 
extensively studied (Mori et al., 2000, Mori, 2009). The mammalian IRE1 homologs are 
IRE1α and IRE1β (Tirasophon et al., 1998, Mori et al., 2000). IRE-1 functions as a sensor for 
ER stress and is a UPR transducer (Mori et al., 2000). Two models have been proposed for 
the activation of IRE1. The first model proposes that inactive monomeric IRE-1 is bound to 
GRP78/BIP which dissociates in response to increased misfolded proteins. The dissociation 
of GRP78/BIP triggers  IRE1  oligomerization and transphosphorylation  (Ron and Walter, 
2007). The second model proposes that direct contact of unfolded proteins in the ER to IRE1 
leads to IRE1 oligomerization and activation (Credle et al., 2005, Gardner and Walter, 2011, 
Walter and Ron, 2011). In both models though, activation is induced by the presence of 
misfolded proteins. Active IRE1 functions as a kinase and endoribonuclease (RNase) 
(Tirasophon et al., 1998, Mori et al., 2000) and exerts its endoribonuclease activity by 
cleaving the mRNA encoding membrane and secretory proteins in a process termed regulated 
IRE1 dependent decay (RIDD).  Additionally, IRE-1 mediates unconventional splicing of 
XBP-1 mRNA in the cytoplasm in response to ER stress, as opposed to conventional splicing 
that occurs in the nucleus (Yoshida et al., 2001a, Calfon et al., 2002, Hirota et al., 2006, 
Iwawaki and Akai, 2006, Uemura et al., 2009). Spliced XBP-1 codes for a transcription 
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factor that has been shown to induce genes involved in protein folding and degradation 
including GRP78/BIP, DNAJ/Hsp40 genes, p58IPK, ERdj4, HEDJ, and EDEM (Lee et al., 
2003a, Hirota et al., 2006). There is a regulatory mechanism which controls XBP-1s induced 
protein degradation, whereby levels of XBP-1s mRNA are reported to progressively decline 
in response to IRE1α inactivation when ER Stress persists and is also regulated through 
ATF6 (Yoshida et al., 2001a, Lee et al., 2003a, Lisbona et al., 2009). Additionally, p53 
upregulated modulator of apoptosis (PUMA) has been suggested to regulate sustained 
activation of IRE-1 through direct interaction in mouse embryonic fibroblasts MEF cells 
(Rodriguez et al., 2012). Together, these reports suggest that IRE-1 is activated in response to 
the accumulation of misfolded proteins, where it activates downstream targets that facilitate 
the transcription of genes involved in protein folding.  
1.6.4 ER stress induced apoptosis 
 
When ER stress persists and the UPR is unable to restore ER homeostasis, apoptosis is 
triggered. The precise mechanisms involved in the UPR switch, from pro-survival to pro-
death in response to ER stress, are not well understood. However, an altering switch between 
autophagy and apoptosis has implicated the expression of ATF4 and CHOP UPR proteins. 
ATF4 is responsible for ER stress induced autophagy and CHOP has been shown to trigger 
the switch to apoptosis in HepG2 cells (Matsumoto et al., 2013). CHOP has been suggested 
to induce apoptosis by enhancing the expression of GADD34, which promotes the de-
phosphorylation of eIF2α leading to enhanced protein translation and ER protein load (figure 
1.10) (Brush et al., 2003, Marciniak et al., 2004). The increase in ER protein load and in 
translation of pro-apoptotic proteins overwhelm the UPR protective processes and triggers 
apoptosis (Sano and Reed, 2013). On the other hand, CHOP has also been shown to repress 
the transcription of Bcl-2, an anti-apoptotic protein (McCullough et al., 2001). This suggests 
that CHOP mediated ER stress induced apoptosis seemingly involves the PERK and the 
mitochondrial-dependent caspase cascade pathways.  
Then again, ER stress associated apoptosis is also linked to UPR via M-Calpain, which is 
activated by caspase 12 (figure 1.10) (Nakagawa and Yuan, 2000). Crosstalks between the 
JNK and IRE-1 signalling pathway have also been shown to be implicated in apoptotic 
induction (figure 1.10). The cytoplasmic domain of IRE-1 is reported to recruit and interact 
with the tumour necrosis factor receptor associated factor 2 (TRAF2) and apoptosis signal-
regulated kinase-1 (ASK-1), and this recruitment is regulated by the c-Jun NH2 terminal 
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inhibitory kinase (JIK). The TRAF2/ASK complex then phosphorylates and activates c-Jun 
kinase (JNK) (Nishitoh et al., 2002). The JNK/MAPK substrates include transcription factors 
such as c-Jun, c-Fos, ATF-2, AP-1, p53 and Elk (Hibi et al., 1993, Minden et al., 1994, 
Whitmarsh et al., 1995). JNK/MAPK is also reported to phosphorylate members of the Bcl-2 
family such as BCL2 and BIM (Lei and Davis, 2003, Wei et al., 2008). Consequently, the 
JNK pathway promotes cellular death by enhancing the expression and activation of proteins 
involved in apoptosis in response to stress stimuli (figure 1.10).  These reports support ER 
stress mediated apoptosis occurring via CHOP, caspase 12 and JNK/MAPK pathway 
activation. 
 
Figure 1.10 Pathways involved in ER stress induced apoptosis. CHOP expression is up-regulated by UPR 
pathways. CHOP down-regulates bcl-2 and promotes the transcription of GADD34 and ERO1. GADD34 and 
ERO1 exacerbate ER stress by promoting protein synthesis and disrupting redox homeostasis respectively. 
Activated IRE1 forms a complex with JIK, TRAF2 and ASK1 leading to the phosphorylation of JNK. TRAF2 
dissociation from pro-caspase 12 (pCP12) and activated m-Calpain activates pCP12 leading to subsequent 
activation of caspase 9 and 3. Bcl-2 family proteins BAK and BAX oligomerise in the ER membrane to permit 
the movement of calcium form the ER to the cytosol. The increased intracellular calcium levels activate m-
Calpain and diffuse into the mitochondria, disrupting the mitochondrial membrane potential and cytochrome c 





1.6.5 Cross-talk between the p38 and MEK/ERK and the  ER stress/UPR pathways  
 
Apart from the IRE1/JNK signalling pathway, UPR pathways have been reported to interact 
with other MAPK signalling pathways which include p38 and the MEK/ERK pathways. 
Recently, accumulating evidence has shown that intracellular stress signals such as ER stress 
can activate the MAPK pathways (Darling and Cook, 2014). 
The UPR pathway transmembrane proteins are also reported to be activated both upstream 
and downstream of MAPK (figure 1.11) (Darling and Cook, 2014). Once triggered, the 
MAPK pathways are activated through sequential phosphorylation/activation of a three tiered 
signalling cascade composed of protein kinases MKKKs, MKKs and MAPK (figure 1.11) 
(Yang et al., 2013, Darling and Cook, 2014). 
.  
Figure 1.11 Activation of the three tiered MAPK signalling cascade and points of interaction with the 
UPR pathways (red). The three tired signalling cascade consists of the MKKKs (blue), the MKK (green) and 
the MAPK (black). The MEK/ERK MAPK signalling cascade is activated by growth factors, hormones and 
intergrins and the UPR. The p38 and JNK MAPK signalling cascade are activated by pro-inflammatory 
cytokines and extracellular stress signals. JNK is also activated through the IRE1 pathway and p38 
phosphorylates CHOP (Darling and Cook, 2014).    
 
Under ER stress conditions, the IRE-1 pathway potentiates cell survival by activating the 
MEK/ERK pathway (Nguyen et al., 2004). For instance, ER stress induced IRE-1 is reported 
to dissociate from adaptor protein non catalytic region of tyrosine kinase (Nck) and activate 
ERK1/2 (Nguyen et al., 2004). Once activated, ERK1/2 phosphorylates/activates various 
transcription factors such as fos, elk1 and p53, cytoskeletal elements and components of 
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MAPK pathway (Pritchard and Hayward, 2013). Since the MEK/ERK pathway promotes cell 
survival, the IRE-1 activated MEK/ERK pathway may also promote cell survival.  
The p38/MAPK belongs to the stress activated protein kinase family; it is activated by 
inflammatory cytokines, irradiation, heat shock, stress inducing chemical agents and also by 
ER stress (Obata et al., 2000, Ranganathan et al., 2006, Cuenda and Rousseau, 2007, Yang et 
al., 2013). The substrates of p38/MAPK include the MAP kinase activated protein kinase 2 
(MAPK) interacting kinase 1 (Mnk1), MAPK interacting kinase 1 (Mnk2) and components of 
the ER stress pathways such as activating transcription factor 6 (ATF6), Nrf2, c-Jun, XBP-1 
and CHOP (Cohen, 1997, Ben-Levy et al., 1998, Thuerauf et al., 1998, Ma and Hendershot, 
2004, Ranganathan et al., 2006). Several studies have suggested that CHOP is phosphorylated 
by p38 at the trans-activation sites (Wang and Ron, 1996, Darling and Cook, 2014). The 
transcriptional activity of ATF6 is reported to be enhanced by phosphorylation with 
p38/MAPK in myocardial cells, promoting the transcription of GRP78/BIP (Thuerauf et al., 
1998). On the one hand, the p38/MAPK pathway has also been shown to be activated 
downstream of the PERK/ATF4 UPR pathway. There is therefore evidence that the 
p38/MAPK pathway is activated both upstream and downstream of ER stress induction, 
interacting with various components of the ER stress and UPR pathways. 
1.6.6 ER Stress and UPR in cancer therapy 
 
The pro-survival function of ER stress and UPR pathways render it a good target for cancer 
therapy as it has been implicated in promoting malignancy (Yadav et al., 2014). For example, 
UPR cytoprotective pathways have been shown to significantly alter cellular transformation 
and progression of multiple myeloma, hepatocellular carcinoma, gastric cancer and breast 
cancer (Song et al., 2001, Shuda et al., 2003, Carrasco et al., 2007, Papandreou et al., 2011). 
In triple negative breast cancer cells,  hetero-dimerization of XBP-1 with hypoxia-inducible 
factors 1 alpha (HIF1α)  has been shown to regulate the transcription of HIF1α target genes, 
which promote tumour progression (Chen et al., 2014). Suggesting that activation of the 
unfolded protein response and ER stress may offer a potential chemotherapeutic target.  
The pro-death function of ER stress and UPR pathways plays a major role in enhancing 
cancer therapy (Yadav et al., 2014). The UPR is commonly quiescent in normal cells, 
whereas cancer cells are exposed to stress stimuli including proteotoxic stress, metabolic 
stress, hypoxia and nutrient starvation and therefore have latent adaptive UPR activity (Pyrko 
27 
 
et al., 2007b, Hersey and Zhang, 2008, Luo et al., 2009). The latent UPR activation in cancer 
cells predisposes them to apoptosis when treated with agents that elevate misfolded protein 
load, as these agents overwhelm the UPR adaptive signals and trigger apoptosis. As a result, 
the UPR and ER stress pathways have been implicated in a number of chemotherapeutic 
approaches (Boelens et al., 2007). For example, photo sensitizer photodynamic therapy (PS 1 
PDT), which is used for treatment of various cancers, is reported to induce apoptosis via the 
ER stress pathway (Li et al., 2015). Therefore activation of the unfolded protein response and 
ER stress is an attractive potential chemotherapeutic target.  
Thapsigargin (TG) is a well established ER stress inducer used as a positive control in this 
study (Andersen et al., 2015) and is a natural product obtained from the roots and fruits of 
wild thapsia garganica. TG (figure 1.12) is known to induce ER stress by inhibiting the 
sarcoplasmic reticulum Ca2+ ATPase (Thastrup et al., 1990, Treiman et al., 1998a). At high 
concentrations, TG is cytotoxic in cancer cells. Accordingly, TG has been shown to induce 
apoptosis in human prostatic carcinoma TSU and rat prostate cancer cell lines by increasing 
intracellular calcium concentrations (Tombal et al., 2000). Emerging evidence suggests that 
thapsigargin based pro-drugs have potential as anticancer agents in humans (Denmeade et al., 
2003) (Denmeade et al., 2003) with the pro-drug currently being on phase II human clinical 






Figure 1.12 Chemical structures of Thapsigargin.  
 
Other ER stress and UPR stress inducing agents that are in human clinical trials or FDA 
approved for cancer therapy, include proteosome inhibitors, HSP90 inhibitors and ER stress 
inducers (Li et al., 2011). Proteosome inhibitors included Boterzomib, salinosporamide A, 
Carfizomib, PS-341, CEP- 18770 (San Miguel et al., 2008, O'Connor et al., 2009, Chauhan et 
al., 2010, Lee et al., 2010). HSP90 inhibitors included Retaspimycin (Heath et al., 2008, 
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Hanson and Vesole, 2009, Richardson et al., 2010, Pacey et al., 2012). Delta (9)-
Tetrahydrocannabinol (THC) is on phase I clinical trials, exerts its anticancer activity against 
glioblastoma multiforme and is classified as an ER stress inducer (Guzman et al., 2006).  
Furthermore, chemotherapeutic drugs commonly used for oesophageal cancer such as 
cisplatin and paclitaxel have been reported to induce ER stress in human melanoma 224, 
colon cancer HCT 116 cell lines and neuroblastoma SK-N-SH (Mandic et al., 2003, 
Tanimukai et al., 2013, Xu et al., 2014).  
Thus, from the aforementioned reports it can be said that ER stress and UPR may be targeted 
in cancer therapy using two different approaches. Anticancer drugs that inhibit UPR in cancer 
cells can abrogate the adaptation of cancer cells to stressful environment leading to cancer 
cell death. Alternatively, the induction of ER stress by anticancer agents can overwhelm pro-
survival UPR activity in cancer cells and trigger cell death. Either way, ER stress and UPR 
targeting agents possess great potential as anticancer drugs.  
1.7   PROJECT OUTLINE  
In the study conducted by Kaschula et al., (2015); the ER was identified as the intracellular 
target for ajoene. On a chemical level, ajoene was shown to S-thiolate multiple protein targets 
through mixed disulfide formation in cancer cells. This was found to lead to an accumulation 
of misfolded protein aggregates. This thesis plans to build on these findings by elucidating 
whether ER stress and UPR are central to the cytotoxicity of bisPMB in oesophageal cancer 
cells. We further present a potential new candidate for OS chemotherapy, bisPMB.  
1.7.1 Hypothesis 
 
The ajoene analogue bisPMB induces cytotoxic activity in WHCO1 cells by activating the 
UPR and MAPK pathway. 
1.7.2 Study Objectives 
2 To determine whether bisPMB affects proliferation, cell cycle progression and induces 
apoptosis in WHCO1 cells 
3 To investigate the effect of bisPMB on global gene transcription in WHCO1 cells.  








BisPMB (figure 2.1 A), a R1 and R2 para-methoxybenzyl substituted ajoene (figure 2.1 B) is 
more active than Z-ajoene against oesophageal squamous cell carcinoma WHCO1 cells 
(Hunter et al., 2008, Kaschula et al., 2011, Kaschula et al., 2012). BisPMB also demonstrated 
selectivity for cancer cells including CT1, PC3, MDA-MB-231 and WHCO1 oesophageal 
cancer cells over the WI31, PNT1A, MCF12A and EPC2 normal cell counterparts (Kaschula 
et al., 2011). The greatest bisPMB selectivity and activity was observed against oesophageal 
cancer WHCO1 cells making it an attractive compound for OS cancer (Kaschula et al., 2011). 
Therefore, we investigated the mechanism of action of bisPMB against the WHCO1 
oesophageal cancer cell line. 
In addition to the anti-proliferative effect of ajoene against cancer cell lines, it has been also 
shown to induce a G2/M cell cycle arrest and apoptosis. Given that bisPMB is a synthetic 
analogue of ajoene and the two compounds share a common pharmacophore (Kaschula et al., 
2011, Kaschula et al., 2012, Hunter et al., 2008), it is possible that bisPMB acts via the same 






                                                                            
Figure 2.1 The Chemical structures of E/Z bisPMB and its parent compound E/Z ajoene represented as isomeric 
mixtures. The substituted R1 and R2 p-methoxybenzyl end groups are highlighted in red. 
 






2.1.1 Overall strategy and experimental approach 
 
In this chapter, different biochemical techniques were used to characterize bisPMB induced 
cytotoxicity in oesophageal cell lines. We determined the 24 h IC50 concentrations required to 
inhibit growth of three oesophageal cancer cell lines to include; WHCO1 and WHCO6 of 
South African origin and were gifted to our lab by Prof Robin Veal from Witwatersrand 
University and KYSE30 of Japanese origin. KYSE30 cell line was purchased from the 
German Resource Center for Biological Material, DSMZ GmbH (Braunschweig, Germany). 
In addition, the 24 h IC50 of the Het-1A cell line (ATCC® CLR-2692™), a normal 
oesophageal epithelial cell line of American origin transformed with the SV-40 T-antigen 
was determined. Het-1A cell (ATCC® CRL2692™) was purchased from the American Type 
Culture Collection (ATCC), Mannasas, USA. We then investigated the time-dependent effect 
of bisPMB on WHCO1 cell proliferation, cell cycle progression, apoptosis and secondary 
necrosis/ late-stage apoptosis.  
2.2   RESULTS 
2.2.1 The effect of bisPMB on WHCO1 cell viability   
 
In order to investigate the effect of bisPMB on WHCO1 cell viability, the colorimetric water 
soluble tetrazolium salt WST (4-[3-(4-lodophenyl-2-(4 nitrophenyl)-2H-5-tetrozolio]-1,3-
benzene disulfonate) based assay was performed as described in section 6.2.1. The WST 
assay indirectly quantifies cell proliferation by quantitating the formation of formazan dye 
from the cleavage of the WST tetrazolium salt by the mitochondrial dehydrogenase in viable 
cells. The WST assay is similar to the MTT assay except its formazan product is soluble as 
opposed to the insoluble formazan crystals produced by MTT cleavage. 
Our results demonstrated that 0.1% DMSO is not cytotoxic to WHCO1 cells, as the cell 
viability profile was similar to the media only control (figure 2.2). Furthermore, the loss of 
WHCO1 cell viability was significantly higher in cells treated with 10 µM bisPMB compared 
to 1 µM bisPMB or untreated controls (figure 2.2). In addition 1 µM bisPMB had no effect 
on WHCO1 cell viability, with a profile similar to untreated controls.  A time-dependent 
effect was seen in which WHCO1 cells treated with 10 µM bisPMB for 48 h (p = 0.0004) and 
24 h (p = 0.034) time points, with the significantly enhanced reduction in cell viability when 
observed in the 48 h treated WHCO1 cells (figure 2.2). This data demonstrated 10 µM 
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Figure 2.2 Time and concentration dependent inhibitory effect of bisPMB on WHCO1 cell viability. 
WHCO1 cells were incubated with 1 μM (purple) or 10 μM (red) bisPMB in 0.1% DMSO or 0.1% DMSO alone 
(green) or media alone (black) for up to 48 h. The WST assay was conducted as described in section 6.2.1. An 
absorbance value of 450 nm with the reference of 620 nm was used to read the photometric signal. Each point is 
an average   SD of three independent experiments. A student t-test was statistical analysis was performed using 
GraphPad Prism, * indicated p < 0.05 and**** indicated p <0.0001 
 
2.2.2 Cytotoxicity of bisPMB in different oesophageal cancer and normal cell lines 
 
To compare the effect of bisPMB on different oesophageal squamous cell carcinoma cell lines 
and a normal cell line (described in section 6.1.1), we quantified this effect by determining 
bisPMB’s 50% inhibitory concentration (IC50). The IC50 was used as a quantitative measure of 
the effectiveness of bisPMB at inhibiting cell proliferation using the MTT assay as described 
in section 6.2.2. The MTT assay indirectly quantifies cell proliferation by measuring the 
formazan produced from the cleavage of the MTT tetrazolium salt in metabolically active cells 
at A595nm, thus measuring cell viability. To interpret results obtained from this assay, it is 
assumed that higher cell numbers are directly correlated with high cell viability. 
From the dose response curves cell viability was defined as absorbance at 595nm against log 
[bisPMB], the IC50 value was calculated for WHCO1, WHCO6 and KYSE30 and Het-1A cells 
(figure 2.3) as described in section 6.3.2. It was found that cell viability decreased with 
increasing bisPMB concentration, with the 7 µM, 14 µM and  3.5 µM concentrations displayed 
on the WHCO1 graph. As expected the 7 µM correlated with 50 % cell viability, the  14 µM 
displayed 27 % cell viability and the 3.5 µM concentration resulted in 81 % cell viability (table 





























2.1). This demonstrated that the 3.5 µM concentration was the least toxic concentration and14 
µM displayed high cytotoxic levels in WHCO1 cells.  
The average of three independent determinations of 24 h IC50’s obtained for cell lines 
WHCO1, WHCO6, KYSE30 and Het-1A are displayed in Table 2.1. As can be seen, the 
bisPMB IC50 concentrations observed for the WHCO1 and WHCO6 cell lines were found to be 
similar being 6.97   0.08 µM and 6.70   1.64 μM respectively (Table 2.2). Furthermore, 
bisPMB was found to be marginally although significantly (1.2 fold) more active in WHCO1 




Figure 2.3 Dose response curves used for 24 hour IC50 determination in WHCO1, WHCO6, KYSE30 and 
Het-1A cells. Oesophageal cell lines were incubated with varying concentrations of bisPMB for 24 hours and 
subjected to an MTT assay as described in section 6.2.2. The bisPMB concentration (µM) is log transformed and 






















































































Table 2.1 Average percentage WHCO1 cell viability for three bisPMB concentrations. The average of the 
percentage WHCO1 cell viability   SD was calculated from the dose response curves of three independent 
determinations.  
BisPMB Concentration Percentage WHCO1 cell viability  SD 
3.5 µM 79  5 
7 µM 50  3 
14 µM 27  6 
 
 
Table 2.2. 24 h IC50 values (µM) with   SD from bisPMB-treated oesophageal cell lines, obtained using the 
MTT assay. Average IC50 values of three independent biological replicates. 
CELL LINE AVERAGE IC50  SD  μM 
WHCO1 6.97  0.08 
WHCO6 6.70  1.64 
KYSE30 8.09  0.06 
HET-1A 33.7  2.15 
 
The bisPMB IC50 concentration on the non-cancer epithelial cell line Het-1A was found to be 
33.7   2.15 μM (Table2.2).  This indicated that bisPMB displayed 5 fold increased 
cytotoxicity in WHCO1 cells compared to the Het-1A cells. These findings demonstrated that 
bisPMB had a similar inhibitory effect on the proliferation of the different oesophageal 
cancer cell lines, and selectivity for cancer over the Het-1A normal oesophageal cell line.  
For the purposes of this study, we used the 3.5 µM, 7 µM and14 µM bisPMB concentration 
values obtained from the WHCO1 cells to investigate the molecular mechanisms of action of 
bisPMB in oesophageal cell lines. These concentrations would provide insight into the 
molecular response of oesophageal cancer cells to different cytotoxic concentrations of 
bisPMB. Furthermore, we chose WHCO1 cells as the model cell line for further experiments. 
2.2.3 Effect of bisPMB on WHCO1 cell morphology 
To evaluate the effect of bisPMB on cell morphology, WHCO1 cells were treated with 24 h 
3.5 µM, 7 µM and14µM bisPMB concentrations and images of the treated cells were captured 
with an Olympus SC30 camera as described in section 6.1.6.  
The untreated WHCO1 cells displayed a multinucleated morphology (figure 2.4A). The 
WHCO1 cells treated with 3.5 µM bisPMB concentration for 24h displayed similar 
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morphological characteristics to the untreated cells (figure 2.4B). However the morphology 
of WHCO1 cells treated with 7 µM appeared flat, rounded and contained vacuole like 
structures in the cytoplasm (figure 2.4C). The WHCO1 cells treated with 14 µM appeared 
round and shrunken, but also had membrane bound sac like structures (figure 2.4D).  
    
 
Figure 2.4 Morphological changes of WHCO1 cells treated with increasing concentrations of bisPMB. 
Images for WHCO1 cells were captured using a phase contrast image with an Olympus SC30 camera. (A) 
Untreated WHCO1 cells, (B) WHCO1 cells treated with bisPMB at 3.5 µM, (C) 7 µM and (D)  14 µM 
concentration at 10   magnification. The inserts in C and D show cells with membrane bound sacs. 
2.2.4 Effect of BisPMB on the Cell Cycle 
In order to determine whether bisPMB has any effect on the cell cycle progression in 
WHCO1 cells, flow cytometry using propidium iodide staining was performed as outlined in 
section 6.5. BisPMB was found to induce a concentration dependent G2/M cell cycle arrest in 
WHCO1 cells (figure 2.5). The untreated cell cycle profile of WHCO1 cell cells displayed a 
greater population of cells at the G0/G1 than the S and G2/M phase (figure 2.5A). The cell 
cycle profile of WHCO1 cells treated with       was similar to the untreated control (figure 
2.5 B). The 7 µM (figure 2.5 C) and 2 7 µM (figure 2.5 D) bisPMB concentrations 
demonstrated a 3.8 (p < 0.001) and 3.3 (p < 0.001) fold increase respectively in the number of 
cells in the G2/M phase compared to the untreated control. The number of cells at the G0/G1 
phase of the cell cycle were found to decrease by 5.7 (p < 0.001  and 3.6 (p < 0.001) fold in 
















to untreated control. Additionally, we observed a 1.6 and 20 fold increases in cells occupying 
the SubG1 peak in WHCO1 cells treated only with the higher 7 µM and  14 µM 
concentrations respectively (table 2.2). Therefore evidence from both morphology & cell 
cycle support the cell viability data that suggests that bisPMB is cytotoxic toWHCO1 cells at 



















Figure 2.5.  The cell cycle profile of WHCO1 cells treated with increasing concentrations of bisPMB. Cell 
cycle analysis of (A) Untreated WHCO1 cells, (B) WHCO1 cells treated with bisPMB at       , (C) 7 µM and 
(D) 14 µM of bisPMB with subG1 peak was performed by flow cytometry using propidium iodide staining as 
described in section 6.5. The x-axis indicates the amount of fluorescence and the y-axis the number of cells. 














Table 2.2 Cell cycle analysis of WHCO1 cells treated with bisPMB. Average percentage ± SD of 3 
independent experiments of WHCO1 cell populations treated with       or 7 µM or 14 µM bisPMB for 24 h. 
 
BisPMB (μM) Sub- G1 (%) G0/G1 (%) S   (%) G2M (%) 
Untreated 0 44.5   3.5 39.8  1.2 15.7 ± 2.4 
       0   44.1   2.9    34.9  3.1   26.9 ± 5.4 
7 µM 1.61    7.7   2.7  31.8 ± 3.4   60.0 ± 6.8 
14 µM 19.9 ± 8.4 
 
   12.3  2.2 36.2 ± 6.5 
 
51.5 ± 5.0 
 
 
2.2.5 BisPMB induces apoptosis in WHCO1 but not in Het-1A oesophageal cell lines at 
the concentrations used. 
 
Apoptosis is defined as programmed cell death and is characterised by biochemical changes 
which is known to include internucleosomal genomic DNA fragmentation. In order to 
determine whether bisPMB induced apoptosis in WHCO1 or Het-1A cells, histone-associated 
DNA fragments (mono and oligonucleosomes) were quantified in the cytoplasm after 
treatment using the Roche cell death ELISA kit. Briefly, WHCO1 or Het-1A cell lysate was 
sandwiched between anti-histone and anti-DNA conjugated to horseradish peroxidise (HRP) 
antibodies in streptavidin coated multiwell plates. The histone associated DNA fragments 
were then photometrically quantified using the colour development from the HRP substrate 
ABTS (2,2'-Azinobis [3-ethylbenzothiazoline-6-sulfonic acid]-diammonium salt). The 
absorbance value obtained correlated with the amount of histone associated DNA fragments, 
indicating apoptosis.  
We observed a 1.2, 1.8 and 3 fold increase in the induction of apoptosis in WHCO1 cells 
treated with       , 7 µM and 14 µM bisPMB concentrations respectively over a 24 h period 
and compared to the untreated control (Figure 2.6A). This result demonstrated the ability of 
bisPMB to induce apoptosis in WHCO1 cells, in a concentration dependent manner.  
However, no apoptotic induction in Het-1A cells treated with the same bisPMB 
concentrations was observed (figure 2.6B). Thus, the 7 µM and the  14 µM concentrations of 
bisPMB induced membrane blebbing, an increase in sub-G1peak and histone associated DNA 




















Figure 2.6.   Induction of apoptosis in WHCO1 and Het-1A cells by bisPMB. WHCO1 cells or Het-1A cells 
were incubated with bisPMB at       or 7 µM or 14 µM for 24 h, and apoptosis was quantified by measuring 
histone associated DNA fragments in the cytoplasm. A)  WHCO1 cells and (B) Het-1A. An absorbance value of 
405 nm with the reference of 492 nm was used to read the photometric signal, measuring cell apoptosis. Each 
bar represents the mean absorbance   SD of two independent experiments. Student t-test and one way ANOVA 
statistical analysis were performed using GraphPad Prism, ****indicated p <0.0001. 
2.2.6 The effect of bisPMB on cell membrane integrity. 
 
To further examine the cytotoxicity of bisPMB in WHCO1 cells, the lactate dehydrogenase 
(LDH) activity assay was detected in cells undergoing late stage apoptosis/secondary 
necrosis. This assay quantifies the activity of the LDH expelled from the cytoplasm of cells 
as a result of a damaged plasma membrane. 
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WHCO1 cells in media or 0.1% DMSO alone served as negative controls for this study. We 
demonstrated that 0.1% DMSO does not have a cytotoxic effect on WHCO1 cells, as there 
was no change in LDH activity in the cytoplasm of these cells over a 48 h period compared to 
the media only sample. Furthermore, our results indicate that 10 μM bisPMB increased LDH 
released by WHCO1 cells after 48 h (Figure 2.7). In contrast, 1 μM bisPMB did not damage 
WHCO1 cell membrane integrity, as we observed no change in LDH activity, even after 48 h 
of treatment (Figure 2.7).  
 


























Figure 2.7 Time and concentration dependent cytotoxic effect of bisPMB on WHCO1 LDH release.  
WHCO1 cells were incubated with 1 μM (red) or 10 μM (purple) bisPMB, 0.1% DMSO (green) or  media alone 
(black) for 3, 6, 24 and 48 h. LDH activity released from the cells was measured. An absorbance value of 
450nm with the reference of 620nm was used to read the photometric signal, measuring cell cytotoxicity. 
 
2.3 DISCUSSION 
The compound bisPMB contains the same vinyl disulfide pharmacophore as ajoene. 
However, para-methoxybenzyl substitution at the terminal ends was found to enhance the 
potency of ajoene against WHCO1 cell proliferation (Hunter et al., 2008, Kaschula et al., 
2011, Kaschula et al., 2012). Kaschula et al., (2011) reported the inhibition of  breast cancer 
MDA-MB-231 and SiHa, cervical HeLa, oesophageal cancer WHCO1 and Kyse520 and 
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transformed fibroblast CT1 cell proliferation by Z-ajoene and bisPMB with the 48 IC50 range 
of 13.7 – 42.1 µM for Z-ajoene and 1.4 – 13.8 µM for bisPMB. BisPMB displayed the 
greatest improvement of ajoene antiproliferative activity against oesophageal cancer WHCO1 
cells with 12 fold enhancement (Kaschula et al., 2011). Thus, this study focused on bisPMB 
cytotoxic activities against WHCO1 cells. Here we demonstrated that bisPMB inhibited 
proliferation of three different oesophageal cancer cell lines with 24 hour IC50’s in the range 
of 6.7 – 8.09 µM. The 24 hour IC50 values for cisplatin treated oesophageal cancer cell lines 
TE-2 and TE-13 is 37.5 and 56.3 µM respectively (Tanaka et al., 2010). This implied that 
bisPMB is more potent than the clinically used drug cisplatin against oesophageal cancer 
cells. Suggesting that bisPMB could be a good candidate for OC therapy. 
We also observed that the inhibition of WHCO1 cell viability increased following treatment 
with 10 µM bisPMB from 24 h to 48 h. This suggested that bisPMB inhibitory effect was 
also time dependent.  In line with this, ajoene is reported to inhibit the proliferation of Burkitt 
lymphoma BJA-B, glioblastoma multiforme cancer stem cells (GBM CSC), breast MDA-
MB-231, pancreatic adenocarcinoma PANC1, lung adenocarcinoma A5949, colon HT29 and 
cervical cancer Hela cells (Scharfenberg et al., 1990, Li et al., 2002a, Ye et al., 2005, Taylor 
et al., 2006, Jung et al., 2014, Kaschula et al., 2011)   
The anti-proliferative activity of ajoene may be attributed to its ability to block cell cycle 
progression. BisPMB was found to induce a G2/M cell cycle arrest in WHCO1 cells in a 
concentration dependent manner. This result is consistent with the reports that ajoene blocks 
the cell cycle progression of HL-60 and U937 cells at the G2/M phase (Li et al., 2002a, Xu et 
al., 2004, Ye et al., 2005). BisPMB induced cell cycle arrest can be linked to the disruption of 
microtubule network which has been shown for Z-ajoene treated normal marsupial kidney 
Ptk2 cells (Li et al., 2002a). Our FACS cell cycle analysis also revealed that bisPMB induced 
a concentration dependent increase in subG1 peak in WHCO1 cells which is indicative of 
cells undergoing apoptosis and has also been observed in HL60 cells treated with ajoene 
(Dirsch et al., 1998).  
Apoptosis is widely implicated in the anticancer activities of chemotherapeutic drugs. Further 
analysis showed that bisPMB induced apoptosis in WHCO1 cells following a 24 h treatment 
at both 7 µM and 14 µM, where both concentrations induced a rounded up and shrunken 
WHCO1 cell morphology. These morphological features resembled the characteristics 
apoptotic cells that include; cell shrinkage, membrane blebbing and loss of cell membrane 
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integrity (Sen and D'Incalci, 1992, Green and Kroemer, 2004). Subsequently, we 
demonstrated that WHCO1 cells displayed a concentration dependent increase of histone-
associated DNA fragments indicative of apoptosis when treated with 7 µM and 14 µM 
concentrations of bisPMB. This agrees with data in the literature where ajoene was found to  
induce apoptosis in leukaemia HL-60 (Dirsch et al., 1998) and basal cell carcinoma BCC 
cells (Tilli et al., 2003) in a concentration dependent manner. Furthermore, Z-ajoene was 
found to trigger apoptosis in leukaemia HL-60 and U937 (Li et al., 2002a, Li et al., 2002o) 
After the induction of apoptosis, secondary necrosis is initiated in cells (Saraste, 1999). This 
event is sometimes referred to as late-stage apoptosis and is characterized by the loss of cell 
membrane integrity (Patel et al., 2005). Cells with damaged cell membranes release 
intracellular enzymes such as LDH and this is an indication of late stage apoptosis (Kaja et 
al., 2015). We observed that bisPMB triggered a time and concentration-dependent increase 
in LDH activity in WHCO1 cells, which was apparent after 48 hours. As expected, this 
finding suggests that LDH released by WHCO1 cells treated with bisPMB occurs at a later 
stage to inhibition of viability and apoptosis induction where an effect is seen at 24h, which is 
suggestive of damaged WHCO1 cell membrane integrity. The observed secondary necrosis 
may not be a phenomena that bisPMB induces in vivo and may have been a consequence of 
the limitations in in vitro cell culture technique, as cells undergoing apoptosis are not cleared 
by macrophages resulting in their intracellular contents are expelled into the media 
(Hochreiter-Hufford and Ravichandran, 2013). Moreover, this observation is consistent with 
reports that show that ajoene triggered the release of LDH in A549 lung cancer cells in a 
concentration dependent manner with an EC50 of 200 µM (Jakobsen et al., 2012).This 
demonstrated that bisPMB cytotoxic activity was superior to that of ajoene as LDH release 
was observed at 10 µM in WHCO1 cells. 
We also observed that bisPMB was approximately five fold more active at inhibiting 
WHCO1 cancer cell proliferation compared to the normal oesophageal epithelial (Het-1A) 
cell line. In addition, no apoptosis was observed in Het-1A cells treated with the same 
bisPMB concentration as in WHCO1 cells. This demonstrated that bisPMB was less 
cytotoxic to non-cancer cell lines and is in agreement with  the reported three fold selectivity 
of bisPMB against the normal esophageal epithelial cells (EPC2) (Kaschula et al., 2011), 
although the effect with HET-1A cells was more dramatic. The Het-1A cell line is 
transformed with the SV-40 large T-antigen, which binds and inactivates p53 (tumour 
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suppressor), rendering it having tumour features. Unlike the Het-1A cells, the EPC2 cells 
have a functional p53 (tumour suppressor) and are immortalised with human telomerase 
reverse transcriptase (Harada et al., 2003). However, both Het-1A and EPC2-hTERT have 
been reported to have tumour like characteristics; EPC2-hTERT cells have been reported to 
yield basal cell hyperplasia in an organotypic tissue culture system, while Het-1A cells have 
been demonstrated to possess a dysplastic appearance (Harada et al., 2003, Underwood et al., 
2010). The Het-1A cell line was chosen as a “normal” model cell line in this chapter because 
it was available in the lab, it’s easier to work with and is cultured with the same media 
(DMEM) as the cancer WHCO1 cells, thus the experimental data is more comparable to that 
of WHCO1 cells. Other reports have shown selectivity of ajoene for cancer over non-cancer 
cell lines. Ajoene has been shown to be two fold more active in Burkitt lymphoma (BJA) 
than the normal baby hamster (BHK21) cells  (Scharfenberg et al., 1990). Similarly, normal 
marsupial kidney cells (Ptk2) were less sensitive to ajoene cytotoxic activity than the 
promyeloleukemia (HL-60) and nasopharyngeal carcinoma (KB) cell lines (Li et al., 2002a). 
Similarly, marsupial Ptk2 cells and the primary fibroblast FS4 cells were found to be less 
sensitive to ajoene than cancer cell lines (Dirsch et al., 1998, Scharfenberg et al., 1990, Li et 
al., 2002o). Furthermore, ajoene has been shown to induce apoptosis in human leukaemia cell 
line, but it did not induce apoptosis in peripheral mononuclear blood cells (Dirsch et al., 
1998).  
Our results on bisPMB are consistent with published data on cytotoxicity of ajoene in cancer 
cells. It is evident from our data that bisPMB is cytotoxic to WHCO1 cells although the mode 
of action and molecular mechanisms underlying these events are still unknown. In order to 
further our investigation into the molecular mechanisms leading to the apoptotic effect of 
bisPMB, we performed a DNA microarray in WHCO1 cells treated with bisPMB at         
concentration. The 3.5 µM concentration was selected as we had already confirmed that this is 
a   non–toxic concentration to WHCO1.  
Since bisPMB displays excellent cytotoxic activity against OC cancer cells lines and in 
addition has a longer shelf life, as unpublished nuclear magnetic resonance spectroscopy 
(NMR) data did not show any decomposition of the compound after 3 years of storage and 
therefore it is easier to work with than ajoene, we decided to probe into the mechanism leading 




CHAPTER 3: TRANSCRIPTIONAL PROFILING OF 
WHCO1 OESOPHAGEAL CANCER CELLS TREATED 
WITH BISPMB 
 
3.1  INTRODUCTION 
In chapter 2 we observed the cytotoxic effects of bisPMB in the oesophageal squamous cell 
carcinoma (WHCO1) cell line. This observation was consistent with the cytotoxicity reported 
for ajoene on various cancer cell lines which include human leukaemia HL-60 (Dirsch et al., 
1998), nasopharyngeal KB, cervical Bel-780, colon HCT, gastric BGC-823 and breast MCF-
7 cancer (Li et al., 2002a) and breast cancer MDA-MB-231 and SiHa, oesophageal cancer 
WHCO1 and Kyse520, transformed fibroblast CT1 and cervical HeLa cell lines (Kaschula et 
al., 2011). The focus of this chapter is on the mechanistic events leading to the cytotoxicity of 
bisPMB in WHCO1 cancer cells.  
Although not widely reported, there is emerging evidence that garlic derived OSC may be 
implicated in ER stress. More specifically, both DADS and DATS are reported to trigger ER 
stress associated apoptosis in colon cancer COLO 205 cells and basal cell carcinoma BCC 
cells respectively (Yang et al., 2009, Wang et al., 2012). Importantly, we have found and 
reported that ajoene targets and localizes to the ER in breast cancer MDA-MB-231 cells 
(Kaschula et al., 2015). Moreover, Z-ajoene was found to S-thiolate a multitude of proteins, 
promote protein aggregate formation and cause an increase in the expression of GRP78/BIP 
in MDA-MB-231 cells (Kaschula et al., 2015). GRP78/BIP is an ER resident chaperone and 
is commonly known to be upregulated under ER stress conditions. Therefore ajoene is 
proposed to target the ER where it interferes with protein folding to generate misfolded 
aggregates which may then activate an ER stress response in MDA-MB- 231 breast cancer 
cells. Based on the similar structures of ajoene and bisPMB and that they both contain the 
vinyl disulfide pharmacophore, we propose that bisPMB may also induce apoptosis by 
triggering ER stress in WHCO1 cells. We therefore chose thapsigargin (TG) as a positive 
control for ER stress induction in WHCO1 cells. TG is a natural compound isolated from the 
Thapsia garganica L plant (figure 3.1) and is a potent inhibitor of the sarco-endoplasmic 
reticulum Ca2+ ATPase (SERCA) in the nanomolar range, and induces apoptosis in the 
micromolar range (Treiman et al., 1998a). Moreover, TG is also reported to exert cytotoxic 
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effects in cancer cells in vitro. For example, TG has been shown to induce apoptosis in 
human TSU and rat prostate cancer cell lines (Tombal et al., 2000).  
In this chapter, WHCO1 cells were treated with the previously determined non-cytotoxic  
      concentration of bisPMB. It was anticipated that this sub-toxic concentration of 
bisPMB may give insights into early stage gene transcriptional changes in WHCO1 cells that 
occur prior to apoptosis induction. In addition, 1 µM TG was used as this concentration is 
reported to induce ER stress in cancer cells (Uemura et al., 2009, Andersen et al., 2015). 
Thereafter, the treated WHCO1 cells were subjected to microarray analysis to examine gene 
global expression changes  
 
3.2 RESULTS 
3.2.1 Effect of bisPMB or thapsigargin on WHCO1 cell morphology and apoptosis. 
To evaluate the effect of bisPMB and TG on WHCO1 cell morphology, WHCO1 cells were 
treated with        bisPMB concentration or 1 µM TG and images of these cells were 
captured with an Olympus SC30 camera. As expected, the morphology of the WHCO1 cells 
treated with bisPMB at       concentration was similar to the untreated control sample 
(figure 3.1 A and B); whereas 1 µM TG treated WHCO1 cells had a shrunken appearance 
(figure 3.1C).  
In order to determine whether bisPMB or 1 µM TG induced apoptosis in WHCO1 cells, 
histone-associated DNA fragments were quantified in the cytoplasm after treatment.  In 
agreement with figure 2.6 A, the        concentration of bisPMB did not induce apoptosis 
and was similar to the untreated control. However, 1 µM TG significantly enhanced apoptosis 
by 2 folds in WHCO1 cells compared to the untreated control (figure 3.2). Taken together, 
these observations suggested that the        bisPMB was not toxic to the cells however 1 µM 














Figure 3.1 WHCO1 cell morphological changes after bisPMB and thapsigargin treatment. WHCO1 cells 
were treated with bisPMB at3.5 µM concentration or 1µM thapsigargin (TG) for 24 h and morphology observed 
under phase contrast at 10   magnification (A) Untreated WHCO1 cells; (B) WHCO1 cells treated with 
bisPMB at       concentration; (C) WHCO1 cells treated with 1µM TG. 










Figure 3.2 Apoptotic induction in WHCO1 cells treated with bisPMB or TG. WHCO1 cells were treated with 
bisPMB at        concentration or 1µM thapsigargin (TG) for 24 h. Subsequently, total cell lysate was used to 
determine histone associated DNA fragments in the cytoplasm. An absorbance of 405 nm with the reference of 
492 nm was used to read the photometric signal, measuring cell apoptosis. Each bar represents the mean 
absorbance   SD of three independent experiments. A t-test statistical analysis was performed using GraphPad 
Prism, * indicated p <0.05. 
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3.2.2 Analysis of RNA extracted from bisPMB-treated WHCO1 cells 
3.2.2.1 RNA Quality Control  
 
Total RNA was extracted in quadruplicate from untreated, bisPMB or TG treated WHCO1 cells, 
followed by RNA quality assessment. Examination of RNA integrity is an important step when 
conducting gene expression studies as intact RNA is key to obtaining accurate data from 
downstream analysis such as qRT-PCR and microarrays (Fleige and Pfaffl, 2006). In this study, 
the quality of the total RNA extracted was assessed at the Centre of Proteomic and Genomic 
Research (CPGR). RNA integrity numbers (RIN) were found to be between 9.9 and 10 (Table 
3.1), indicative that the RNA was of good quality and not degraded; intact RNA is considered to 
have a RIN value between 7 and 10 (Kawasaki, 2006). These results demonstrated that the RNA 
samples used in this study were of good quality and suitable for downstream cDNA microarray 
analysis. 
Table 3.1. Quantification of the integrity of RNA samples used for cDNA microarray analysis. Total RNA was 
extracted in quadruplicate from the untreated, bisPMB and TG treated WHCO1 cells. The RNA integrity number 
(RIN) obtained from the samples was between 9.9 and 10. All the samples passed the quality control examination. 
 
RNA Sample RIN Comment 
Untreated 10 Pass 
Untreated 10 Pass 
Untreated 10 Pass 
Untreated 10 Pass 
BisPMB 10 Pass 
BisPMB 10 Pass 
BisPMB 10 Pass 
BisPMB 10 Pass 
TG 10 Pass 
TG 10 Pass 
TG 10 Pass 
TG 10 Pass 
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3.2.2.2  cDNA microarray analysis in WHCO1 cells 
Affymetrix human gene ST 2.0 arrays were used to conduct microarray analysis at the CPGR. 
The procedure depicted in figure 3.3 was conducted on an affymetrix platform and used to 
perform the cDNA microarray analysis, where labelled cRNA was fragmented and 
hybridized onto Affymetrix array ST 2.0 GeneChip. The raw probe intensity values obtained 
from the gene ST 2.0 arrays were computed on affymetrix .CEL files (figure 3.3). Thereafter, 
Partek®Genomics Suite™ (Partek Inc., 2014) software was used for data analysis.   
The raw probe intensity values from the .CEL files were imported in the Partek®Genomics 
Suite™ (Partek Inc., 2014) software and normalized using the robust multi-array average 
(RMA) (Irizarry et al., 2003). The RMA normalizes the raw probe intensity values from 
different arrays by adjusting for the background, performing Log2 transformations, quantile 










Figure 3.3. Workflow of cDNA microarray analysis with affymetrix GeneChip 2.0 array platform. The RNA 
extracted from bisPMB or TG treated WHCO1 cells were reverse transcribed into cDNA which was subsequently 
fragmented, labelled and hybridized into Affymetrix gene ST 2.0 array GeneChip. After hybridization, the array 
was washed and stained. Subsequently, the array was scanned using the GeneChip® scanner 3000 which stored the 




Following normalization of the arrays, the similarities and differences in the gene expression 
profiles of untreated, bisPMB or TG samples was examined using the principal component 
analysis (PCA) and hierarchical clustering methods (Peterson, 2002). The PCA takes into 
account the variability of the gene expression data set within each sample group and also 
between the three sample groups studied. The PCA demonstrated that the biological replicates 
within each sample group clustered together with a single outlier observed in one of the 
thapsigargin treated samples (figure 3.4 A). The hierarchical clustering confirmed the 
reproducibility of the biological replicates within each sample group (figure 3.4B). Thus no 








Figure 3.4. The Principal Component Analysis (PCA) score plot and hierarchical clustering heat map of 
microarray data in WHCO1 cells. (A) PCA plot of the gene expression data that was generated by Affymetrix 
GeneChip® Human Gene 2.0 ST Array from 12 samples of untreated WHCO1 cells (Red, n = 4) or treated with 
BisPMB (Green, n = 4) or  TG (Blue, n = 4). Each dot represents a single array sample. The samples from each 
treatment group clustered well, except for the one outlier that was detected in the TG sample. (B) The hierarchical 
clustering of the genes in WHCO1 cells. The dendogram branches on y-axis represent the biological replicates of 
the untreated WHCO1 cells (Orange), treated with bisPMB (Red) and TG (Yellow) while the x-axis is indicative of 
the genes in the array. The red columns represent upregulated genes and the blue columns represented down 
regulated genes.                                     
The differentially expressed genes (DEGs) derived from the bisPMB or TG samples were 
subsequently determined. Two way analysis of variance (ANOVA) was used to select the 
significantly deregulated genes, in bisPMB and TG treatment samples compared to the untreated 
control, by determining p-values. Multiple testing of these p-values using the Bonferroni test 
was conducted in order to calculate the false discover rate (FDR). The FDR conceptualized the 




bisPMB or TG samples was set at 1.5 fold with a statistically significant FDR value set at α 
 0.05. 
The number of DEGs uniquely expressed in the bisPMB or TG sample and those shared in both 
samples was then visualised using a Venn diagram (figure 3.5). A higher number of DEGs were 
observed in the TG sample compared to the bisPMB samples. A total of 6341 DEGs were found 
in the TG sample with 488 DEGs in the bisPMB sample. Of these, 295 DEGs were found to be 
common between both bisPMB and TG samples. The shared DEGs accounted for 60.5% and 
4.7% of the total DEGs in bisPMB and TG samples respectively. Collectively, this demonstrated 
that the majority of the DEGs from the bisPMB sample were shared with TG sample but many 







Figure 3.5. Venn diagram displaying the DEGs in WHCO1 cells treated with bisPMB (Red circle) and TG 
(Green circle) and those shared between the two treatments (overlap). There are 6046 and 193 unique DEGs in 
the TG and bisPMB treated WHCO1 cell samples respectively while 295 DEG’s were common between oth 
samples 
3.2.2.3 Validation of selected microarray DEGs involved in protein processing by qPCR  
 
The results obtained from the cDNA microarray were validated by q - RT PCR on the same 
RNA samples used for the microarray analysis; and also independently repeated by extracting 
new RNA from two independent repeats. The validation was conducted using 23 DEGs shared 
between the bisPMB and TG groups (Table 3.2). A line representing the untreated control was 
set at one and drawn across the bar chart (See figure 3.6). Consequently, all data above the line 
indicated upregulated DEGs in the indicated samples and data below the line represent down 
regulated DEGs compared to untreated control.  The DEGs selected were based on involvement 
in ER stress and protein processing pathways in the ER. The qPCR results for 4 (DDOST, Ubc6, 




fold change of the microarray data. We observed consistency in 19 of the 23 DEGs in the 
bisPMB sample and in all DEGs in the TG sample with regards to the direction of fold change in 
gene expression between the qPCR and cDNA microarray results. Thus we were satisfied that 
the RNA sent for microarray analysis gave the correct results, that the fold changes observed 
were reproducible and that the independent biological replicates displayed striking similarities 
with the RNA used for microarray. This authenticated the microarray results and rendered them 
suitable for use in functional enrichment analysis studies.  
Table 3.2 Genes selected of relevance to ER stress and protein processing pathways. BisPMB and TG DEGs 
with cDNA microarray fold changes. The negative fold changes represent downregulated genes and the positive 
fold changed indicate upregulated genes relative to the untreated control. 
GENE DESCRIPTION BISPMB TG 
Sec61 Translocation protein Saccharomyeces Cerevisiae 61 homolog -1.67757 2.98533 
Sec63 Translocation protein Saccharomyeces Cerevisiae 63 homolog -1.02034 2.51986 
rrbp1 Ribosome binding protein 1 -1.54513 2.00086 
tram Translocating chain – associated membrane -1.60647 2.50978 
ero1l Endoplasmic reticulum oxidoreductin-1-like protein B -1.52044 5.49922 
vimp VCP-interacting membrane protein -1.72005 2.8603 
sel1L Suppressor of lin-12-like -1.50057 5.95984 
ssr3 Signal sequence receptor subunit gamma -1.7 4.5663 
ddost Dolichyl-diphosphooligossacharide-protein glycosyltransferase 1.14939 2.24069 
lmna1 Lamin A related sequence 1 1.57643 3.72986 
ask Apoptosis signal regulating kinase 1 -1.619 -5.79027 
sec24D Translocation protein  S. Cerevisiae family member 24D -1.66651 2.16198 
ire1 Inositol –Requiring enzyme 1 1.05086 2.20624 
ubc6 Ubiquitin-conjugated enzyme E2 1.6063 2.629 
grp94 Glucose regulated protein 94 1.53431 4.88002 
edem ER degradation- enhancing alpha-mannosidase like protein 1.92258 -2.35283 
pdia4 Protein disulfide isomerise A4 1.65048 5.68534 
atf6 Activating transcription factor 6 1.50036 2.0337 
casp4 Caspase 4 1.72382 2.10505 
xbp-1s X-box binding protein 1 spliced variant 1.54864 3.48261 
grp78 Glucose regulated protein 78 1.56787 3.66649 





























Figure 3.6 Validation of microarray fold change in gene expression by qPCR. The selected DEGs were 
analysed using qPCR. The fold changes of the DEGs obtained from the microarray (black) and qPCR (grey) 
were compared and normalized to the untreated control being a value of one (A) Bar graph comparing 
microarray with qPCR fold changes of bisPMB RNA sample. (B) Bar graph comparing the microarray and 
qPCR TG sample fold changes. The microarray DEGs were normalised relative to RMA normalization whereas 











































































3.2.3 Functional enrichment analysis of microarray derived bisPMB and TG DEGs  
3.2.3.1 Gene Ontology analysis 
In order to mechanistically interpret the microarray gene expression data and determine the 
molecular events triggered by bisPMB or TG in WHCO1 cells, gene ontology (GO) analysis 
was performed. We generated GO using the WebGestalt web based software which uses 
published information on genes in the human genome and gene attributes to organize bisPMB or 
TG DEGs into various biological contexts. GOs are organised into three domains namely; 
biological processes, molecular function and cellular components. In addition, the Bonferroni 
test is applied to determine the adjusted p-value/false discovery rate (FDR). The FDR 
significance level cut off for the analysis performed in bisPMB or TG DEGs was set at α  0.05. 
This type of analysis enabled identification of the most prominent biological events in the 
bisPMB and TG samples. 
We observed numerous GO biological processes enriched with bisPMB DEGs, these included 
metabolic process, biological regulation, response to stimuli, cell communication, multi-cellular 
organismal process, localization, development process, cellular component organization, death, 
multi-organism process, reproduction, cell proliferation and growth (figure 3.7). Higher 
resolution into specific biological processes was obtained using a directed acyclic graph (DAG). 
The DAG illustrated that the “activation of signalling protein activity involved in unfolded 
protein response” (UPR), was the most specific and significant (adjP/FDR of 2.95e-120)  
biological process enriched with bisPMB DEGs with the (figure 3.8). Thus, this demonstrated 
that bisPMB primarily affected genes involved in the UPR in WHCO1 cells. BisPMB also 
appeared to affect biological processes such as metabolic processes, which are commonly 
associated with cancer progression and response to treatment. Furthermore, the most specific 
biological process involved the unfolded protein response.  
Overrepresented TG DEGs were found to be those involved in the metabolic process category, 
biological regulation and response to stimuli, multi-cellular organismal process, cellular 
component organizations, cell communication, localization, developmental process, cell death, 
cell proliferation, reproduction, multi-organism process and cell growth (figure 3.9). Further 
resolution into the most specifically enriched biological process converged on mitosis 
(FDR=3.97e-28) and DNA metabolic processes (FDR=1.74e-21); with 184 and 326 the TG DEGs 
forming part of these clusters respectively (figure 3.10). Ultimately, the bisPMB and TG 
samples were both found to deregulated similar biological process categories but the specific 
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mode of action of TG was related to cell division, which is essential in cancer proliferation and 
cell death and that of bPMB is UPR & ER stress.  
In order to investigate the cellular components relevant to the bisPMB or TG DEGs, Bar Chart 
and Directed Acyclic Graphs were constructed. The cellular components from the bisPMB 
sample were found to include the membrane, nucleus, membrane enclosed lumen, cytosol, 
endomembrane system, macromolecular complex, endoplasmic reticulum, Golgi apparatus,  
mitochondrion, vesicle, cytoskeleton, cell projection, extracellular space, envelope, endosome, 
chromosome, vacuole, extracellular matrix, microbody and lipid particle (figure 3.11). The most 
specific and significant cellular components, under the membrane and membrane enclosed 
lumen category in the bisPMB sample, were the endoplasmic reticulum membrane and the 
endoplasmic reticulum lumen with FDR values of 1.21e-07 and 1.18e-02 respectively (figure 
3.12). These significantly enriched cellular components fall in line with the biological processes 
data on the bisPMB sample as the UPR has been associated with genes localized in the ER 
membrane and lumen. 
Comparably, the membrane, nucleus, membrane enclosed lumen, macromolecular complex, 
cytosol, endomembrane system, cytoskeleton, endoplasmic reticulum, mitochondrion, Golgi 
apparatus, cell projection, vesicle, chromosome, envelope, extracellular space, endosome, 
vacuole, extracellular matrix, microbody, ribosome, lipid particle and external encapsulating 
structure were the cellular components containing the TG DEGs (figure 3.13). The most specific 
and significantly enriched cellular components where TG DEGs were active included the 
“cytoplasmic part” with FDR of 3.75e-35, “intracellular organelle” (FDR= 9.25e-43) and in the 
“intracellular membrane- bound organelle” (FDR= 3.85e-51) (figure 3.14). This can be expected 
as the different stages of TG triggered events, such as ER stress, occur in the above mentioned 
cellular compartments. For example, the splicing of XBP-1 mRNA occurs in the “cytoplasmic 
part of the cell and the dissociation of GRP78/BIP from transmembrane proteins take place in 
the ER, and “intracellular organelle” or “intracellular membrane- bound organelle”.  
The GO findings demonstrated that bisPMB and TG regulated similar biological processes and 
cellular components. However, bisPMB was primarily implicated in UPR while TG was 
implicated in mitosis and DNA metabolic processes. This provided a broad overview of 
intracellular mechanistic events occurring in both the bisPMB and TG samples. In order to gain 
more information into the underlying molecular events of the above mentioned biological 
processes, pathway analysis was conducted. 
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Figure 3.7 Bar graph representing Gene Ontology biological processes ancestral categories in the bisPMB 
sample. Each bar signifies broad ancestral biological process category and the numbers of bisPMB DEGs 






































































































































































Figure 3.8. Gene Ontology biological processes significantly enriched in bisPMB sample. Directed acyclic graph 
(DAG) showing the hierarchical order, from ancestral to more specific biological processes. The biological processes 




























Figure 3.9   Bar graph representing Gene Ontology biological processes ancestral categories in the TG 
sample. Each bar signifies broad ancestral biological process category and the numbers of TG DEGs involved 





































































































































































Figure 3.10. Gene Ontology biological processes significantly enriched in TG sample Directed acyclic graph 
(DAG) showing the hierarchical order of biological processes showing further resolution to more specific biological 
processes. The biological processes highlighted in red indicate the significantly enriched categories. Bonferroni 





























Figure 3.11 Bar graph representing Gene Ontology cellular component ancestral categories in the 
bisPMB sample. Each bar signifies broad ancestral cellular component and the numbers of bisPMB DEGs 


























































































































































































Figure 3.12. Gene Ontology cellular components significantly enriched in bisPMB. Directed acyclic graph 
(DAG) showing the hierarchical order of cellular components showing further resolution to more specific 
cellular components. The cellular components highlighted in red indicate the significantly enriched categories. 

























Figure 3.13. Bar chart representing Gene Ontology cellular component ancestral categories in the TG 
sample. Each bar signifies broad ancestral cellular component category and the numbers of TG DEGs involved 
















































































































































































































Figure 3.14 Gene Ontology cellular components significantly enriched in TG.  Directed acyclic graph (DAG) 
showing the hierarchical order of biological processes showing further resolution to more specific cellular 
component. The cellular components highlighted in red indicate the significantly enriched categories. Bonferroni 
statistical test was used to calculate FDR (p<0.05). 
61 
 
3.2.3.2 Pathways Analysis 
 
Examination of the molecular pathways activated by bisPMB or TG was conducted using the 
KEGG pathway network module and the ingenuity pathway analysis (IPA). Numerous KEGG 
pathways were found to contain bisPMB DEGs (figure 3.15). The three with the largest number 
of bisPMB DEGs included pathways in cancer, protein processing in the endoplasmic reticulum 
and the MAPK signalling pathways (figure 3.15). Similarly, the most significantly enriched 
KEGG pathways in the TG sample included protein processing in ER, cell cycle, pathways in 
cancer and MAPK signalling pathway (figure 3.16). Further resolution of the KEGG pathway 
network modules revealed the presence of ER Stress/UPR genes in the protein processing in the 
ER pathway category for both bisPMB & TG (figure 3.17). These pathways that formed part of 
the protein processing in the ER pathway category included; UPR, endoplasmic reticulum 
associated degradation (ERAD) and protein translocation pathways for both bisPMB & TG 
(figure 3.17). However, the number of bisPMB DEGs overrepresented in protein processing 
pathways in the ER was found to be much lower than the TG DEGs (figure 3.17 A and B).  
The bisPMB DEGs represented in the UPR pathways were found to include ATF6, XBP-1, 
GRP78/BIP and CHOP, all of which were upregulated. Similarly, the TG DEGs that were 
represented in the UPR pathway were upregulated and they included the PERK, ATF6, IRE1, 
GADD34, CHOP and XBP-1. The ERAD DEGs such as EDEM, Ubc6 and VIMP were present 
in both bisPMB and TG sample (figure 3.17). Furthermore, the majority of the bisPMB DEGs 
represented in the protein translocation pathways were down regulated and these included the 
Sec63, TRAM, Sec24D and SSR3/TRAP but were upregulated in the TG sample. These 
findings suggest that WHCO1 cells respond to bisPMB by regulating genes involved in 
enhancing the UPR and ERAD, which promote protein folding to degrade terminally misfolded 
proteins. BisPMB also downregulated the genes that play a role in the import of proteins to the 
ER by down-regulating genes involved in the protein translocation pathways. In comparison, TG 
upregulated DEGs involved in the UPR, ERAD and the translocation pathway. Suggesting that 
bisPMB ad TG induces ER stress, however the ER stress mechanisms of these two compounds 
may not be identical.  
Evidence for the significant deregulation of ER Stress and UPR pathways in the bisPMB and 
TG samples was provided by the canonical pathways generated with the ingenuity pathway 
analysis (IPA) software. Our results demonstrated that the ER Stress pathway was the most 
significantly enriched canonical pathway in the bisPMB sample, with 9.5 % down regulated and 
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23.8 % up regulated DEGs (figure 3.18). Comparatively, the ER Stress pathway was found to be 
one of the significantly enriched canonical pathways in the TG sample with 4.8 % down 
regulated and 38.1 % up regulated genes (figure 3.19). These findings demonstrate that activation 
of ER stress is one of the primary modes of action for bisPMB in WHCO1 cells and only one of the 
pathways activated in the TG sample..  
Generally, bisPMB and TG DEGs shared the majority of the Kyoto encyclopaedia of genes and 
genomes (KEGG) pathways. TG elicited a stronger response compared to bisPMB in WHCO1 
cells as more genes were deregulated by TG in each KEGG pathway. On the other hand, the ER 
stress and UPR pathway was more important than other pathways in the bisPMB sample as 
evidenced by the GO biological processes and IPA results. Furthermore, both bisPMB and TG 
samples displayed high number of DEGs in the “protein processing in the ER” KEGG pathway 
compared to the other pathways. This demonstrated that bisPMB and TG elicited similar 















Figure 3.15 KEGG Pathways enriched with bisPMB DEGs. Bar chart indicating the number of DEGs 
represented in each pathway category. The names of the pathways are indicated on the y-axis and the number of 
DEGs present in each pathway is on the x-axis.        
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Figure 3.16 KEGG Pathways enriched with TG DEGs. Bar chart indicating the number of DEGs represented 
in each pathway category. The names of the pathways are indicated on the y-axis and the number of DEGs 
present in each pathway is on the x-axis.
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Figure 3.17 KEGG pathway map showing the significantly enriched protein processing in endoplasmic 
reticulum pathway. The WebGestalt program was used to generate the significantly enriched KEGG pathways 
from a list of imported DEGs. The KEGG pathway map is composed of green rectangular boxes which 
represent gene products such as protein or RNA. The names of the gene products are written in black and the 
DEGs found in the (A) bisPMB sample and (B) TG samples are highlighted in red in the protein processing in 






























Figure 3.18 significantly deregulated canonical pathways in WHCO1 cells treated with BisPMB. The 
names of the deregulated pathways are written on the y-axis, each bar corresponds to each pathway. The 
coloured sections of each bar represent genes that overlap with the genes in each pathway, while the clear 
sections represent lack of overlap. The green bars show genes that are down regulated, while the red indicated 
up regulation. The numbers indicated at the top of each bar represent the total number of genes that are found in 
that particular pathway. The top x-axis indicates the percentage of genes in a data set that overlap with genes in 
a pathway, while the bottom x-axis represents the significance of the pathway as calculated with the Fischer’s 
test and shown in –log (p-value). The yellow line illustrates the significance of each pathway. The bar graphs 
represent the canonical pathways generated from the bisPMB sample.  
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Figure 3.19 Significantly deregulated canonical pathways in WHCO1 cells treated with 1µM TG. The 
names of the deregulated pathways are written on the y-axis, each bar corresponds to each pathway.  The 
coloured sections of each bar represent genes that overlap with the genes in each pathway, while the clear 
sections represent lack of overlap. The green bars show genes that are down regulated, while the red indicated 
up regulation.  The numbers indicated at the top of each bar represents the total number of genes that are found 
in that particular pathway. The top x-axis indicates the percentage of genes in data set that overlap with genes in 
pathway, while the bottom x-axis represents the significance of the pathway as calculated with the Fischer’s test 
and shown in –log (p-value). The yellow line illustrates the significance of each pathway. The bar graphs 
represent the canonical pathways generated from the TG sample. 
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3.2.3.3 Network Analysis 
 
The gene network making up the ER stress pathway was generated using IPA, a web-based 
software that organizes gene expression data into pathways and networks using the IPA 
knowledge base (IPKB) for reference. The genes in the ER stress network include the ER 
transmembrane proteins IRE-1, PERK and ATF6, which are transducers of the UPR signalling 
pathway. We observed an upregulation of ATF6 while no change was observed in the 
transcription of IRE1 and PERK in the bisPMB sample (figure 3.20). Additionally, we observed 
an up regulation of molecular chaperones GRP78/BIP and GRP94; transcription factors CHOP 
and XBP1 and a down regulation of ASK and the PERK inhibitor p58i (figure 3.20).  
 
Figure 3.20 The gene network involved in the ER Stress pathway. The DEGs obtained from the bisPMB sample 
are highlighted in either green or red. Green indicates down regulated genes, while the red indicate the up regulated 
genes. The intensity of the red or green demonstrates the magnitude of the fold change. The cellular compartments 
are labelled inside the shape demarcating them. 
 
Comparatively, all TG DEGs involved in the ER stress pathway network were found to be 
upregulated except for ASK1 (figure 3.21). Specifically, the transcription of IRE-1, ATF6 and 
PERK were upregulated in the TG sample, implying that all transmembrane proteins were 
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involved in TG ER stress/UPR pathways. Together, these results suggest that bisPMB may 
induce ER stress in WHCO1 cells, leading to subsequent increase in the transcription of the 
ATF6 gene. The subtle changes observed in the bisPMB sample can be attributed to the sub-
toxic concentration used in these experiments.  On the other hand, TG enhanced the 
transcription of all UPR target genes, which included IRE-1, ATF6 and PERK ER 
transmembrane proteins. 
 
Figure 3.21 The gene network involved in the ER Stress pathway. The DEGs obtained from the TG sample are 
highlighted in either green or red. Green indicates down regulated genes, while the red indicate the up regulated 
genes. The intensity of the red or green indicates the magnitude of the fold change. The cellular compartments are 
labelled inside the shape demarcating them.  
 
In order to identify genes that are functionally and physically related and underlie the observed 
pathways in the bisPMB and TG samples, relevant molecular gene networks were generated in 
IPA. IPA networks are named according to the molecular function categories that they mediate. 
Additionally, IPA ranks networks according to the number of DEGs it contains and the number 
of connections arising between the genes in each network. We observed that the most highly 
ranked molecular network in the bisPMB sample was named “Cellular Compromise, Cellular 
Function and Maintenance, Cellular Assembly and Organization” and was composed of 34 
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DEGs containing ER Stress DEGs ATF6, XBP1 and BiP (grp78 or HSPA5) (figure 3.22A). In 
addition, the DEG with the highest number of connections to other genes in this network was 
XBP-1 (figure 3.22A). This suggests that XBP-1 may be the most biologically relevant gene in 
this network, as it influenced the highest number of genes that are involved in various other 
cellular functions through its connections. The genes that were connected to XBP-1 included 
STARD5, GLGA4, SEC24D, FKBP14, EDEM2, EDEM1, PDIA4, HSP90B1, AFT6, 
SEC61A1, SRPRB, COPE, SSR3, SEC31A and HSPA5/GRP78/BIP. In the TG sample, the 
most highly ranked molecular gene network was composed of 35 DEGs and named the “cell 
cycle, cellular assembly and organization, DNA replication, Recombination and Repair”. 
However, the DEG with the most connections to other genes, thus the most biologically relevant 
gene in the TG sample was the small ubiquitin –like modifier (SUMO2) gene (figure 3.23). 
The IPA findings are consistent with the GO, KEGG and IPA results which suggest that bisPMB 
primarily triggers the ER stress/UPR pathway. In addition, the molecular gene network implies 
that the XBP-1 gene is central to regulating most of these intracellular functions by regulating 
the expression of the highest number of DEGs. Whereas the pathways important in TG treated 






                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
 
 
Figure 3.22 Cellular Compromise, Cellular Function and Maintenance, Cellular Assembly and 
Organization molecular gene network and functional categories for bisPMB. The highest ranked gene 
network containing bisPMB DEGs. Green indicates down-regulated genes and red are up-regulated. The lines 




















Figure 3.23 Cell cycle, cellular assembly and organization, DNA replication, Recombination and Repair.  
Molecular gene network containing TG DEGs. Gene highlighted in red are up-regulated and highlighted in green 
are down-regulated.  The lines connecting the genes indicate biological relationship between the genes. 
 
3.3 DISCUSSION 
To gain insights into the genes deregulated in WHCO1 cells in response to bisPMB treatment, 
we investigated the change in gene transcription at a sub-toxic concentration of bisPMB. Based 
on the observation that ajoene targets and accumulates in the ER in MDA-MB-231 cells and 
induces GRP78/BIP expression (Kaschula et al., 2015); we hypothesized that the ajoene 
analogue bisPMB may induce ER stress in WHCO1 cells. To tests this hypothesis, we compared 
the gene transcriptional response of bisPMB to that of TG, a known ER stress inducer (Treiman 
et al., 1998d).   
Gene transcriptional deregulation was assessed using cDNA microarray analysis, which 
revealed 488 and 6359 differentially expressed genes (DEGs) in WHCO1 cells treated with 
bisPMB and TG respectively at the 1.5 cut off. The higher number of DEGs observed in the TG 
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sample may be attributed to the cytotoxic concentration of TG used in this study compared to 
that chosen for bisPMB. The toxicity of the 1µM TG concentration was exemplified by its 
ability to induce apoptosis in WHCO1 cells by two fold. On the other hand, the low number of 
DEGs observed in the bisPMB sample is consistent with that reported for 10 µM ajoene in 
human leukaemia HL60 cells, in which only 28 genes were found to be differentially expressed 
from a cDNA microarray chip containing 2400 genes (Fang et al., 2002). The 10 µM ajoene 
concentration does not induce apoptosis in HL60 cells (Dirsch et al., 2002). Thus the number of 
DEGs observed could be attributed to the toxicity of the concentration used for bisPMB versus 
TG.  
The microarray gene expression data obtained in this study was validated by q-RT PCR. For the 
validation, we used the same RNA sample that was submitted for microarray analysis and also 
performed q-RT PCR on independent samples 23 genes were chosen for validation that were 
found to be deregulated in both the bisPMB and the TG samples. The genes were selected 
because they formed part of the protein processing in the ER pathway. We observed consistency 
between cDNA microarray analysis and q-RT PCR in 19 of the 23 selected DEGs in the bisPMB 
sample. Comparably, none of the selected DEGs in the TG sample demonstrated inconsistencies 
between cDNA microarray analysis and q-RT PCR results. Discrepancies observed in the 4 
selected DEGs in the bisPMB sample, (Ub6, DDOST, GRP94 and CASP4), may be accredited 
to factors including different normalisation methods between the two techniques (RMA method 
for microarray and GAPDH for q-RT PCR) and the low fold change (< 2 fold) observed in the 
microarray genes (Morey et al., 2006). For example, the cut off fold change in this study was set 
at 1.5 fold and the majority of the deregulated genes in the bisPMB sample displayed less than 2 
fold change in gene expression. In contrast, the gene expression changes in the TG sample were 
all greater than two. Consequently, there was a greater reproducibility in the TG sample 
compared to the bisPMB sample. Nonetheless, the majority of the DEGs in both bisPMB and 
TG samples were reproducible, rendering the microarray data suitable for downstream analysis. 
Gene expression data was then biologically interpreted using the functional enrichment analysis 
of Gene ontology (GO). Similarities were observed between bisPMB and TG, in which the 
biological process categories with the largest number of DEGs included metabolic processes, 
biological regulation and response to stimuli. These biological processes encompass DEGs such 
as CYP1A1 (cytochrome p450 family 1 subfamily A polypeptide 1), CDH13 (cadherin 13), 
MMP13 (matrix metallopeptidase), AXL (AXL receptor tyrosine kinase), XBP-1 (X box 
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binding protein 1) and IL8 (interleukin 8). These genes are involved in a range of well 
documented cellular functions such as inflammation, xenobiotic and drug metabolism, collagen 
degradation and the unfolded protein response. In addition, this observation is consistent with 
reports on ajoene induced anti-inflammatory properties (Schafer and Kaschula, 2014) and DAS 
altering the activity of cytochrome P450 enzymes in hepatic microsomes (Brady et al., 1988).  
The most specific and significantly enriched GO biological process in the bisPMB sample was 
termed “activation of signalling protein activity involved in unfolded protein response”. The 
unfolded protein response (UPR) is a cytoprotective response triggered by ER stress as a result 
of an increase in misfolded proteins in the ER (Herr and Debatin, 2001, Hosoi et al., 2010, 
Hosoi and Ozawa, 2010). Data from our lab has illustrated that Z-ajoene enhances the 
expression of GRP78/BIP and promotes misfolded proteins and protein aggregation, in MDA-
MB-231 breast cancer cells (Kaschula et al., 2015).These reports were consistent with our GO 
findings which suggest that the most significantly enriched cellular component in the bisPMB 
sample was the ER membrane and the ER lumen, a cellular location for UPR. For instance, the 
UPR involves the activation of three ER transmembrane proteins namely; PRK-like 
endoplasmic reticulum kinase (PERK), Inositol requiring enzyme 1/ ERN 1(IRE1) and 
activating transcription factor 6 (ATF6) (Schroder et al., 2005). The IRE1 and ATF6 pathways 
activate the transcription of genes that aid in protein folding such as chaperones and foldases 
(Han et al., 2009, Ye et al., 2000) which include GRP78/BIP and PDI and are located in the 
lumen of the ER (Wang and Tsou, 1993, Griesemer et al., 2014). Our findings and literature 
reports support bisPMB primarily triggering the UPR in WHCO1 cells,  
In comparison, the most significantly enriched biological process in the TG sample was mitosis 
and DNA metabolic process with the most significantly enriched cellular components being 
located in the cytoplasm, intracellular organelle and intracellular membrane bound organelle. 
Although TG is an ER stress inducer, the TG concentration used in this study promoted the 
induction of apoptosis, which may account for the TG DEGs being involved in functions 
promoting cell death and affecting the cell cycle. TG is toxic to cancer cells at micromolar 
concentrations (Treiman et al., 1998a). GO analysis found that bisPMB primarily targets UPR 
activation in WHCO1 cells, while TG targets the cell cycle at the selected concentrations. In 
order to gain a better understanding of the molecular events underlying these broad cellular 
processes, pathway analysis was performed.  
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The KEGG pathway illustrated that pathways in cancer, protein processing in the ER and the 
mitogen activated protein kinase (MAPK) pathway were the most significantly enriched 
pathways in both bisPMB and TG samples. The deregulation of pathways in cancer in both 
samples was expected as this study was conducted in a cancer cell line. Moreover, bisPMB, 
ajoene and TG have been previously reported to have cytotoxic effects against various cancer 
cell lines (Dirsch et al., 2002, Kaschula et al., 2012, Dubois et al., 2013). In addition, the 
bisPMB and TG DEGs represented in the pathways in the cancer category included cyclin D1, 
cyclin E, and p27/KIP, which are all key players in cell cycle regulation. ER stress has been 
shown to inhibit cell cycle progression through the induction of p27 expression (Han et al., 
2013). Therefore both bisPMB and TG may regulate pathways involved in cancer progression 
and cancer cell death.  
The protein processing in the ER pathway was also deregulated in both bisPMB and TG treated 
WHCO1 cells.  The similarities in WHCO1 cell response to bisPMB and TG in this pathway 
category was the upregulation of UPR and ERAD pathways. While the main difference was the 
deregulation of the DEGs in protein translocation pathway (Sec63, TRAM, Sec24D and 
SSR3/TRAP) that were upregulated in the TG sample and downregulated in the bisPMB sample. 
This finding was in line with the IPA analysis data that identified the ER stress pathway as the 
most significantly enriched canonical pathway in the bisPMB sample and one of the 
significantly enriched pathways in the TG sample. These observations implied that bisPMB may 
activate ER stress in WHCO1 cells. In agreement with these observations, ER stress has been 
suggested to play a role in the anti-apoptotic activity of the garlic OSCs DADS (Yang et al., 
2009) and DATS (Wang et al., 2012) against human colon cancer and basal cell carcinoma cell 
lines.  
In order to identify the DEGs that are biologically related to other genes within the ER stress 
pathway in both bisPMB and TG samples, we generated molecular gene networks using the 
IPA. The ER stress pathway gene network revealed that the PERK pathway may not be 
transcriptionally deregulated by bisPMB. Interestingly, p58i was down regulated in the bisPMB 
sample but up regulated in the TG sample. P58i is an ER resident HSP40 chaperone family 
member and an inhibitor of PERK (Lee et al., 1994, Polyak et al., 1996, Yan et al., 2002, 
Rutkowski et al., 2007). This suggests that PERK may not involved in UPR activation initiated 
by bisPMB but may be involved in TG treated WHCO1 cells although the microarray data is 
only a guide to generate an hypothesis and the response in bisPMB sample was low. Moreover, 
PERK pathway activation in the TG sample may in turn be regulated by p58i in WHCO1 cells. 
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We also observed no change in IRE-1 transcription but an increase in XBP-1 transcription in the 
bisPMB sample. The XBP1 mRNA is activated through splicing orchestrated by IRE1 
endonuclease activity (Iwawaki and Akai, 2006, Koong et al., 2006, Han et al., 2009). 
Comparatively, TG displayed an upregulation of both IRE-1 and XBP-1. Furthermore, the 
transcriptional increase in XBP-1 indicates a possible mechanism to compensate for the un-
spliced XBP-1 mRNA pool. An increase in XBP-1 activity has been associated with cancer cell 
proliferation and progression; moreover the inhibition of XBP-1 has led to the sensitization of 
multiple myeloma cells to ER Stress induced apoptosis (Koong et al., 2006, Chen et al., 2014). 
The data presented here suggests that bisPMB and TG increased XBP-1 transcription in 
WHCO1 cells.  
We observed an increase in ATF6 transcription in the bisPMB sample. When ER stress is 
induced, the ATF6 transmembrane protein translocates to the Golgi apparatus and is cleaved by 
site 1 and 2 protease (sp1 and sp2). This generates the 50 kDa transcription factor, which 
regulates  transcription of the ER resident chaperones and forms heterodimers with XBP-1  to 
regulate transcription of the ER associated degradation (ERAD) system (Yamamoto et al., 
2007). ATF6α has been implicated in the pathogenesis of hepatocellular carcinomas (Arai et al., 
2006). However, an anticancer agent desiprimine was found to activate ATF6 in C6 glioma cells 
(Ma et al., 2013). IRE1 is upstream of ATF6 activation during ER stress (Wang et al., 2000). 
The increase in ATF6 transcription during ER stress has been attributed to a possible positive 
feedback loop aimed at replenishing the ATF6 transmembrane protein (Koong et al., 2006). 
Therefore, the increase in ATF6 transcription in the bisPMB sample may be attributed to the 
activation of ATF6 and IRE1UPR pathway. 
In addition to the PERK, IRE-1 and ATF6 UPR pathways, ER stress also activates another 
cytoprotective mechanism called endoplasmic reticulum associated degradation (ERAD). ERAD 
involves the removal of terminally misfolded proteins through degradation via the ubiquitin – 
proteasome system (Stolz and Wolf, 2010). Aberrations in protein ubiquitination have been 
associated with various types of cancer, such as the ubiquitin proteasome system (Grande et al., 
2012, (Xu and Jaffrey, 2013). Furthermore, ubiquitin-proteasome degradation has been 
identified as a potential target for cancer treatment and prevention (Chen et al., 2010). We 
observed a deregulation of DEG’s involved in the ERAD pathway including Ubc6 and EDEM in 
the bisPMB sample. This suggests that the ubiquitin-proteasome degradation system may be a 
possible target for bisPMB. Consistently, the Ub6 and EDEM also formed part of DEGs from 
the TG sample. Thus, ERAD may be triggered by both bisPMB and TG in WHCO1 cells.  
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Another pathway that we had observed to be enriched in the bisPMB and TG sample was the 
MAPK pathways. The MAPK includes p38, JNK and MEK/ERK. The p38 and JNK/MAPK 
pathways are associated with cellular stress and the induction of apoptosis, while MEK/ERK is 
associated with cell survival (Chang and Karin, 2001). The enrichment of these pathways may 
be caused by WHCO1 cancer cell stress response to bisPMB or TG. It is well known that cross-
talk exists between the MAPK and ER stress pathways. JNK is activated in response to ER 
stress through the IRE1 transmembrane protein (Urano et al., 2000). Furthermore, the ATF6 
UPR transmembrane protein is a p38 target for phosphorylation. For example, the p38 MAPK 
enhances the trans - activation activity of the ATF6 transcription factor (Thuerauf et al., 1998, 
Luo and Lee, 2002). Together, this implies that WHCO1 cells may respond to bisPMB and TG 
treatment by activating stress-associated pathways involving crosstalk between MAPK and ER 
stress pathways. 
In addition to the ER stress and MAPK pathways, the cholesterol biosynthesis canonical 
pathways including the superpathway of cholesterol biosynthesis, cholesterol biosynthesis I, 
cholesterol biosynthesis II (via 24, 25- dihydrolanosterol) and cholesterol biosynthesis III (via 
Desmosterol) are upregulated in both the bisPMB and TG sample.  Garlic derived compounds 
ajoene and allicin have been implicated in cholesterol biosynthesis. Ajoene has been reported to 
inhibit cholesterol synthesis in a liver homogenate (Sendl et al., 1992). Ajoene and allicin 
inhibited cholesterol biosynthesis in a concentration dependent manner at the stage of HMG-
CoA-reductase and at a later stage of lanosterol 14 alpha-demethylase in HepG2 cells and rat 
hepatocytes (Gebhardt et al., 1994). Ajoene was also shown to inhibit cholesterol biosynthesis 
by affecting the 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG-CoA) reductase and late 
enzymatic steps of the mevalonate (MVA) pathway (Ferri et al., 2003). It is likely that bisPMB 
inhibits cholesterol biosynthesis like ajoene. Thus the elevation in gene transcription of the 
genes involved in cholesterol biosynthesis canonical pathway in the bisPMB sample can be 
attributed to a negative feedback mechanism.  
 
In order to demonstrate how DEGs relate with genes from different pathways, global molecular 
gene networks were generated with IPA. Genes have been suggested to interact physically or 
functionally as a network in order regulate molecular functions. The IPA ranks gene molecular 
networks according to the total number of genes in the network and the number of interactions 
between the genes forming part of the network. In addition, the IPA scores the gene networks 
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according to the number of DEGs included in the network with  the most highly interconnected 
genes in high ranking networks affecting more cells functions called network hubs (Ravasz et 
al., 2002, Spirin and Mirny, 2003, Grigoryev et al., 2011). In this study, the most highly ranked 
and thus top scoring network in the bisPMB sample was the “cellular compromise, function and 
maintenance and cellular assembly and organization” network. The most interconnected DEG in 
this network was found to be XBP1. The genes that are interconnected with XBP1 are all 
involved in the protein processing pathway and are reported to be downstream targets of XBP-1 
transcriptional activity.  Thus, the direct interaction of the genes with XBP-1 is based on XBP-1 
transcriptional activity. XBP1 regulates the transcription of Grp78 (HSPA5), PDI, EDEM1, 
EDEM2, Grp94 (HSP90B1) and DNAJC3 (p58i), which are involved in protein folding and 
degradation (Lee et al., 2003a, Koong et al., 2006, Yamamoto et al., 2007). Furthermore, XBP-1 
also regulates the transcription of GOLGA4, SEC24D, FKBP14, SEC61A1, SRPRB, COPE and 
SSR3 in NIH-3T3 fibroblast cell line (Sriburi et al., 2007). These genes are involved in protein 
translocation into the ER and trafficking to the Golgi apparatus. On the other hand, ATF6 
regulates the transcription of XBP-1 (Yoshida et al., 2001a, Sriburi et al., 2007) which suggests 
that XBP-1 plays a significant role in the WHCO1 cell response to bisPMB. Thus the early 
response of WHCO1 cells to sub-toxic concentrations of bisPMB may be primarily governed by 
XBP-1 transcription during UPR activation. 
In comparison, the most highly ranked molecular network in the TG sample was called the “cell 
cycle, cellular assembly and organization, DNA replication, Recombination and Repair”. The 
most interconnected gene within this network was found to be the small ubiquitin like modifier 
2 (SUMO2), which binds to other proteins in order to post translationally modify them for DNA 
repair, mitosis and signal transduction (Schou et al., 2014, Gonzalez-Prieto et al., 2015). This 
finding is in line with the GO biological process reports in which TG was found to significantly 
enrich mitosis and DNA metabolic process, deregulate cell cycle KEGG pathway and deregulate 
the IPA canonical pathway “role of BRCA1 in DNA mediated response”. The activation of this 
pathway has been reported to implicate DNA damage induced cell cycle checkpoint (Wu et al., 
2010). Thus at the selected concentration, TG essentially regulates DNA damage and cell cycle 
functions in WHCO1 cells.  
Here, we have demonstrated that bisPMB primarily deregulated genes involved in UPR 
signalling. Compared to other canonical pathways, the ER stress pathway was found to be the 
most significantly enriched pathway in both bisPMB and TG samples. Moreover, the molecular 
gene networks revealed that XBP-1 drove the molecular response in the bisPMB sample. 
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However, the SUMO2 gene regulated the response in the TG sample. Although TG also 
deregulated the ER stress pathway, as expected, it primarily mediated DNA damage and cell 
cycle pathways. This may be due to the cytotoxic concentration used. In hindsight, a nanomolar 
concentration of TG may have presented a better positive control to compare to a 3.5 µM 
concentration of bisPMB. In order to confirm the induction of ER stress/UPR and MAPK in 
bisPMB-treated WHCO1 cells, proteins and ER stress genes representing the UPR arms and 















CHAPTER 4: Role of UPR and MAPK signalling 
pathways in the cytotoxicity of bisPMB in WHCO1 cells 
 
3.1    INTRODUCTION 
The unfolded protein response (UPR) is made up of pro-survival intracellular pathways which are 
activated in response to ER stress. The role of UPR activation is to enable the cell to restore ER 
homeostasis (Schroder and Kaufman, 2005, Hetz, 2012). However, if ER stress persists, and 
homeostasis is not restored, the UPR pathways trigger apoptosis (Szegezdi et al., 2006). Emerging 
reports have illustrated that garlic OSC induce ER stress in cancer cells. Our lab has found that 
ajoene targets and accumulates in the ER of cancer cells where it S-thiolate numerous proteins to 
interfere with protein folding, resulting in an accumulation of misfolded protein aggregates. In 
support of this, ajoene was further found to increases levels of ubiquitinated proteins and to 
elevate GRP78/BIP expression levels in MDA-MB-231 breast cancer cells (Kaschula et al., 2015), 
supporting  UPR induction. Furthermore, ER stress markers have been implicated in garlic OSC 
induced apoptosis. DADS and DATS triggered ER stress associated apoptosis in human basal cell 
carcinoma BCC and colon cancer COLO 205 cells respectively (Yang et al., 2009, Wang et al., 
2012). Therefore ER stress and UPR activation may play an important role in garlic OSC 
cytotoxic activity. 
Emerging evidence has demonstrated that UPR induced apoptosis is linked to MAPK signalling 
(Szegezdi et al., 2006, Darling and Cook, 2014). The most studied members of the MAPK 
pathway include the JNK1/2, MEK/ERK and p38. The JNK1/2 and p38 MAPK proteins belong to 
the stress activated protein kinase (SAPK) family of proteins which are activated by stress stimuli 
such as chemotherapeutic drugs and are associated with apoptosis (Raingeaud et al., 1995, Davis, 
2000, Mhaidat et al., 2007). In contrast, the MEK/ERK pathway is a pro-survival pathway which 
has been implicated in apoptosis suppression (Erhardt et al., 1999). The garlic OSCs are reported 
to enhance the activation of MAPK in vitro. For example DADS, DATS and ajoene have been 
shown to activate the JNK, p38 and MEK/ERK signalling pathways in various cancer cell lines 
(Antlsperger et al., 2003, Xiao et al., 2004, Yang et al., 2006b, Shin et al., 2012, Shin et al., 2014).  
Chapter 3 of this thesis showed that bisPMB, an ajoene analogue, primarily elicited transcriptional 
changes in genes that form part of the UPR pathway in the ER. In addition, bisPMB and TG, an 
ER stress inducer, significantly enriched protein processing in the ER and MAPK signalling 
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pathways. This suggests that the UPR and the MAPK signalling pathways may play a role in the 
cytotoxicity of bisPMB in WHCO1 cells. Thus, in this chapter, we investigated whether bisPMB 
induces activation of the UPR and MAPK signalling pathways by assessing changes in expression 
levels and certain posttranslational modifications of key proteins in these pathways. Furthermore 
inhibitors were used to further probe the importance of these pathways in the cytotoxic 
mechanism of action of bisPMB. TG, a well documented ER stress inducer, was used as a positive 
control in all experiments. For the experiments conducted in this chapter, we chose to use 7 µM 











Figure 4.1 Schematic representation of the mechanism of action of ajoene in cells. Upon, ajoene treatment, nascent 
proteins form mixed disulphide bonds with ajoene (in this case: bisPMB), leading to protein misfolding. The misfolded 
proteins are either degraded via the ubiquitin proteosome system or they trigger UPR and ER stress activation. On the other 
hand, properly folded proteins are directed to the Golgi apparatus to the extracellular space or plasma membrane (Kaschula 
et al., 2015).  
 
3.2   RESULTS 
3.2.1 Expression of GRP78/BIP in bisPMB treated WHCO1 cells 
 
In response to an accumulation of misfolded proteins in the ER, cells activate the UPR which results in 
increased expression of foldases and molecular chaperones including GRP78/BIP.  
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In order to determine if bisPMB affects the expression of GRP78/BIP, western blot analysis was 
performed as described in section 6.9. The total expression of GRP78/BIP (72 kDa and 78 kDa) was 
found to increase 4 - 5 fold in WHCO1 cells treated with bisPMB at the 7 µM concentration from 1 h 
and this was sustained up to 24 h. TG (1 M) was used as a positive control and was found to trigger an 
approximate 5-fold increase in GRP78/BIP expression (figure 4.2).   
Interestingly, the majority of the GRP78/BIP in bisPMB-treated cells was in the 72 kDa form as 
opposed to TG which was in the 78 kDa form. The clear increase in total GRP78/BIP expression 
supports bisPMB inducing UPR in WHCO1 cells.  
 
 
             
 
             
 
 
Figure 4.2 The induction of GRP78/BIP protein expression in bisPMB treated WHCO1 cells. Total cell lysate extracted 
from WHCO1 cells treated with 7 µM concentration of bisPMB for 1, 2, 4, 6, 8, 16 and 24 hours or 1µM TG for 24 hours, 
was analysed by western blot. The nitrocellulose membrane was subsequently probed with anti-GRP78 and anti-GAPDH 
antibodies. Relative quantities of total GRP78 (78 and 72 kDa) expression bands were normalised and quantified relative to 
GAPDH. This blot is representative of three independent experiments.   
 
3.2.2 BisPMB increased protein ubiquitination in WHCO1 cells 
 
One of the processes that occur in response to ER stress induced by an accumulation of misfolded 
proteins is ER associated degradation (ERAD). The ERAD attempts to recover ER homeostasis and 
reduce ER protein load, by eliminating misfolded proteins that can no longer be refolded (Oslowski 
and Urano, 2011). The ubiquitin proteasome system (UPS) forms an integral part of ERAD (Meusser 
et al., 2005), where misfolded proteins are ubiquitinated and targeted for degradation.  
In order to ascertain whether bisPMB activates the UPR, the levels of ubiquitinated proteins in 
WHCO1 cells treated with bisPMB were detected using western blot analysis. There was no change in 
the level of protein ubiquitination between 2 - 4 hour post bisPMB treatments, compared to the 
untreated control.  BisPMB treated WHCO1 cells were found to display an increase in ubiquitinated 
proteins between 6 - 24 hours compared to the untreated control, with maximal 5-fold between  8 and 
Time (Hours) 
GRP78/BIP  
GAPDH (35 kDa) 
UT 2 4 6 8 16 24 TG 1 
72 kDa 
78 kDa 
1.00 4.60 4.44 4.39 4.43 4.61 4.64 4.58 4.87 
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16 hours (figure 4.3). No increase in the levels of Ub proteins were however observed in the 1 µM TG 
treated cells (figure 4.3). Although TG is an ER stress inducer, and thus expected to increase protein 
ubiquitination. The absence of change in protein ubiquitination in the TG sample can be attributed to 
the time point selected for TG treatment as ubiquitination appeared to be an early event for the 
bisPMB compound.  All in all, these findings support bisPMB promoting ubiquitination of proteins in 
WHCO1 cells, which may suggest ERAD activation. 
 
 
     
 









Figure 4.3 The induction of protein ubiquitination in bisPMB treated WHCO1 cells. Total cell lysate was collected 
from WHCO1 cells treated with bisPMB at the half 7 µM concentration for 2, 4, 6, 8, 16 and 24 hours or 1µM TG for 24 
hours and analysed by western blot. The blot was probed with anti-ubiquitin and anti-GAPDH primary antibodies and 
quantitated relative to GAPDH. This blot is representative of three independent experiments.   
 
Apart from increased GRP78/BIP expression and induction of ERAD, cells respond to the misfolded 
protein accumulation by activating the UPR. The UPR is activated through three transmembrane 
proteins PERK, IRE-1 and ATF6. 
3.2.3 BisPMB increases ATF4 expression  
 
The activation of the PERK/ATF4 UPR pathway leads to the phosphorylation and inactivation of 
eIF2α, which selectively enhances the translation of ATF4 (Lai et al., 2007). In order to examine 
GAPDH (35 kDa) 
Ubiquitin 
1.00 5.21 4.86 2.28 0.86 0.97 1.51 1.41 





whether bisPMB activates the PERK/ATF4 pathway, the time-dependent expression of ATF4 in 
bisPMB treated WHCO1 cells was analysed and compared to TG. There is an initial decrease in 
ATF4 expression in WHCO1 cells after one hour of bisPMB treatment compared to the untreated. 
No changes were observed between 2 – 6 h compared to untreated control.  BisPMB was found to 
trigger a time dependent increase in the expression of ATF4 in WHCO1 cells (figure 4.4). The 
increase in ATF4 protein levels was more pronounced in the later time points from 8 - 24 hours with 
maximal expression at 24 h, and in the 1 µM TG for 24 hours. From this data, it appears that bisPMB 
may mediate UPR signalling through the PERK/ATF4 signalling pathway.  
 
 
              
              
  
Figure 4.4.  Time dependent increase of ATF4 protein expression in WHCO1 cells. Total cell lysate was 
extracted from WHCO1 cells treated with 7 µM concentration of bisPMB for 1, 2, 4, 6, 8, 16 and 24 hours or with 1 
µM TG for 24 hours, and analysed by western blot. The membrane was probed with an anti-ATF4 antibody and 
GAPDH was used as a loading control. The protein levels were normalized and quantified relative to GAPDH levels. 
This blot is representative of 2 independent determinations. 
3.2.4 BisPMB activates the ATF6 pathway  
 
The UPR pathway is also activated through the ATF6 sensor. In response to ER stress, the ATF6 
transmembrane protein is cleaved, by site specific proteases 1 and 2 in the Golgi apparatus, from a 
90 kDa protein to a 50 kDa transcription factor (Ye et al., 2000). The activation of ATF6 was 
investigated in WHCO1 cells treated with bisPMB at the 7 µM concentration. No change was 
observed in the ATF6α 90 kDa expression levels between the untreated and after 1 hour bisPMB 
treatment in WHCO1 cells. On the other hand, bisPMB induced decrease in the protein levels of 
ATF6α (90kDa) between 2 - 24 hours compared to the untreated control (figure 4.5). There was 
no detectible ATF6 (90 kDa) at the time point 2 - 6 hours followed by a subsequent rise in ATF6α 
(90 kDa) expression was observed from 8 - 24 hours in the bisPMB treated sample. Additionally, 
TG-treated WHCO1 cells were also found to display decreased ATF6α (90 kDa) expression 
 ATF4 (37 kDa) 
GAPDH (35 kDa) 
Time (Hours) 
UT 2 4 6 8 16 24 TG 1 
1.0 1.0 1.1 1.1 1.3 1.6 1.4 2.1 2.6 
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(figure 4.5). Taken together, these results strongly imply that bisPMB, activates the ATF6 arm of 
UPR pathway in WHCO1 cells between 4 - 6h.  
 
 
        
              
              
 
Figure 4.5 Time dependent decrease in ATF6α (90 kDa) protein expression in WHCO1 cells. Total cell lysate 
extracted from WHCO1 cells treated with 7 µM concentration of bisPMB for 1, 2, 4, 6, 8, 16 and 24 hours or 1 µM 
TG for 24 hours, and analysed by western blot. The membrane was probed with anti-ATF6α and GAPDH was used as 
a loading control. The protein levels were normalized and quantified relative to GAPDH. This blot is representative of 
2 independent determinations 
3.2.5 BisPMB activates the IRE-1/XBP-1 pathway 
 
After observing ATF6 activation, the IRE-1/XBP-1 UPR pathway was examined in WHCO1 cells 
treated with bisPMB or TG. When activated, IRE-1 orchestrates cleavage of XBP1 mRNA. The 
resulting spliced XBP1 (XBP1s) mRNA variant is translated into a transcription factor that 
regulates the expression of certain ER stress genes. By RT-PCR bisPMB was found to cause an 
increase in XBP1 spliced variant between 1- 5 hour only but not at the later time points between 8 
and 24h. In comparison, the TG control was also found to cause spliced XBP1 at the late 24 h 
time point (figure 4.6). These results suggest that bisPMB activates the IRE-1/ XBP-1 pathway 




   
Figure 4.6 Time dependent splicing of XBP1 mRNA in bisPMB or TG treated WHCO1 cells.  mRNA was 
extracted from WHCO1 cells incubated with bisPMB at 7 µM concentration for 1, 5, 8 and 24 hours or 1 µM TG for 
24 hours. XBP1 and GAPDH gene expression was analysed by RT-PCR. The PCR products show the presence of the 
XBP-1s in WHCO1 cells treated with bisPMB for 1 - 5 hours or with 1µM TG for 24 hours. The blot above is 
representative of three independent experiments. 
XBP-1 (s) 
GAPDH 
UT 1 5 8 24 TG 
Time (Hours) 
ATF6α  
GAPDH (35 kDa) 
Time (Hours) 
XBP-1 (u) 
UT 6 8 16 24 TG 1 2 4 





3.2.6 ER stress and cytotoxicity  
3.2.6.1 BisPMB increases CHOP/GADD153 expression in a time dependent manner 
 
When UPR is insufficient in establishing ER homeostasis, apoptosis is induced. All three UPR 
pathways i.e PERK/ATF4, ATF6 and IRE1/XBP-1 converge on the transcription of 
CHOP/GADD153 (Ma et al., 2002, Oyadomari and Mori, 2004), which is associated with ER 
stress induced apoptosis.  
In order to determine if WHCO1 cells treated with 7 µM concentration of bisPMB induce the 
expression of CHOP/GADD153, western blot analysis was conducted. The CHOP/ GADD153 
expression decreased between 1 - 6 hours of bisPMB treatment compared to the untreated control 
(figure 4.7). CHOP/GADD153 expression was then found to be elevated in WHCO1 cells treated 
with bisPMB between 8 -16 hours and 1 µM TG for 24 hours compared to the untreated control 
(figure. 4.7). These results show that both bisPMB and TG induce CHOP/GADD153 expression 
in WHCO1 cells.  
 
                                                             
                     
                    
                  
 
Figure 4.7 Time dependent increase of CHOP/GADD153 protein expression in bisPMB treated WHCO1 cells. 
Total cell lysate was collected from WHCO1 cells treated with bisPMB at the 7 µM concentration for 1, 2, 5, 8 and 24 
hours or 1 µM TG for 24 hours and analysed by western blot. The blot was probed with anti-CHOP and anti-GAPDH 
antibodies and protein bands were quantified relative to untreated cells and the GAPDH loading control. This blot is 
representative of 2 independent determinations. 
 
3.2.6.2 Silenced CHOP/GADD153 reverses the anti-proliferative activity of bisPMB 
 
Seeing that bisPMB enhanced CHOP/GADD153 expression and that CHOP/GADD153 promotes 
ER stress induced apoptosis (Matsumoto et al., 1996, Oyadomari and Mori, 2004, Marciniak et 
al., 2004).We addressed the question of whether CHOP/GADD153 played a role in the inhibitory 
CHOP (27 kDa) 
GAPDH (35 kDa) 
UT 1 2 6 8 16 24 TG 4 




effect of bisPMB in WHCO1 cell viability by silencing CHOP using siRNA and testing for 
WHCO1 cell viability following bisPMB treatment. 
In order to validate the silencing of CHOP/GADD153 by siRNA, we stimulated CHOP/ 
GADD153 expression with bisPMB following pre-incubation with siCHOP and siControl. The 
siControl was used as a negative control for CHOP/ GADD153 silencing in this study. As 
expected, bisPMB enhanced the expression of CHOP compared to the untreated control. In 
addition, the combination of bisPMB and siControl also enhanced CHOP/ GADD153 expression 
compared to the untreated control. Ultimately, 60nM of CHOP/GADD153 siRNA was chosen as 
this concentration was found to reduce the expression of CHOP by approximately 3 folds 
compared to the bisPMB treated and the siRNA control (figure. 4.8). We were therefore able to 










Figure 4.8 CHOP siRNA reduced protein expression of CHOP in WHCO1 cells treated with bisPMB. Total cell 
lysate was extracted from WHCO1 cells incubated with media only or 60 nM CHOP siRNA or 60 nM control siRNA 
and bisPMB for 8 hours and examined for CHOP protein expression by western blot. The blot was subsequently 
probed with anti-CHOP and anti-GAPDH antibodies and protein bands were quantified relative to the untreated 
control and to GAPDH. This blot is representative of 2 independent determinations. 
 
Following the successful silencing of CHOP/GADD153, WHCO1 cells were incubated with 
bisPMB in combination with siCHOP or siControl for 24 hours and subjected to the MTT assay, 
which quantified WHCO1 cell viability. As expected the 7 µM concentration of bisPMB and 1 
µM TG significantly reduced WHCO1 cell viability by 2 folds (figure 4.9). Furthermore, the 
siControl had no effect on the inhibitory effect of bisPMB and TG on WHCO1 cell viability. 
However, the siRNA mediated CHOP/GADD153 knockdown was found to completely abrogate 
the ability of bisPMB to inhibit WHCO1 cell viability; and this was not observed in the siControl 
or in the untreated cells (figure 4.9 A). Furthermore, CHOP was found to have a similar effect in 
siCHOP - - - + 
siControl - - + - 
 bisPMB (8h) - + + + 
     
GAPDH (35 kDa) 
CHOP/ GADD153 (27 kDa) 
1.00 1.89 5.50 4.03 
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TG (figure 4.9 B) as seen for bisPMB. These findings demonstrate that CHOP/GADD153 plays a 













Figure 4.9 Reversal of bisPMB antiproliferative activity by CHOP knockdown. WHCO1 cells were incubated 
with control and CHOP siRNA prior to treatment with bisPMB at 7 µM concentration (A) or 1 µM TG (B) 24 hours 
and cell viability was determined using the MTT assay. Each column represents an average of three technical 
replicates     although the graphs are representative of three independent experiments. A) Average cell viability in 
WHCO1 cells treated with bisPMB, in the presence of siControl and siCHOP. B) Average cell viability in WHCO1 
cells treated with , TG, in the presence of siControl and siCHOP. A t-test statistical ** indicated p-value < 0.01, 
****indicated p-value < 0.0001. 
 
3.2.7 BisPMB induced MAPK signalling activation in WHCO1 cells 
3.2.7.1 Induction of JNK activation by bisPMB in WHCO1 cells  
 
ER stress induced apoptosis is linked to the JNK pathway, which in turn is triggered through the 
IRE-1 pathway. JNK pathway activation is commonly examined by measuring the 
















































































We observed that bisPMB increased JNK1/2 phosphorylation/activation in a time dependent 
manner compared to the untreated control with maximal activation at 8 h (figure 4.10). However, 
there was no change in the phosphorylated levels of JNK1/2 in TG treated WHCO1 cells 
compared to the untreated control. This data suggests that bisPMB induces JNK pathway 
activation in WHCO1 cells. The role played by JNK activation in bisPMB induced cytotoxicity 
was further examined using a SP600125 chemical inhibitor. 
 
      
                    
 
        
Figure 4.10 BisPMB induced JNK1/2 activation in WHCO1 cells. Total cell lysate was extracted from WHCO1 
cells treated with bisPMB at the 7 µM concentration for 5, 8, 12, 16 and 24 hours or with 1 µM TG for 24 hours and 
analysed by western blot . The blot was  probed using both anti-phosphorylated JNK1/2 and anti-JNK1/2 antibodies 
and protein bands were quantified and normalised relative to the untreated control and total JNK1/2. This blot is 
representative of 2 independent determinations. 
 
3.2.7.2 Effect of JNK inhibition on bisPMB anti-proliferative activity 
 
Prior to using the JNK inhibitor SP600125 in WHCO1 cells, the optimal concentration had to be 
established. The phosphorylation/activation of JNK was found to be progressively inhibited with 
increasing SP600125 concentration (figure 4.11) and 30 µM SP600125 was found to induce the 
greatest reduction of JNK phosphorylation.  
 
          
                                                                                                                      
 
                         
 
Figure 4.11 Inhibitor SP600125 reduces JNK1/2 phosphorylation in a concentration dependent manner.  
WHCO1 cells were incubated with 5, 10, 20 or 30 µM SB600125 for 24 hours. Total cell lysate was extracted and 
analysed by western blot. The membrane was subsequently probed with anti-phosphorylated JNK1/2 and l JNK1/2 
primary antibodies. The phosphorylated and total JNK1/2 protein expression was quantified and normalised relative 
to untreated control and total JNK1/2. This blot is representative of 2 independent determinations. 
 





UT 5 8 12 16 24 TG 
Time (Hours) 
UT 5 10 20 30 
1.00 2.20 4.34 2.16 1.76 2.01 1.09 
1.00 1.18 1.03 0.69 0.19 
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Consequently, 30 µM SP600125 was selected for analysis of the role of JNK activation in 
bisPMB and TG cytotoxicity. Following pre-incubation with 30 µM SP600125, WHCO1 cells 
were incubated with bisPMB at 7 µM concentration or TG. The MTT assay was then performed in 
these cells to assess viability. The 30 µM SP600125 alone, had no effect of WHCO1 cell viability. 
WHCO1 cells were found to display a 47 % and 34 % decrease in cell viability respectively after 
treatment with bisPMB alone or in combination with SP600125 (figure 4.12). This demonstrated 
that the inhibition of JNK phosphorylation by SP600125 had no effect on bisPMB cytotoxic 
activity against WHCO1 cells. As previously observed, 1 µM TG significantly reduced WHCO1 
cell viability by 2 folds. However, the inhibition of JNK activation completely reversed the 
cytotoxicity of TG in WHCO1 cells (figure 4.12). This demonstrated that the JNK pathway plays 
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Figure 4.12 The effect of JNK inhibitor SB600125 bisPMB antiproliferative activity. WHCO1 cells were pre-
incubated with 30 µM SB600125 and subsequently treated with the 7 µM concentration of bisPMB for 24 hours. 
WHCO1 cell viability was subsequently measured using the MTT assay. Each bar represents the average absorbance 
reading from four technical replicates and is representative of three independent experiments. A t-test statistical 





3.2.8 BisPMB induces an increase in p38 activation  
 
The p38 MAPK signal transduction pathway has been linked to apoptosis induction and is known 
to be activated in cells in response to external stimuli such as ER stress. In order to determine if 
the 7 µM concentration of bisPMB enhanced the activation of p38, western blot analysis was 
performed in WHCO1 cells. BisPMB was found to enhance the phosphorylation/activation of p38 
in a time dependent manner (figure 4.13) which occurred within 2 hours and was sustained 
continually at a level of 4 fold up to 24 hours. TG was also found to increase p38 activation in 
WHCO1 cells compared to the untreated control. 
   
 
 
            
Figure 4.13 BisPMB induced p38 phosphorylation/activation in WHCO1 cells in a time dependent manner. 
Total cell lysate was extracted from WHCO1 cells treated with bisPMB at 7 µM concentration for 2, 4, 6, 8, 16, 24 
hours and 1 µM TG for 24 hours and analysed by western blot. The membrane was subsequently probed with anti-
phosphorylated p38 or total p38 antibodies and protein bands were and normalized to total p38. This blot is 
representative of 2 independent determinations. 
 
 
3.2.8.1 The role of p38 MAPK on bisPMB induced anti-proliferative activity 
 
The phosphorylated/activated form of p38 is commonly detected in stressed cells. In order to 
determine the concentration of the p38 inhibitor SB 203580 required to reverse the bisPMB 
induced phosphorylation of p38, whole cell lysate was extracted from cells pre-treated with 
varying concentrations of SB 203580 together with the 7 µM concentration of bisPMB. BisPMB 
alone and in combination with 10, 50 and 100 µM SB 203580 displayed elevated phosphorylated 
p38 expression levels compared to the untreated control (figure 4.14). SB 2035580  was found to 
reduce bisPMB induced p38 phosphorylation/activation in a concentration dependent manner in 
bisPMB treated cells (figure 4.14). Consequently, 100 µM of SB 203580 was found to display the 
lowest levels of bisPMB induced p38 phosphorylation, although it did not completely inhibit p38 
phosphorylation, it was chosen as the concentration of inhibitor for the study as it did not induce a 
cytotoxic effect in WHCO1 cells.  













   
 
Figure 4.14 Inhibition of p38 activation with SB 203580 in WHCO1 cells treated with bisPMB. Total cell lysate 
was extracted from WHCO1 cells pre-treated with 10, 50 and 100 µM SB203580 followed by treatment with bisPMB 
at 7 µM concentration analysed using western blot. The membrane was subsequently probed with anti-phosphorylated 
p38 or Total p38 antibodies and protein bands were quantified and normalised relative to the untreated control and 
total p38. This blot is representative of 2 independent determinations. 
In order to determine the role played by p38 activation in the cytotoxic effect of bisPMB in 
WHCO1 cells, cells were treated with bisPMB in the absence and presence of p38 inhibitor SB 
203580 and cell viability was then evaluated using the MTT assay. The 100 µM SB 203580 alone 
did not have any effect on WHCO1 cell viability (figure 4.15). As expected, 7 µM concentration 
of bisPMB and 1 µM TG significantly reduced WHCO1 cell viability and the inhibition of p38 by 
SB 203580 was found not to affect the cytotoxic activity of bisPMB or TG in WHCO1 cells 
(figure 4.15). This demonstrated that p38 did not play a major role in bisPMB and TG cytotoxic 








Figure 4.15 The role played by p38 on bisPMB and TG-induced cytotoxicity in WHCO1 cells. WHCO1 cells 
were pre-incubated with 100 µM SB203580 and treated with the 7 µM concentration of bisPMB or 1 µM TG for 24 
hours. WHCO1 cell viability was measured using the MTT assay as described in section 6.2.2. Each bar represents 
the average absorbance reading from four technical replicates +- SD. This graph is representative of three independent 
experiments. A t-test and one-way ANOVA statistical analysis was performed using GraphPad Prism and ** 
indicated p-value < 0.01, *** indicated p-value < 0.0001. 
Phosphorylated p38 
Total p38 
1.00 2.72 2.10 1.62 1.21 




















































3.2.9 MEK/ERK activation by bisPMB 
 
The MEK/ERK pathway is known as a survival MAPK pathway and is activated by various garlic 
derived compounds such as ajoene (Antlsperger et al., 2003). The activation of the MEK/ERK 
pathways is usually evaluated by assessment of phosphorylated ERK1/2 MAPK. Total cell lysate 
extracted from WHCO1 cells treated with the 7 µM concentration of bisPMB or 1 µM TG was 
therefore analysed by western blot. BisPMB was found to enhance the ERK1/2 
phosphorylated/activated levels in a time dependent manner compared to the untreated control and 
TG was also found to increase ERK1/2 phosphorylation (figure 4.16). BisPMB induced 
phosphorylation/activation of ERK1/2 was markedly pronounced within 5 minutes and with 
maximal induction at 4 hour (figure 4.16). However, the levels of phosphorylated ERK1/2 
declined after 6 hours of bisPMB treatment with complete inactivation observed at 16 h. These 
results suggest that bisPMB induced transient, early activation of ERK1/2 activation while TG 
ERK1/2 activation was still observed at 24 hours. 
 
 
                                                     
 
 
                       
 
Figure 4.16 Time dependent activation of ERK in WHCO1 cells treated with bisPMB or TG. Total 
WHCO1 cell lysate was extracted and analysed by western blot as described in section 6.9.  Antibodies against 
phosphorylated ERK1/2 and ERK2 were used for probing. Each bar represents the area density of the p-ERK1/2 
protein band relative to the total ERK2 band. This blot is representative of three independent experiments. 
 
3.2.9.1 The role of MEK/ERK signalling in bisPMB anti-proliferative activity 
 
In order to determine the function of the MEK/ERK signal transduction pathway in the cytotoxic 
activity of bisPMB, specific MEK1/2 inhibitor, U0126 was used to block ERK1/2 activation. 
Phosphor ERK1/2 
Total ERK2 
UT 4 6 8 16 TG 5 min 30 min 2 
Time (Hours) 
1.00 6.58 11.86 2.80 2.06 0.92 2.56 4.91 5.86 
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Initially, a concentration dependent experiment for U0126 was performed in WHCO1 cells to 
ascertain the amount of U0126 required for MEK1/2 inhibition. The reduction in ERK1/2 
phosphorylation was clearly visible in WHCO1 cells treated only with U0126. However, MEK1/2 
inhibition was evident by the concentration dependent reduction in ERK1/2 phosphorylation in 
WHCO1 cells treated with bisPMB for 30 minutes (fig. 4.17). As a result, 10 µM U0126 was 
chosen as the most effective concentration as it resulted in the greatest reduction in ERK1/2 











Figure 4.17 Concentration dependent inhibition of ERK1/2 phosphorylation with U0126. Following 
WHCO1 incubation with indicated concentrations of U0126, bisPMB and TG, cell lysate was extracted and 
analysed by western blot. The membrane was subsequently probed with anti-phosphorylated ERK1/2 or total 
ERK2 antibodies and protein bands were quantified and normalised relative to the untreated control and total 
ERK 2. This blot is representative of 2 independent determinations. 
 
Following establishment of the optimal U0126 concentration, the role played by the 
MEK/ERK signal transduction pathway in the cytotoxic activity of bisPMB was investigated. 
The untreated control and 10 µM U0126 only treated WHCO1 cells displayed maximal cell 
viability. Furthermore, the 7 µM concentration of bisPMB significantly reduced the WHCO1 
cell viability. Inhibition of the MEK1/2 using 10 µM U0126 was in fact found to display an 
increase in the cytotoxic behaviour of bisPMB in WHCO1 cells (figure 4.18). On the other 
hand, 1 µM TG reduced WHCO1 cell viability compared to the untreated control. However, 
MEK1/2 inhibition was found to have no effect on the cytotoxic activity of 1 µM TG (figure 
4.18). These results suggest that the activation of the MEK/ERK pathway in bisPMB treated 
WHCO1 cells plays a pro-survival role. Therefore inhibition of MEK1/2 seemingly sensitizes 
WHCO1 cells to bisPMB    
P-ERK1/2 
Total ERK2 
1.00 0.15 0.16 3.13 3.45 1.67 2.95 0.24 



























































Figure 4.18 Inhibition of ERK1/2 increased the cytotoxic activity of bisPMB in WHCO1 cells. WHCO1 
cells were pre-incubated with 10 µM U0126 and subsequently treated with the 7 µM concentration of bisPMB 
or 1 µM TG for 24 hours. WHCO1 cell viability was subsequently measured using the MTT assay. Each bar 
represents the average absorbance reading from three technical replicates. This graph is representative of three 
independent experiments. A t-test and one-way ANOVA statistical analysis was performed using GraphPad 
Prism and * indicated p-value < 0.05 and *** indicated p – value < 0.0001. 
 
3.3    DISCUSSION 
ER stress and the MAPK signalling pathways have been implicated in the cytotoxic mechanism of 
action of garlic derived DAS, DADS and DATS, (Das et al., 2007, Yang et al., 2009, Wang et al., 
2012). In addition, garlic derived ajoene is reported to activate MAPK in human leukaemia HL60 
cells (Antlsperger et al., 2003) and enhances the expression of ER stress marker GRP78/BIP in 
MDA-MB-231 cells (Kaschula et al., 2015). However the role played by the ER stress and UPR in 
these cytotoxic effects is not clear. Moreover, the role played by MAPK, ER stress and UPR has 
not been clearly defined for bisPMB. 
We followed up from Chapter 3, where bisPMB was observed to primarily target the UPR. Here 
we show that bisPMB, an ajoene analogue, induced UPR and MAPK signalling pathways in 
WHCO1 cells in a time dependent manner. Throughout the study, bisPMB was compared with 
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thapsigargin because it is a well known ER stress inducer and is widely used as an ER stress 
positive control (Treiman et al., 1998d). 
Prior to this study, our lab have been the first to demonstrate that ajoene localises to the ER of 
MDA-MB-231 breast cancer cells (Kaschula et al., 2015). We also found that ajoene disrupts 
protein folding and enhances the expression of GRP78/BIP (Kaschula et al., 2015). In response to 
ER stress, cells enhance the expression of molecular chaperones such as GRP78/BIP to aid the 
folding of misfolded proteins and restore ER homeostasis (Gething, 1999). The garlic compounds 
DATS and DADS have been shown to increase the expression of the ER resident molecular 
chaperone GRP78/BIP in basal cell carcinoma BCC and COLO 205 cells respectively (Yang et 
al., 2009, Wang et al., 2012). Thus garlic derived OSC DADS, DATS and ajoene may act via a 
similar mechanism to trigger ER stress in different cancer cell lines. 
Consistent with reports on OSC induced GRP78/BIP expression; in this chapter we have shown 
that bisPMB mediated a fivefold increase in the GRP78/BIP expression at levels comparable to 
the thapsigargin positive control in WHCO1 cells. The GRP78/BIP antibody used  detected both 
the 72 and 78 kDa GRP78/BIP protein bands, where the 72 kDa band  was found to be more 
pronounced in  bisPMB treated WHCO1 cells than in  thapsigargin treated cells. This has been 
observed in other cancer cell lines as the 72 and 78 kDa GRP78/BIP proteins were also detected in 
untreated and Faclarindiol treated human colon cancer HCT 116 cells. The 72 kDa GRP78/BIP 
protein is referred to as the GRP78/BIP isoform and is present in certain cancer cells (Rauschert et 
al., 2008, Shani et al., 2008, Hammadi et al., 2013). The 72 kDa GRP78/BIP protein is reported to 
be the product of deglycosylation of the 82 kDa GRP78/BIP protein isoform (Rauschert et al., 
2008, Shani et al., 2008). The higher expression of the 72 kDa GRP78/BIP in bisPMB compared 
to the TG treated WHCO1 cells imply that bisPMB may possibly increase deglycosylation or 
most likely inhibit GRP78/BIP glycosylation more than TG. Ultimately, both bisPMB and TG 
increased GRP78/BIP overall expression, demonstrating that both compounds induced ER stress. Cells 
undergoing ER stress promote the degradation of terminally misfolded proteins through ER 
associated degradation (ERAD) (Meusser et al., 2005). The execution of ERAD involves the 
activation of ubiquitin proteosome system UPS. Proteins targeted for destruction via the UPS are 
labelled by multiple ubiquitin molecules resulting in poly ubiquitination. These poly ubiquitinated 
proteins are then targeted to 26S proteosome for degradation (Glickman and Ciechanover, 2002). 
We observed that bisPMB increased the expression levels of ubiquitinated proteins in WHCO1 
cells at in a time dependent manner. Suggesting that bisPMB enhanced protein ubiquitination and 
targeting of misfolded proteins for degradation. These results are in agreement with those found 
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for ajoene in MDA-MB-231 cells (Kaschula et al., 2015). On the other hand, TG did not alter the 
ubiquitination of proteins in WHCO1 cells. This could be attributed to the 24 hour time point at 
which TG induced protein ubiquitination was investigated, as the UPS event is reported to be 
short lived (Hershko and Ciechanover, 1998). Furthermore, to our knowledge, TG has not been 
reported to enhance protein ubiquitination. Our data therefore supports the idea of cancer cells 
restoring ER homeostasis by enhancing the expression of GRP78/BIP and triggering the ERAD 
process in response to bisPMB treatment. These observations imply an increase in misfolded 
proteins in bisPMB treated cells as the UPS is reported to degrade misfolded proteins (Glickman 
and Ciechanover, 2002). 
In response to an accumulation of misfolded proteins, ER stress ensues and in turn activates the 
UPR which is orchestrated through three ER transmembrane proteins namely PERK, ATF6 and 
IRE-1(Li et al., 2011). Following ER stress activation, PERK phosphorylates eIF2α which leads 
to a reduction in global protein synthesis (Koumenis et al., 2002) and to the selective enhancement 
of ATF4 translation (Harding et al., 2000). ATF4 expression is often used as a marker for PERK 
pathway activation, even though several other kinases such as GCN2, HRI and PKR, are also 
reported to be responsible for phosphorylation of eIF-2α and subsequent enhancement of ATF4 
translation (Donnelly et al., 2013). However, under ER stress conditions ATF4 enhanced protein 
expression is considered a good indicator of PERK activation (Ohoka et al., 2005, Rouschop et 
al., 2010). In this work, bisPMB and TG were found to increase the expression of ATF4 in a time 
dependent manner. These results imply that the PERK/ATF4 pathway is activated by bisPMB and 
TG in WHCO1 cells. Moreover, this observation is consistent with reports that demonstrate that 
the DATTS increases the expression of ATF4 in human colon cancer cells (Saidu et al., 2013).  
The second UPR transmembrane protein is ATF6; whose activation is characterized by ATF6 
(90kDa) transmembrane protein cleavage to ATF6 (50kDa) transcription factor by site specific 
proteases in the Golgi apparatus (Ye et al., 2000). ATF6 (50kDa) regulates the expression of ER 
stress genes involved in cell survival (Yoshida et al., 2001a). BisPMB was found to reduce the 
expression of ATF6 p90 in a time dependent manner, with the maximal reduction observed 
between 4 to 6 hours of bisPMB treatment. The reduction of ATF6α p90 was also observed in the 
TG treated WHCO1 cells. This suggested that bisPMB enhanced the cleavage of ATF6 p90 to 
give rise to ATF6 p50. However, ATF6 p50 could not be detected with the antibody used in this 
study. The reduction of ATF6 full length pre-cursor has been used to monitor ATF6 activation in 
A549 cells exposed to hypoxic conditions (Gewandter et al., 2009). Moreover, the activation of 
ATF6 in MDA-MD-231 breast cancer cell lines has also been observed for other anticancer 
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compounds such as Taxol (Notte et al., 2015). Thus, bisPMB enhanced the activation of ATF6 in 
WHCO1 cells. The increase in ATF6 activation has been implicated in the induction of ER 
resident chaperones and XBP-1 mRNA, which is activated by the IRE-1 transmembrane protein 
(Yoshida et al., 2001a, Yamamoto et al., 2007). 
The XBP1/IRE1 UPR pathway is essential for proper protein folding and protein degradation in 
the ER (Lee et al., 2003a). The activation of the IRE1/ XBP1 pathway is characterized by  IRE1 
induced XBP1 mRNA splicing to produce spliced XBP-1 (XBP-1s) (Iwawaki and Akai, 2006, 
Koong et al., 2006, Han et al., 2009). In Hela cells, XBP1 mRNA is reported to be spliced in 
response to ER stress induced by TG (Yoshida et al., 2001a). BisPMB was found to transiently 
induce mRNA XBP-1 splicing at 8 h; whereas TG was found to induce XBP-1 splicing at 24 
hours. This suggests that bisPMB and TG enhanced IRE-1 endoribonuclease activity but the 
transient activation of XBP-1 in bisPMB treated WHCO1 cells is possibly due to regulation of 
IRE-1 RNAse activity. The IRE-1 RNAse activity is regulated by its direct interaction with BAX, 
BAK, PUMA and BIM (Hetz et al., 2006, Rodriguez et al., 2012). For example, double knockout 
of PUMA and BIM in mouse embryonic fibroblast cells resulted in the transient activation of 
XBP-1 (Rodriguez et al., 2012).  
ER stress induced apoptosis is mainly orchestrated by the CHOP and the JNK pathways (Urano et 
al., 2000, Marciniak et al., 2004), however all UPR pathways converge on the transcription of 
CHOP/GADD153 (Oyadomari and Mori, 2004). CHOP/GADD153 is the downstream target of 
ATF4, ATF6 and XBP-1s and has been reported to regulate the transcription of genes involved in 
cellular survival and death and to elicit intracellular pro-apoptotic protein-protein interactions 
(Matsumoto et al., 1996, Zinszner et al., 1998, McCullough et al., 2001, Yamaguchi and Wang, 
2004). BisPMB was found to increase CHOP/GADD153 expression in WHCO1 cells, in a time 
dependent manner. This observation was found to be in agreement with that reported for DADS 
and DATS in human colon cancer and basal cell carcinoma cells respectively (Yang et al., 2009, 
Wang et al., 2012). As expected, TG enhanced CHOP /GADD153 expression in WHCO1 cells. 
This result is consistent with TG induced upregulation of CHOP/GADD153 in human colon 
cancer cells HCT116 (Yamaguchi and Wang, 2004). To test whether CHOP plays an important 
role in bisPMB cytotoxicity in WHCO1 cells, the effect of siRNA knockdown of 
CHOP/GADD153 was assessed in bisPMB and TG treated WHCO1 cells. We found that 
expression of CHOP/GADD153 was a key determinant in the cytotoxicity of bisPMB in WHCO1 
cells. Thus far, there have been no reports on the role of CHOP/ GADD153 on OSC cytotoxic 
activities in cancer cells. On the other hand, we found that CHOP/GADD153 also play a central 
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role in TG cytotoxic activity. This consistent with the observation that CHOP/GADD153 siRNA 
knock down reduces TG apoptotic activity against human colon cancer HCT 116 cell line 
(Yamaguchi and Wang, 2004). Altogether, these findings demonstrated that CHOP/GADD153 
plays a critical role in bisPMB and TG cytotoxicity in WHCO1 cells. 
We then addressed the question of whether JNK plays a role in the cytotoxic activity of bisPMB 
and TG. The JNK pathway is a member of the MAPK pathways and is known as a stress activated 
protein kinase (SAPK). In this study, bisPMB was found to induce a transient increase in JNK 
phosphorylation/activation. This observation is consistent with that for ajoene and DADS which 
are reported to induce JNK activation in HL60 and COLO 205 cells respectively (Antlsperger et 
al., 2003, Yang et al., 2009). Furthermore, ER stress associated apoptosis inducing agents: 
thapsigargin, tunicamycin and dithiothreitol are reported to induce JNK activation in rat acinar 
AR42J cells (Urano et al., 2000). This suggests that the JNK pathway is activated by bisPMB and 
that it may be involved in bisPMB’s cytotoxic activity. However, JNK inhibition was found to 
have no effect on the cytotoxicity of bisPMB in WHCO1 cells. This implies that JNK activation 
does not play a major role in bisPMB induced cytotoxic effects in WHCO1 cells. Interestingly, 
JNK inhibition played a more significant role for TG. These findings suggest that the duration of 
JNK activation is related to its role in apoptosis induction. For example, transient JNK activation 
(approximately 5 hours) was not involved in ajoene induced apoptosis in human leukaemia cells, 
whereas  sustained JNK activation in DATS treated bladder cancer cells played a major role in its 
apoptotic induction (Antlsperger et al., 2003, Shin et al., 2014). Since bisPMB lead to JNK 
activation, other MAPK signalling pathways such as MEK/ERK and p38 were also investigated, 
as they have been previously shown to interact with each other and with the UPR pathways. 
Furthermore, the microarray data in Chapter 3 demonstrated that the MAPK signalling pathways 
were also significantly deregulated by bisPMB and TG in WHCO1 cells. 
The p38 MAPK signalling pathways are reported to be involved in apoptosis induction by 
inflammatory cytokines and stress inducing chemotherapeutic agents (Obata et al., 2000, 
Ranganathan et al., 2006, Cuenda and Rousseau, 2007, Yang et al., 2013). In addition, the 
interaction of p38 activation and UPR has been reported. The substrates of p38 MAPK include the 
MAP kinase activated protein kinase 2, MAPK interacting kinase 1 (Mnk1), MAPK interacting 
kinase 1 (Mnk2) and components of the ER stress pathways such as activating transcription factor 
6 (ATF6), Nrf2, c-Jun, XBP-1 and CHOP (Cohen, 1997, Ben-Levy et al., 1998, Thuerauf et al., 
1998, Ma and Hendershot, 2004, Ranganathan et al., 2006). Several studies have suggested that 
CHOP is phosphorylated by p38 at the trans-activation sites (Wang and Ron, 1996, Darling and 
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Cook, 2014). Furthermore, the transcriptional activity of ATF6 is reported to be enhanced by 
phosphorylation with p38 MAPK in myocardial cells, promoting the transcription of GRP78/BIP 
(Thuerauf et al., 1998). In contrast, the p38 MAPK pathway has also been shown to be activated 
downstream of the PERK/ATF4 UPR pathway.  It has been suggested that the natural compound 
seletinite induced PERK/ATF4 pathway inhibit HSp90, a negative regulator of p38, resulting in 
enhanced p38 MAPK activity in human promyelocytic leukaemia NB4 cells (Jiang et al., 2014). 
We observed that bisPMB increased phosphorylated p38 MAPK expression levels in WHCO1 
cells. However, the inhibition of phosphorylated p38 with the SB203580 chemical inhibitor 
showed no effect on bisPMB and TG cytotoxic activity against. These findings are consistent with 
reports showing that p38 does not play a major role in ajoene induced apoptosis in human 
promyeloleukemia cells (Antlsperger et al., 2003). From these reports and our observations, it can 
be said that the observed ATF6 activation by bisPMB may be influenced by p38 MAPK. 
However, the central role of CHOP/GADD153 in bisPMB cytotoxic activity against WHCO1 
cells may not influenced by p38 MAPK phosphorylation. 
We then investigated the role played by the MEK/ERK pathway on bisPMB or TG induced 
cytotoxic activity in WHCO1 cells. The activation of the MEK/ERK pathway is known to be 
associated with cell survival. We demonstrated that bisPMB markedly enhanced the 
phosphorylation/activation of ERK1/23.5 µM in a time dependent manner and to a lesser extent in 
the TG treated sample. The transient activation of ERK1/2 activation has also been observed in 
ajoene treated human promyeloleukemia cells (Antlsperger et al., 2003). Furthermore, the 
elevation of ERK1/2 activation is possibly due to the initial pro-survival response of the cells to 
bisPMB induced stress because the inhibition of ERK1/2 activation with the specific MEK1/2 
inhibitor U0126 led to an increase in bisPMB induced cytotoxicity. This observation is consistent 
with the protective effect of ERK1/2 pathway from ajoene induced apoptosis in HL-60 leukaemia 
cells (Antlsperger et al., 2003). Interestingly, the protective role of the MEK/ERK pathway was 
not observed in the TG treated sample, suggesting that the MEK/ERK pathway did not have a 
significant effect for TG.     
The findings presented in this Chapter support our hypothesis that bisPMB induced ER stress/ 
UPR and MAPK signalling pathways in WHCO1 cells. BisPMB increased the expression of pro-
survival UPR associated events such as ubiquitination and an increased expression in GRP78/BIP 
and activation of the UPR pathways. As expected, ERK1/2 protected WHCO1 cells against 
bisPMB cytotoxic activity. On the other hand, CHOP played a key role in bisPMB induced 
cytotoxicity but JNK and p38 MAPK signalling pathways were activated but not key for 
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cytotoxicity. Whereas, CHOP and JNK activation were seemingly required for TG induced 
cytotoxic activity. 
Thus far, widely studied molecular mechanisms of garlic derived OSC include the induction of the 
mitochondrial dependent caspase cascade, activation of mitogen activated protein kinase (MAPK) 
pathways, intracellular calcium mobilization and enhancement of reactive oxygen species (ROS) 
production in various cancer cells. However, ER stress induction by garlic OSC is not a widely 
held hypothesis. To our knowledge, our lab was the first to show that ajoene targets the ER, 
promotes the accumulation of protein aggregates, increases protein ubiquitination and enhances 
GRP78/BIP expression in MDA-MB-231 breast cancer cells (Kaschula et al., 2015).  
The findings from this chapter provided new insights into the mechanism of action of bisPMB in 
WHCO1 cancer cells. It showed that CHOP plays a central role in bisPMB inhibitory activity and 















CHAPTER 5: GENERAL DISCUSSION, CONCLUSION 
AND FUTURE WORK 
 
5.1 GENERAL DISCUSSION 
This thesis investigated the role played by UPR and MAPK signalling pathways in bisPMB 
induced cytotoxic activity against oesophageal cancer WHCO1 cells. The findings of this 
study provided insight into the mechanisms of action of bisPMB as a potential therapeutic 
against OC cancer.     
In vitro and in vivo studies have reported ajoene induced cytotoxic activity against a variety 
of cancer cell lines (Li et al., 2002a, Hassan, 2004). BisPMB is an ajoene analogue that is 
found to be more active than ajoene against various cancer cells lines, with best potency and 
selectivity against esophageal cancer WHCO1 cells (Hunter et al., 2008, Kaschula et al., 
2011). In line with these reports, we found the anti-proliferative activity of bisPMB in 
WHCO1 cells to be time and concentration dependent with similar 7 µM values in the three 
oesophageal cancer cell lines tested (WHCO1, WHCO6 and KYSE30 cells). The potency of 
bisPMB was found to be greater than cisplatin at inhibiting oesophageal cancer cell 
proliferation (Tanaka et al., 2010). Therefore bisPMB shows chemotherapeutic potential .   
We found that bisPMB induces a concentration dependent G2/M cell cycle arrest and 
apoptosis in WHCO1 cells. The ability of anticancer agents to promote cell cycle arrest and 
apoptosis is key in managing the uncontrollable growth  of cancer cells due to their ability to 
evade cell cycle check points and apoptosis (Hanahan and Weinberg, 2011).  Ajoene has been 
shown to induce G2/M cell cycle arrest and apoptosis in human leukaemia HL-60 cells 
(Dirsch et al., 2002, Li et al., 2002a), basal cell carcinoma TE354T (Tilli et al., 2003) and the 
prostate cancer DU145 cell line (Xiao et al., 2004). We found that bisPMB was more potent 
than ajoene at inducing cell cycle arrest and apoptosis. For example, cell cycle arrest and 
apoptotic activity of ajoene in human leukaemia HL60 cells was observed at a 40 µM 
concentration (Li et al., 2002a). Whereas we observed bisPMB induced G2/M cell cycle arrest 
in WHCO1 cells at 7 µM  concentration (7 µM) further demonstrating that  bisPMB has an 




We found that the antiproliferative activity of bisPMB was five times more pronounced and 
apoptosis was enhanced in WHCO1 cells compared to the normal oesophageal epithelial Het-
1A cells. This was consistent with previous reports from our lab that  bisPMB demonstrates 
enhanced anti-proliferative activity against a variety of cancer cell lines compared to  their 
normal counterparts with the largest fold change selectivity of 2.9 for WHCO1 compared to 
normal EPC2 cells (Kaschula et al., 2011). In the case of ajoene, there are several reports that 
demonstrate selective cytotoxicity for cancer cells. Specifically, ajoene is reported to be more 
active against Burkitt lymphoma BJA-B than baby hamster kidney BHK21 (Scharfenberg et 
al., 1990) and against human leukaemia HL60, breast cancer MCF-7, nasopharyngeal KB,  
hepatocellular Bel 7402, gastric cancer BGC 823 and colon cancer HCT than kidney 
marsupial PtK2 cells (Li et al., 2002a). The human leukemic HL60 cell line is  reported to be 
more sensitive to ajoene induced apoptosis than normal peripheral mononuclear blood PBMC 
cells from healthy donors (Dirsch et al., 1998). Selectivity is a necessary  characteristic for 
cancer drugs as it can heighten the effect of the agent at low concentrations (Mencher and 
Wang, 2005). In addition, cancer cell selectivity by anticancer agents also minimizes toxic 
side effects to normal cells (Rao et al., 2013). Thus our findings provide further evidence that 
bisPMB may be a good candidate for the treatment of OC because it’s selectively for cancer 
cells.  
Following the above mentioned in vitro cytotoxicity observations; we performed mechanistic 
studies to unravel the molecular mechanisms underlying bisPMB induced cytotoxic activity 
in WHCO1 cells. Structure-activity studies revealed the vinyl disulfide group to be the 
pharmacophore for bisPMB in WHCO1 OC cancer cell line (Kaschula et al., 2012). Further 
reports support the hypothesis that ajoene and related garlic OSC induce their cytotoxic 
effects through S-thiolation of cellular thiols via mixed disulfide formation (Gargouri et al., 
1989, Gallwitz et al., 1999, Hosono et al., 2005, Kaschula et al., 2012). We have recently 
found that ajoene targets the endoplasmic reticulum in breast cancer MDA-MB-231 cells 
where it S-thiolate numerous protein targets and interferes with protein folding (Kaschula et 
al., 2015). This effect was found to increase the expression of GRP78/BIP in the MDA-MB-
231 breast cancer cell line (Kaschula et al., 2015). GRP78/BIP, an ER resident chaperone, is 
commonly indicative of ER stress and unfolded protein response (UPR) . Consistent with 
these reports, our gene expression study demonstrated that bisPMB primarily targets the UPR 
mainly driven by XBP-1. The role of XBP-1 in cancer thus far has been pro-survival (Chen et 
al., 2014). Since the bisPMB concentration used in this the gene expression study displays 
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minimal toxicity to the cells, it can be suggested that the initial response of WHCO1 cells to 
bisPMB is pro-survival to counteract the imbalance caused by bisPMB entrance into the cell. 
In addition, we found that bisPMB and the ER stress inducer TG affected some common 
pathways in WHCO1 cells. These common pathways included the protein processing in the 
endoplasmic pathway, pathways in cancer and the MAPK signalling pathways. The protein 
processing in the ER pathway was inclusive of the ER stress pathway, which was found to be 
the most significantly enriched pathway in the bisPMB sample. UPR pathways have been 
implicated in crosstalks with the MAPK pathways and garlic OSCs are known to activate the 
MAPK signalling pathways (Antlsperger et al., 2003, Shin et al., 2012, Darling and Cook, 
2014). In addition, there is some emerging evidence that garlic OSC may also induce ER 
stress in cancer cells. ER stress was activated by DADS in human colon cancer cells COLO 
205 (Yang et al., 2009) and by DATS in basal cell carcinoma BCC cells (Wang et al., 2012).  
We found that BisPMB and TG deregulate ER stress/UPR pathways in a time dependent 
manner as evidenced by the increase in ATF4 expression, GRP78/BIP expression and 
decreased ATF6 p90 expression as well as increased splicing of XBP-1mRNA in WHCO1 
cells. This confirmed the Gene Ontology data, which showed that bisPMB primarily induces 
UPR activation in WHCO1 cells. The ER stress pathway is increasingly been studied as a 
target for cancer therapy (Boelens et al., 2007), as the triggering of ER stress in already 
stressed cancer cells may sensitise the cells to apoptosis. Thus, the activation of ER stress by 
bisPMB may potentiate its effects as an anticancer agent. 
Prolonged UPR is known to trigger ER stress induced apoptosis, which is associated with the 
induction of CHOP and the activation of the JNK signalling pathway (Urano et al., 2000, 
Matsumoto et al., 2013). We observed a time dependent induction of CHOP and JNK1/2 
phosphorylation/activation. Furthermore, siRNA silencing of CHOP abolished the cytotoxic 
activity of bisPMB and TG in WHCO1 cells; illustrating that CHOP is a central regulator in 
bisPMB induced cytotoxic activity in WHCO1 cells. CHOP has been reported to play a 
critical role in TG induced apoptosis in prostate cancer cell lines LNCaP, A2780S and 
DU145 (Yamaguchi and Wang, 2004). On the other hand, the inhibition of JNK activation 
was found to have no effect on bisPMB induced cytotoxicity, implying that JNK activation is 
secondary to CHOP induction and not critical for cytotoxicity. Our finding is supported by 
that in the literature in which inhibition of JNK activation by the JNK 1-3 inhibitor SP600125 
did not alter ajoene induced apoptosis in HL-60 cell lines (Antlsperger et al., 2003). This 
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suggested that BisPMB induced cytotoxic activity required CHOP but not JNK MAPK 
activation in WHCO1 cells, whereas TG required CHOP and JNK activation to induce its 
cytotoxic activity against WHCO1 cells. This is the first time that cytotoxicity of garlic-
related disulfides has been exclusively linked to UPR and induction of CHOP. 
Like the JNK signalling pathway, other MAPK family members such as p38 and ERK1/2 
have been implicated in ER stress induced apoptosis. BisPMB was found to induce a time 
dependent phosphorylation/activation of p38 and ERK1/2 MAPK. This is in line with ajoene 
and Z-ajoene induced p38 and ERK1/2 phosphorylation/activation in human leukaemia HL-
60 cells (Antlsperger et al., 2003) and human glioblastoma multiforme cancer stem cells 
(Jung et al., 2014). The inhibition of p38 MAPK had no effect on bisPMB cytotoxicity. 
However, the inhibition of ERK signalling pathway with U0126 MEK1/2 inhibitor enhanced 
the cytotoxic activity of bisPMB. This may be explained by the MEK/ERK pathway playing 
a pro-survival role in response to bisPMB as the MEK/ERK pathway promotes cell survival, 
differentiation and proliferation (Yang et al., 2013). Also, MEK/ERK pathway has been 
implicated downstream of ER stress activation. IRE-1 induced ERK1/2 activation is reported 
to enhance the proliferation of gastric cancer cells under ER stress conditions (Zhang et al., 
2009). Chronic ER stress promotes tumour progression of hepatocellular carcinoma cells 
through enhancement of  the activation of ERK pathway (Dai et al., 2009). The MEK/ERK 
activation may diminish the cytotoxic activity of bisPMB as breast and lung cancer cell lines 
resist thapsigargin or tunicamycin induced ER stress induced cell death by activating the 
MEK/ERK pathway to promote cancer cell survival (Hu et al., 2004). Moreover, the 
inhibition of the MEK/ERK pathway is reported to enhance the anticancer activity of known 
chemotherapeutic drugs such as cisplatin and paclitaxel in non small cell lung cancer 
(NSCLC) cell lines A549, H460 and H1703 (MacKeigan et al., 2000, Kim et al., 2015). In 
addition, the inhibition of MEK/ERK pathway by U0126 and PD 98059 enhanced ajoene 
induced apoptosis in HL-60 cell (Antlsperger et al., 2003). From these observations, it is clear 
that the MEK/ERK pathway opposes the effect of cancer cell killing agents, including 
bisPMB.  
The modulation of multiple intracellular pathways by anticancer agents is beneficial to cancer 
therapy as the cancer disease is characterised by the abnormal functioning of numerous 
molecular events (Hanahan and Weinberg, 2011). In addition, anticancer drugs targeting 
multiple pathways are reported to re-establish the balance caused by abnormality of disrupted 
molecular events that underlie tumour progression (Mencher and Wang, 2005). For this 
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thesis, BisPMB was found to activate key components of the UPR and MAPK pathways at 
different time points. The initial response appears to be pro-survival as the data collected at 
the early time points (2 – 6 hours) showed that bisPMB had no effect on WHCO1 cell 
viability and a dramatic increase in ERK1/2 activation, ATF6 cleavage and XBP-1 splicing. 
This seems to be orchestrated by IRE1 as both XBP-1 and ERK1/2 have been reported to be 
downstream of IRE1 activation (Lee et al., 2003a, Zhang et al., 2009, Iwawaki and Akai, 
2006). At the later time points (8 – 24 hours), we found that bisPMB induced a decrease in  
WHCO1 cell viability which correlated with an increase in protein ubiquitination, CHOP, 
JNK activation, p38 activation and ATF4.  Thus far, it can be said that CHOP and the 
MEK/ERK pathways may play a significant role in bisPMB induced cytotoxic activities in 
WHCO1 cells. Thus, bisPMB may be a good target for OC therapy because it influences the 
activity of multiple pathways. 
We previously found that ajoene targets the endoplasmic reticulum, where it S-thiolate newly 
synthesized proteins (Kaschula et al., 2015), disrupting the protein’s ability to fold.  This 
would lead to an increase in misfolded proteins in the ER, resulting in ER stress and 
subsequent UPR activation. We observed that bisPMB induced activation of UPR was 
accompanied by an increased GRP78/BIP protein expression and protein ubiquitination 
(figure 5.1). Moreover, bisPMB induced UPR pathways including ATF6, IRE-1 and PERK 
facilitate an increase in the transcription factor CHOP/GADD153, which reduced WHCO1 
cell viability (figure 5.1). Simultaneously, the MEK/ERK pathway counteracted the anti-
proliferative activity of bisPMB. Although, bisPMB activated the JNK and p38 MAPK, they 
were not central to its cytotoxic activity (figure 5.1). 
Identification of novel intracellular pathways is vital for rational drug combination design in 
cancer therapy as drug synergism is often attained by drugs that target different pathways 
(Clark et al., 2010). In this thesis, the ER stress and MAPK pathways were shown to act as 
the primary targets for bisPMB cytotoxic activity. Numerous ER stress inducing anticancer 
agents such as cisplatin, carboplatin  and  thapsigargin based pro-drug G202, have been 
shown to have positive outcomes in cancer patients (Tombal et al., 2000, Rabik et al., 2008, 
Brozovic et al., 2013, Antonarakis and Carducci, 2010, Michelangeli and East, 2011). Since 
the MEK/ERK pathway counteracts the cytotoxic activity of bisPMB,  combination of 
bisPMB with agents that inhibit the MEK/ERK pathway such as Vermurafenib, Trametinib, 
MEK162, AZD6244, SCH772984 in different phases of drug development (Samatar and 



















Figure 5.1 Schematic representation of summary of the key findings of this study in WHCO1 cells treated 
with bisPMB. The red box indicates the proposed bisPMB induced protein S-thiolation in the endoplasmic 
reticulum of WHCO1 cells. The arrows and entities in black represent pathways and cellular processes 
documented in the literature. In purple are the pathways and findings identified in this thesis.      
 
5.2 CONCLUSION 
This thesis provided insights into the intracellular pathways contributing to the cytotoxicity of 
bisPMB in WHCO1 cells. It also demonstrated that WHCO1 cell response to bisPMB shared 
similarities with TG, an ER stress inducer.  
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We showed that bisPMB induced its cytotoxic activity in oesophageal cancer cells by 
inhibiting cell viability, inducing G2/M cell cycle arrest, apoptosis and late stage apoptosis/ 
secondary necrosis. We then demonstrated that bisPMB primarily targets the UPR at sub-
toxic concentrations. Furthermore, bisPMB activated the ER stress/UPR and MAPK 
pathways. Moreover, CHOP/GADD153 and ERK1/2 were critical to the cytotoxic activity of 
bisPMB in WHCO1 cells. 
Even though ER stress and MAPK are activated in bisPMB treated WHCO1 cells, it is 
unlikely that they may be solely responsible for bisPMB’s cytotoxicity. The findings of this 
thesis contribute to the current understanding of the molecular mechanisms underlying the 
anticancer activity of bisPMB and its parent compound, ajoene. Consequently, a 
comprehensive understanding of bisPMB underlying molecular events may serve as a vital 
tool in rational design of anticancer drug combinations with ajoene or bisPMB.  
 
5.3 FUTURE WORK 
5.3.1 Drug combinations 
 
Since the cytotoxic activity of bisPMB was found to be reduced by ERK1/2 activation and 
enhanced by CHOP, it would be interesting to evaluate synergism in drug combinations of 
bisPMB and clinically used MEK/ERK inhibitors. The MEK/ERK inhibitors that can be used 
in these experiments include the Vermurafenib, Trametinib, MEK162, AZD6244, and 
SCH772984. In addition to the above mentioned anti-cancer drugs,cisplatin, a commonly 
used drug for oesophageal cancer has been shown to induce ER stress in human melanoma 
224 and colon cancer HCT116 cell lines (Mandic et al., 2003). The induction of ER stress has 
been documented to enhance the efficiency of cisplatin chemotherapeutic effect (Xu et al., 
2014).  Thus, the effect of the combination of cisplatin with another ER stress inducing 
compound like bisPMB on treatment of oesophageal cancer should be evaluated. For the 
future experiments of this study, bisPMB and cisplatin can be used in combination to treat 






5.3.2 Animal studies 
 
The cytotoxic effect and the data on the molecular mechanisms of bisPMB in oesophageal 
cancer cells observed in this thesis demonstrate bisPMB as a promising OC cell killing agent. 
In the drug discovery process, in vivo studies are conducted following in vitro tests. In 
addition, reports on in vivo mouse models studies conducted in both wild type (CHOP+/+) 
and knockout (CHOP-/-) mice. Thus, the next step would be to perform animal studies on 
WHCO1 cell engrafted mice and monitor change in tumour size.     
5.3.3 ROS Production and inhibition of calcium ATPase 
 
ROS plays a major role in therapy cancer cell death (Benhar et al., 2002) and mediates OSC 
induced apoptosis in cancer cells. ROS production is key in ajoene induced apoptosis in 
human lymphoma U937 cells (Kelkel et al., 2012), leukaemia HL60 (Dirsch et al., 1998) and 
adipocytes 3T3-L1(Yang et al., 2006b).In addition ROS accumulation is reported to trigger 
ER stress in prostate cancer cell lines treated with Shikonin (Gara et al., 2015). Thus the 
ability for bisPMB to increase ROS production in WHCO1 cells should be evaluated. 
 
Garlic OSC, DADS was  found to inhibit the growth of human colon, lung and skin cancer by 
reducing the expression of calcium ATPase activity and consequently increasing intracellular 
calcium levels (Sundaram and Milner, 1996). Since TG induces ER stress by inhibiting the 
Ca ATPase, it would be interesting to test whether bisPMB had any effect on the expression 
of Ca2+ ATPase. Therefore, future experiments should include the detection of Calcium 












CHAPTER 6:  MATERIALS AND METHODS 
 
6.1     Cell Culture 
6.1.1 Cell lines used in the project 
 
The experiments in this study were conducted in human oesophageal squamous epithelial 
carcinoma cell lines WHCO1, WHCO6 and KYSE30. The SV40 large T-antigen 
immortalised Het1-A cell line was used as a normal epithelial control cell line. WHCO1 and 
WHCO6 were derived from biopsies of South African patients (Veal & Thornly, 1989). The 
KYSE30 cell line was derived from the middle intra-thoracic oesophagus of a 64 year old 
Japanese man (Shimada et al., 1992). Het1-A cell line, immortalized with SV40 large T-
antigen,was derived from a 25 year old black male and obtained from the American type 
culture collection (ATCC® CLR-2692™)(Stoner et al., 1991). All the cells were grown in 
Dulbecco’s Modified Eagle medium (DMEM) (Gibco®, Life Technologies, USA) 
supplemented with 10% foetal bovine serum (FBS)( (HyClone™ ,GE Healthcare Life 
Sciences, USA),  100 U/ml penicillin and 100µg/ml streptomycin (Pen strep) (Biochrom, 
Berlin, Germany) (complete media). The cells were maintained in a 37°C incubator with 5% 
carbon dioxide in 95% humidity. 
 
6.1.2 Sub-culturing   
 
Cells were cultured in complete media.  Confluent (80%) cells were split at 1:3 ratio into 
100mm culture dishes.  For the splitting procedure; adherent cells were rinsed with phosphate 
buffer saline (PBS) (pH7.5) and lifted with 0.5% Trypsin 0.53mM 
Ethylenediaminetetraacetic acid (EDTA) in PBS. The 0.5% Trypsin/EDTA was then 
deactivated by adding equal volume of DMEM/FCS to the detached cells. The cells were 
then transferred to a 12 ml tube and spun at 4000 rpm for 3 minutes (Hettich®EBA 20 
Centrifuge, sigma-Aldrich, USA). The supernatant was removed and discarded and the pellet 
resuspended in DMEM/FCS and cultured in100mm culture dishes. 
6.1.3 Freezing/Thawing of cells 
For long term storage, the cells were frozen in liquid nitrogen. The culture medium was 
removed from adherent cells which were then detached with 0.5% Trypsin/EDTA for 3 
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minutes. An equal volume of DMEM/FCS was added to detached trypsinised cells. The cells 
were centrifuged at 4000rpm for 3 minutes and the pellet was resuspended in freeze down 
media (DMEM supplemented with 20% foetal calf serum FCS and 10% dimethyl sulfoxide 
(DMSO), Sigma Aldrich, USA). A volume of 10 µl of the resuspended cells was 
subsequently stained with tryphan blue (Molecular Probes®, life technologies, USA), counted 
using cells countess counter with countess glass slides (Invitrogen™, Life technologies, USA) 
and 1X106 cells are aloquoted in cryotubes. The aliquot tubes were then placed at -80°C for 
24 hours and transferred to the liquid nitrogen tank for long term storage.  
6.1.4 Thawing protocol 
 
When required, cells were removed from the nitrogen storage and immediately thawed in a 
37˚C water bath. The cells were then transferred to 12 ml falcon tubes and centrifuged at 
4000rpm for 3 minutes; this was followed by the removal of the freeze down media. The cells 
were resuspended in fresh complete medium and cultured in 100mm culture dishes. 
6.1.5 Mycoplasma Test 
 
I order to ensure cells were mycoplasma free, cells were cultured in pen/strep free DMEM 
media. The cells were then spun at 4000rpm for 3 minutes and supernatant was removed. 
Following the resuspension of cells with pen strep free media, drops of the cells were added 
to sterile cover slip which were transferred to a 6 well plate and incubated at 37˚C incubator 
for 1 hour. After incubation, the full media was added carefully to each well and incubated at 
37˚C overnight. Subsequent to the overnight incubation, a fixative solution was added twice 
to each well and incubated at room temperature for a few seconds. Distilled water was used 
to rinse off the fixative solution and then the cover slips were incubated with the staining 
solution for no longer than 30 seconds. The stain was washed off with distilled water and 
placed face down onto the glass slide. The slide was then viewed under an Olympus 
florescent microscope (Olympus© X81S8F, Japan) at 100X magnification, and images were 
captured using digital camera (Olympus© X81S8F, Japan). 
6.1.6 Morphology 
The cells were seeded at a density of 5x104 cells per well in a 6 well plate and allowed to 
attach overnight at 37˚C. The following day, the cells were treated with       or 7 µM or  14 
µM of bisPMB for 24 hours or 0.1% DMSO for 24 hours. The images of the cells were 
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subsequently captured using an Olympus SC30 digital camera (Olympus© SC30, Japan) at 10 
and 20 x magnification. Phase contrast images were then captured using a microscope digital 
camera (Olympus© SC30, Japan) and analysed with the analysis getIT image analysis 
software (Olympus© SC30, Japan). 
 
6.2    Cell viability assays 
6.2.1 WST assay 
 
The WST-1 assay was used to quantify cell proliferation. The water soluble tetrazolium 
(WST) (Roche, Indianapolis, IN, USA) salt is cleaved by metabolically active cells to form 
formazan. Briefly, 2.5 x 103 cells/well were seeded in a 96 well culture plate (SPL life 
sciences, Korea) and allowed to settle overnight.  Following incubation with the test 
compound 10μl/well of wst reagent was added onto the cells and incubated at 37  for 4 
hours. The colorimetric intensity of the formazan was measured at the absorbance of 450nm, 
with a reference reading of 650nm using the Multiskan FC multi well plate reader (Thermo 
scientific, USA). The data obtained from the absorbance readings was presented as mean   
SD of quadruplicate technical replicates using GraphPad Prism version 5.01 software. 
6.2.2 MTT assays 
 
The MTT assay was used to indirectly measure cell proliferation by quantifying the viability 
of metabolically active cells (Mosmann, 1983). Viable cells reduce the yellow tetrazolium 
salt to blue-purple formazan crystals, with the aid of the cofactors nicotinamide adenine 
dinucleotide phosphate (NADPH) and nicotinamide adenine dinucleotide (NADH). The MTT 
assay was carried out by seeding 2.5 x 103 cells/ well to a final volume of 90µl in a 96 well 
culture plate (SPL life sciences, Korea). Following the desired incubation with the test 
compound, 10μl of thiazol blue tetrazolium bromide (MTT) (Sigma Aldrich, USA) was 
added to the cells and incubated at 37°C for 4 hours. The blue formazan crystals that resulted 
from the reduction of the yellow MTT by viable cells were solubilised with 100μM sodium 
lauryl sulphate (SLS) for 16 hours at 37 . The resulting colorimetric intensity was measured 
at the absorbance of 595nm with Multiskan FC multi-well reader (Thermo scientific, USA). 
The data obtained from the absorbance readings was presented as mean   SD of 
quadruplicate technical replicates using GraphPad Prism version 5.01 software. 
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6.3 Cytotoxicity assays 
6.3.1 IC50 determination 
 
The IC50 in WHCO1, WHCO6, KYSE30 and Het-1a cells were determined by seeding 2.5 x 
103 cells /well in 96 well culture plates and allowed to attach overnight. A twofold dilution 
series of the bisPMB dissolved in DMSO was prepared and then added to the cells at 1:1000 
dilutions, to achieve 0.1% DMSO final concentration. The cells were subsequently incubated 
with the bisPMB for 24 or 48 hours, depending on time point of the IC50 determination. 
Following treatment, 10µl MTT reagent (Roche, Indianapolis, IN, USA) was added to the 
cells and incubated at 37˚C for 4 hours, after which 100μl solubilisation reagent (SLS) was 
added to the cells. The plates were then incubated overnight and read at 595nm with the 
Multiskan FC multiwell reader (Thermo scientific, USA).  
6.3.2 IC50 Data Analysis 
 
The IC50 and 95% confidence interval (CI) were derived from quadruplicate data retrieved 
from the Multiskan FC multiwell reader (Thermo scientific, USA). The data was analysed 
with version 5.0 of GraphPad prism version 5.01 software (GraphPad Prism software Inc., 
San Diego, USA). The values obtained from the absorbance readings were presented as mean 
  SD, log transformed and fitted onto a non linear regression log (inhibitor) vs. response 
equation in order to construct a sigmoidal dose response curve.  
6.3.3 Lactate dehydrogenase (LDH) assay 
 
The quantification of cell cytotoxicity was performed with the lactate dehydrogenase activity 
assay kit (Roche Diagnostics, Mannheim Germany). The LDH assay was carried out as 
described in the manufacturer’s instructions. Briefly, 3 x 103 WHCO1 cells per well were 
seeded in a 96 well culture plate and allowed to attach at 37˚C overnight. The following day, 
WHCO1 cells were treated with 1µM or 10µM bisPMB dissolved in DMSO or 0.1% DMSO 
for 3h, 6h, 24h and 48 hours. Lysis buffer was added to the cells followed by incubation at 
room temperature for 15 minutes with gentle shaking. The reaction mixture (see appendix A) 
was prepared according to the manufacturer instructions and added to the lysate. The 
absorbance was read at 492 nm with the reference wavelength of 620 nm, with a Multiskan 
FC multiwell reader (Thermo scientific, USA) and analysed using GraphPad Prism version 
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5.0 (GraphPad Prism software Inc., San Diego, USA). The assay was conducted in 
quadruplicate and data was presented as mean   SD.  
6.4    Histone associated DNA fragmentation apoptosis assay 
Apoptosis was detected using the Cell death Detection Elisa PLUS kit (Roche Diagnostics, 
Mannheim Germany), which quantified cytoplasmic mono and oligonucleotides in cells 
undergoing apoptosis. The histone associated DNA fragmentation apoptosis assay was 
carried our according to manufacturer’s instructions. Briefly,        cells/ well were seeded 
in a 96 well culture plate and allowed to attach at 37°C overnight. Following the 24 hour 
treatment of the cells with bisPMB or 0.1% DMSO, the 96 well culture plate was centrifuged 
for 10 minutes at 200  . Subsequently, 50µl of the supernatant was removed from each 
well, followed by the addition of the lysis buffer and 30 minute incubation at 25 . After cell 
lysis was complete, 20µl of the cell lysate was transferred to a streptavidin coated 96 well 
culture plate and then 80µl of immunoreagent  containing anti-histone-biotin, anti-DNA-POD 
(anti- DNA horse radish peroxidise) and incubation buffer was added. The 96 well culture 
plate was then incubated on a shaker (200 rpm) at 25  for 2 hours covered with an adhesive 
foil. This was followed by the removal of the immunoreagent and washing of the wells with 
incubation buffer. 100µl of ABTS solution was subsequently added to the wells incubated for 
10 minutes while shaking at 200rpm. Following the colourimetric development, 100µl of 
ABTS stop solution was added to stop the reaction and then the absorbance of developed 
colour intensity was measured at 405nm with the reference wavelength of 492nm using the 
Multiskan FC multiwell plate reader (Thermo scientific, USA). The data obtained from the 
absorbance readings was presented as mean   SD of triplicate technical replicates using 
GraphPad Prism version 5.01 software. 
6.5  Cell cycle analysis  
The effect of the bisPMB on the cell cycle was determined by fluorescence activated cell 
sorting (FACS) analysis in cells stained with propidium iodide. Briefly, 1     WHCO1 
cells were seeded in a 100mm culture dish and allowed to attach overnight at 37°C. 
Following the treatment of with bisPMB for 24 hours, the cells were harvested (including 
floating cells) with 0.5% Trypsin EDTA, fixed with 70% ethanol and stored at -20°C for up 
to two weeks.  Cells were then spun at 4000rpm for 5 minutes and washed twice with 1  
 PBS.  After the washing step, the cells were incubated with 50μg/ml RNase A (Roche, 
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Indianapolis, IN, USA) for 15 minutes at 37°C and stained with the propidium iodide staining 
solution. The flow cytometer (FACScalibur®, Becton Dickinson (BD) Biosciences, San Jose, 
CA ) was used to count 50000 cells for each analysis. The analysis of the cell cycle data was 
carried out using the ModFit 3.0 software (Verity, Topsham, ME).  
6.6   Transient knock down of CHOP in WHCO1 cells   
In order to attenuate the expression of CHOP in WHCO1 cells we used CHOP specific small 
interfering (siRNA). Briefly, 1.5      WHCO1 cells are seeded in a 12 well culture plate 
and allowed to settle overnight at 37˚C. Afterwards, the cells were washed with 1     and 
then incubated with the transfection solution containing transfectin (TransFectin™ Lipid 
reagent, BIO-RAD, Hercules, CA) and 40nM CHOP siRNA (Sigma- Aldrich, USA) or 
control siRNA (Santa Cruz Biotechnology, USA) in serum free DMEM. Six hours post 
transfection; the transfection media were removed and replaced with complete DMEM.  
6.7  Polymerase chain reaction (PCR) 
6.7.1 RNA Extraction 
Total RNA was isolated from cells using the phenol-chloroform extraction method 
(Chomczynski and Sacchi, 1987). Briefly, 1 x 106 cells were seeded in 100mm culture dishes 
and allowed to attach overnight. The cells were then incubated with the compound of interest 
for the desired experimental period. Following treatment, the media was removed from the 
cells and then the cells were rinsed twice with ice cold PBS. Subsequently, 1ml of QIAzol® 
lysis reagent (QIAGEN, Venlo, Netherlands) was added to the cells and immediately scraped 
off with a cell scraper (Greiner Bio-One, Monroe, NC). The cell lysate was then 
homogenised by passing it through a pipette several times, transferred it to a 1.5µl eppindorfs 
and incubated it on ice. This was followed by the addition of 200µl of chloroform and 
subsequent incubation for 3 minutes. The samples were then centrifuged at 12 000 rpm for 15 
minutes   After the separation of phases, the top aqueous phase was transferred to a clean 
1.5ml eppie and mixed with Isopropanol in order to precipitate the RNA from the solution. 
The RNA was subsequently washed with 75% diethylpyrocarbonate (DEPC) (Sigma Aldrich, 
USA) ethanol. The RNA pellet was air dried for 10 minutes and resuspended with 30μl 
DEPC treated water. The RNA sample preparation was followed up with 5 minute incubation 
at 55˚C in the heating blocks, to dissolve the RNA. For long term storage, the RNA was then 
preserved at -80 . 
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6.7.2  RNA clean up 
 
RNA clean up was carried out using the RNeasy mini kit (QIAGEN, Venlo, The 
Netherlands). The RNA clean up was carried out as described by the manufacturer. 
Subsequent to dissolving the RNA in DEPC water, the volume was adjusted to 100μl with 
RNAse free water. The RTL buffer (see appendix A) and 100% ethanol was used to 
precipitate the RNA with a Qiashredder (QIAGEN, Venlo, The Netherlands) and washed 
with 70% ethanol. RNAse free water was then used to elute the RNA from the column. 
6.7.3 RNA Quantification 
 
Total RNA concentration was measured using the Nanodrop 2000 (Thermo Fischer 
Scientific, USA). The absorbance was measured at the wavelength 260 and 280nm RNA that 
had A260/280 ratio between 1.8 - 2.0 was considered pure.   
6.7.4 Formaldehyde gel electrophoresis for RNA quality evaluation 
 
The quality of the RNA was assessed by 1.5% formaldehyde gel electrophoresis. 1.5gof 
agarose powder (Roche Diagnostics, Mannheim Germany) was dissolved in 4-
Morpholinepropanesulfonic acid (MOPS) by heating. After cooling of the solution 
formaldehyde and 0.001% of ethedium bromide (Sigma Aldrich, USA) was added to the 
solution and allowed to set on the casting tray. Approximately 2μg of RNA was loaded onto 
the formaldehyde gel and separated at 100V for 30 minutes. The gel was visualised under UV 
in the UVP BioSpectrum™500 Imaging System (UVP, LCC Upland, CA, USA) and images 
were captured using the CCD camera (Canon Inc., Tokyo). 
6.7.5 Complementary DNA synthesis 
 
RNA was reverse transcribed using the ImpromII Reverse transcription system (Promega© 
Inc, Madison, WI, USA) kit. Complementary DNA (cDNA) synthesis was performed 
according to the manufacturer instructions.  Briefly, 3µg of RNA was mixed with 50µM 
oligo-dT (15) primer, 10mM dNTPs and nuclease free water and incubated at 70  for 10 
minutes. This was followed by the addition of master mix, contains 1.5 mM MgCl2, dNTPs, 
RNAse inhibitor (RNAsin), 5   first strand reaction buffer and reverse transcriptase (RT), 
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and incubation at 42  for 2 hours, followed by heat inactivation at 70  for 10 minutes. For 
long term storage, cDNA was stored at -20   
6.7.6 Quantitative PCR 
 
Quantitative polymerase chain reaction (qPCR) was conducted in order to measure the 
relative change in gene transcription. Briefly, 2   KAPATM SYBR® fast qPCR master mix 
(KAPA BIOSYSTEMS, Boston, Massachusetts), RNAse free water, 0.5µmol forward and 
reverse primers (see appendix B) and cDNA were loaded onto low profile 96 well culture 
plate (SPL Life Sciences, Korea). Glyceraldehyde 3- phosphate dehydrogenase (GAPDH) 
primers were used as a reference for each experiment. Following brief centrifugation of the 
96 well plates, the light cycler 480 (Roche, Mannheim Germany) was then used for PCR 
amplification. Each qPCR experiment had four technical replicates and at least two biological 
replicates. 
6.7.7 Relative Quantification 
 
The threshold cycle (Ct) values obtained from the light cycler 480 were used to calculate fold 
changes in gene expression.  The 2-ΔΔCt method was used to calculate fold change in gene 
expression (Yuan et al., 2006). This method normalizes the gene of interest with a reference 
gene such as GAPDH and then calculates the difference in gene expression between two 
experimental conditions for example treated (T) versus untreated (UT). This method assumes 
that the amplification efficiency of each experiment is 2. Therefore the fold induction is equal 
to 2-ΔΔCt   and ΔΔCt= [Ct (gene of interest) UT - Ct (reference gene) UT] – [Ct (gene of interest) T 
- Ct (reference gene) T].                                                                                                                                                                                   
6.8 Microarray 
6.7.2  RNA Preparation 
In order to investigate the effect of bisPMB on WHCO1 gene expression and to ascertain if 
bisPMB induced ER stress, the microarray analysis was conducted. Total RNA was extracted 
from WHCO1 cells treated with 3.5 µM bisPMB concentration, 1µM Thapsigargin or 
incubated in DMEM for 24 hours. Each experiment was conducted in quadruplicate.  




The quality control (QC) and microarray analysis was performed at the Centre for Proteomic 
and Genomic Research (CPGR). Twelve RNA samples were analysed using the nanodrop 
ND1000 spectrophotometer (Thermo Fischer Scientific, USA) and the Agilent 2100 
Bioanalyser Eukaryotic Total RNA Nano Assay (Agilent Technologies, Germany) with an 
internal control RNA sample ~ 20ng/μl bieng included. The nanodrop was used to measure 
the sample concentration and the presence of possible contaminants and the Agilent 2100 
Bioanalyser Nano assay was used determine RNA integrity and suitability (Panaro et al., 
2000). The RNA Integrity Number (RIN) number was used to evaluate the suitability of the 
RNA sample (Schroeder et al., 2006). RNA samples with a RIN of 7.00 – 10.00 were 
considered suitable for further processing. The RNA samples were then processed and 
hybridized to the Affymetrix Human Gene ST 2.0 chip, which contains over 24 000 probe 
sets. Briefly, total RNA was converted into biotin labelled complementary RNA (cRNA) 
transcribed from cDNA. The cRNA was then hybridized onto the Affymetrix human gene ST 
2.0 array and stained. The quantification of fluorescent intensity and distribution patterns of 
transcripts was obtained with the GeneChip® Scanner 3000 7G, from which the Affymetrix 
CEL files were generated. 
6.8.3 Data analysis 
 
The Affymetrix CEL files containing the raw intensities of the probe set were imported onto 
the Partek® Genomics  
Suite™ software version 6.6 (Partek Inc., St Louis, MI, USA).  The data loaded onto the 
Partek® software was assigned to categorical comparison groups based on the biological 
replicates of the samples. The samples were subsequently subjected to the robust multi array 
average (RMA) method, which was used for normalization, background correction and 
summarization of the probe intensity values. The principal component analysis (PCA) and the 
hierarchical clustering were generated in order to demonstrate the clustering of biological 
replicates, identification of outliers and reproducibility of the samples.  After that the 2 way 
Analysis Of Variance (ANOVA) between the untreated and bisPMB or thapsigargin treated 
samples p-values were calculated to measure significance of differentially expressed genes 
(DEGs). These p-values were further corrected using the Bonferroni test for false discovery 
rate (FDR). Additionally, the cut off for the significantly deregulated genes was set at -1.5 to 
+ 1.5 fold and FDR p-value <0.05. The DEG list generated using these parameters were then 
used for functional enrichment analysis. The DEG list generated was used to construct a 
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Venn diagram, using the Partek® Genomics Suite™ software version 6.6, to visualize DEGs 
that are uniquely expressed or shared between the bisPMB and TG samples.  
6.8.4 Functional Enrichment Analysis 
 
The DEGs were inputted onto the web based integrated system GEne SeT AnaLysis Toolkit 
(WebGestalt) at http://bioinfo.vanderbilt.edu/webgestalt. WebGestalt was used to identify the 
significantly enriched gene ontologies (GO) and KEGG pathways from the DEG list (Wang 
et al., 2013). Furthermore the ingenuity pathway analysis (IPA) software was used to 
generate significantly enriched canonical pathways and interactive gene networks 
http://www.ingenuity.com (Viswanathan et al., 2008). 
6.9 Western blotting 
 
Western blot analysis was performed in order to quantify any change in protein levels or 
detection of post translational modifications induced by treatment in cells. 
6.9.2  Protein Extraction 
 
3 106 WHCO1 cells were seeded in 145mm culture dishes and treated with bisPMB or 0.1% 
DMSO for desired periods. Subsequently, cells were washed with cold 1   PBS and lysed 
using 1   Ripa buffer (Cell Signalling Technology, USA) supplemented with proteinase 
inhibitor (Roche, Mannheim Germany). Rubber cell scrapers (Greiner Bio-One, Monroe, NC) 
were used to scrape the lysate off the culture dish. After which, the lysate was transferred to 
1.5ml eppendorf tubes, incubated on ice for 30 minutes and sonicated twice for 10 seconds. 
Subsequently, the whole cell lysate was centrifuged at 14000rpm for 5 minutes at 4  and 
transferred to a new 1.5ml eppendorf tube for storage at -20 . 
6.9.3 Protein Quantification 
 
Protein quantification was performed using the Pierce® Bradford Protein Assay kit (Thermo 
Fischer Scientific, USA). Protein concentration was determined through the use of a standard 
curve from a serial dilution of bovine serum albumin (BSA) standards. 25µl of BSA 
standards and 2.5µl of cell lysate was seeded on a 96 well culture plate and mixed with the 
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Bradford coomassie reagent followed by 30 minute incubation at 37 . The intensity of the 
colour was measured with the Multiskan FC multiwall plate reader (Thermo scientific, USA) 
at the absorbance value of 595nm.  
6.9.4 Sodium dodecasulfate Polyacrylamide gel electrophoresis (SDS-PAGE) 
6.9.4.1 Polyacrylamide Gel Electrophoresis  
 
Proteins in whole cell lysate were separated on sodium dodecasulfate polyacrylamide gel 
electrophoresis (SDS-PAGE). The 1.5mm spacer glass plates (Bio-Rad, California, USA) 
were assembled into casting clamps (Bio-Rad, California, USA) for set up. After set up, 4% 
stacking and 6% to 10% separating gel (table 6.2) were prepared and loaded onto the glass 
plates. Subsequently, 50µg of protein was mixed with reducing 4  loading buffer and boiled 
at 95  for 5 minutes was then separated by electrophoresis at 150V for 1 hour. 
Table 6.2 Reagents and volumes required for the preparation of the stacking and separating gel for 
western blot  
Reagents 4% Stacking gel 6 % Separating gel 10 % Separating gel 
Distilled H2O 3.65ml 4.09ml 2.75ml 
Tris buffer 0.625ml 3.75ml 3.75ml 
30% bisacrylamide 0.650ml 2ml 3.35ml 
10% SDS 50µl 100µl 100µl 
10% APS 25µl 50µl 50µl 
TEMED 5µ 5µl 5µl 
 
6.9.4.2     Protein Transfer to nitrocellulose membrane 
 
Once protein separation was completed, the proteins were transferred onto a 0.2µm 
nitrocellulose membrane (Bio-Rad, California, USA). The gel, nitrocellulose membrane, 
filter paper and sponges were used to make a sandwich in electrophoresis cassette (Bio-Rad, 
California, USA). This sandwich was then placed in transfer apparatus in the presence of 1   
transfer buffer. The transfer of protein was then performed at 100V on ice for 1 hour. After 
the transfer, the membrane is washed for 10 minutes with Tris-Buffered Saline / 0.1% Tween 
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20 (TBST) (see appendix A) on a shaker and briefly stained with the ponceau stain (Sigma 
Aldrich, USA) to check for protein loading and transfer efficiency.  
6.9.4.3    Probing with primary and secondary antibody 
 
Following the quality testing of protein transfer, the nitrocellulose membrane was blocked by 
5% fat free powder milk (Clover, South Africa) dissolved in 1   Tris-Buffered Saline / 0.1% 
Tween 20 (TBST) (Sigma Aldrich, USA) for 1 hour at room temperature in a shaker. The 
nitrocellulose membrane was then incubated with primary antibody (table 6.3) in 5% fat free 
powder milk (Clover, South Africa) dissolved in 1   Tris-Buffered Saline / 0.1% Tween 20 
(TBST) (Sigma Aldrich, USA) at 4  overnight. Subsequently the TBST was used to wash 
the membrane 3 X 15 minutes in order to remove excess primary antibody prior to incubation 
with secondary antibody (table 6.3) containing horse radish peroxidise (HRP) for 1 hour at 
room temperature.  The chemiluminescent (LumiGloReserve, KPL Incorporated, USA) 
substrate solutions A and B prepared in a 1:2 ratio was added to the nitrocellulose membrane. 
The protein on the membrane was visualised under UV light in the dark room of the UVP 
BioSpectrum™500 Imaging System (UVP, LCC Upland, CA, USA), captured by the CCD 
camera (Canon Inc., Tokyo) and analysed with the Visionworks LS Acquasition analysis 
software (UVP, LCC Upland, CA, USA). 
6.9.4.4 Protein Band Quantitation 
 
The bands in the image captured by the UVP CCD camera were quantified using image J 
software. Once the western blot image has been opened with image J, the “analyze” tab was 
selected in order to choose the “gels” drop option. Following the selection of the “gels” 
option, a rectangle that covers the band of the first lane of each gel is drawn using the 
“rectangular selection”. The same rectangle is used to demarcate the band area in all the lanes 
of the image. Once an area of interest is outlined in each lane it is numbered using the control 
command in order to identify the lane. The density data from the band are is used to generate 
histograms of each lane, where the peaks of the histograms correspond to intensity of the 
band. The density data from the band are is used to generate histograms of each lane, where 
the peaks of the histograms correspond to intensity of the band. The value of the intensity of 







Table 6.3 The sources of Primary and Secondary antibodies and their dilutions used for western blot 
analysis. P-JNK/p38/ERK indicates antibodies that detect phosphorylated forms of the proteins. 
 
Protein Supplier Catalogue number Dilution Blocking Source 
GAPDH Santa Cruz Biotechnology sc-25778 1:1000 5% milk in TBST Rabbit 
CHOP Cell Signaling Technology D46F1 1:1000 5% milk in TBST Rabbit 
ATF4 Sigma Aldrich SAB2500130 2mg/ml 5% milk in TBST Goat 
ATF6α Santa Cruz Biotechnology sc-22799 1:500 5% milk in TBST Rabbit 
UBIQUITIN Santa Cruz Biotechnology sc-9133 1:500 5% milk in TBST Rabbit 
JNK1/2 Cell Signaling Technology 9252 1:1000 5% milk in TBST Rabbit 
P-JNK1/2 Cell Signaling Technology 9251 1:1000 5% milk in TBST Rabbit 
GRP78 Sigma Aldrich G9043 1:4000 5% milk in TBST Rabbit 
P- P38 Cell Signalling Technology 9211 1:500 5% milk in TBST Rabbit 
P38 Cell Signaling Technology 9212 1:1000 5% milk in TBST Rabbit 
P-ERK1/2 Cell Signaling Technology 9106 1:500 5% BSA in TBST Mouse 
ERK 2 Santa Cruz Biotechnology Sc153 1:1000 5% milk in TBST Rabbit 
 
6.10 Kinase inhibition 
In order to determine the significance of the role played by activated JNK and MEK-ERK 
signal transduction pathways, chemical inhibitors U0126 (MEK1/2 inhibitor) and SP600125 
(JNK1/2 inhibitor) were used to inhibit the pathways. Briefly, 3.5   105 were seeded in 6 well 
culture plates and allowed to settle overnight. Different concentrations of U0126 (1µM, 5µM 
or 10µM) and SP600125 (5µM, 10µM, 20µM or 30µM) were used in order to determine the 
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Acrylamide/Bisacrylamide Solution (30%) 
To make the stork solution, 29g of acrylamide and 1g of bisacrylamide were dissolved in 
100ml of distilled water and stored at 4  away from light. 
7.5M Ammonium acetate, pH7.4  
57.81g of ammonium acetate were dissolved in 60ml of distilled water and the pH was 
adjusted to pH 7.4.  
 
10 % Ammonium persulfate (APS): 
100 mg APS was dissolved in 1 ml double-distilled water, and stored at 4 °C. 
 
Coomassie staining solution: 
0.5 g Coomassie BB was diluted in 200 ml methanol, 100 ml acetic acid and 400 ml double-
distilled water. It autoclaved and stored at room temperature. 
 
Destaining solution: 
100 ml acetic acid, 100 ml methanol and 800 ml double-distilled water were mixed and 
stored at room temperature. 
 
Dulbecco’s minimal eagle media (DMEM): 
DMEM Powder with catalogue number 12800-017 was prepared according to the 
manufacturer’s instructions. 
 
6X DNA Loading Dye: 
25mg of bromophenol blue, 25mg of xylene cyanol FF and 4mg of sucrose were dissolved in 







0.5 M EDTA (pH 8.0): 
37.22 g Na2EDTA·2H2O was added to 140 ml of distilled water. The pH was adjusted to 8.0 
and then distilled water was added to a final volume of 200 ml. The solution was 
subsequently autoclaved and stored at room temperature. 
 
Ethedium Bromide: 
10µl of stork solution (10mg/ml) was added to 200ml distilled water, to obtain a 0.5mg/ml 
final concentration. 
 
Freeze down media: 
7ml of fetal bovine serum (FBS), 2ml DMEM and 1ml Dimethylsulphoxide (DMSO).  
 
Membrane stripping solution: 
To make 1 M Glycine, 37.5g of glycine was added to 400ml of distilled water. The solution 
was then adjusted to pH 2.5. Distilled water was added up to 500ml final volume, and then 
stored at room temperature. 
 
MOWIOL® 4-88 mounting medium: 
75 g MOWIOL 4-88 ® (Calbiochem) mounting medium was diluted in 300 ml 1× PBS and 
stirred for 16 hours at room temperature. After that, 150 ml glycerol was added to the 
solution and then it was stirred for an additional 16 hours at room temperature. The solution 
was subsequently centrifuged for 15 minutes at 4000 rpm and the pH was adjusted to pH8. 
The supernatant was then stored at - 20 °C and n-Propylgallate supplement was added. 
 
5 % Non-fat blocking solution: 
3.3 mg non-fat milk powder was dissolved in 30 ml TBST 
 
5 mg/ml 3-[4, 5-dimethylthiazol]-2,5-diphenyltetrazolium bromide (MTT): 
100 mg MTT (3-[4, 5-dimethylthiazol]-2, 5-diphenyltetrazolium bromide) (Sigma) added to 
20ml of 1 x PBS at pH 7.5 (under sterile condition). The solution was then stored at 4 °C 







For the preparation of the penicillin G/streptomycinsulfate solution, 604 mg (999620 IU) 
penicillin G and 1316 mg (1000160 IU) streptomycinsulfate was dissolved in 100 ml double-
distilled water, and filter sterilised. 
 
10 × Phosphate Buffer Saline (PBS) (pH 7.5): 
For a 10 × PBS preparation NaCl (Merck), KCl (Merck), Na2HPO4 (Merck) and KH2PO4 
(Merck) powders were diluted in double distilled water to 1.37 M , 27 mM, 43 mM and 14 
mM respectively, and finally calibrated to a final pH of 7.5. 
 
Ponseau staining solution: 
The Ponseau (usb®) staining solution was prepared by diluting Ponseau powder and acetic 
acid in double-distilled water to 0.2 % and 5 % respectively. 
 
Propidium iodide (PI) staining solution: 
Stocks of 100% Triton X-100, 1 M MgCl2, 1 M NaCl, 0.1 M PIPES and 1 mg/ml PI were 
diluted in 20 ml double-distilled water to give a final concentration of 0.1 % Triton X-100, 2 
mM MgCl2, 0.1 M NaCl, 10 mM PIPES and 0.01 mg/ml PI. The solution was stored in a 50 
ml Falcon tube and covered with foil as it is sensitive to light. 
 
4 X Protein loading buffer: 
24 ml 1 M Tris at pH 6.8, 4 ml 20 % SDS, 0.2 ml 0.1 % bromophenol blue and 4 ml glycerol 
were mixed. 50 μl bromophenol blue (Merck) was added after the solution was diluted to a 1 
x concentration. 
 
10 × Running buffer: 
Tris, glycine and SDS were diluted in double distilled water to a final concentration of 240 
mM, 1.92M and 35 mM respectively. 
 
10 % Sodium dodecyl sulphate (SDS): 
10 g SDS was dissolved in 80 ml double-distilled water, then made to a final volume of 100 





10 % Solubilisation reagent: Sodium Lauryl Sulfate (SLS): 
5 ml 1 M HCl was added to 50 g SLS (MERCK). The solution was further diluted with 
double distilled water to a final volume of 500 ml. 
 
4 % Stacking gel: 
0.63 ml 1 M Tris (Merck) at pH 6.8, 0.65 ml 30 % acrylamide/bisacrylamide (Sigma®) and 
50 μl 10 % SDS (Merck) was diluted in 3.65 ml double-distilled water. Immediately before 
adding to the gel tray, 25 μl 10 % ammonium persulfate (APS) (MERCK) and 5 μl TEMED 
(Sigma) was added to the solution. 
 
8 % stacking gel: 
For the preparation of 8 % stacking gel, 3.75 ml 1 M Tris at pH 8.8, 2.7 ml 30 % 
Acrylamide/bisacrylamide and 100 μl 10 % SDS was diluted in 3.39 ml double-distilled 
water. Immediately before adding to the gel tray, 50 μl 10 % ammonium persulfate (APS) 




To make up TBST, 50 ml 1 M tris-base, 20 ml 5 M NaCl and 250 μl Tween-20 was dissolved 
in 100 ml double-distilled water, and stored at room temperature. 
 
10 × Transfer buffer: 
3.03 Tris and 14.5 glycine (Merck) were diluted to a final concentration of 24 mM and 193 
mM respectively in 1 L double distilled water. 
 
 
Tris-buffered saline (TBS): 
3.03 g Tris (pH 7.5) and 9 g NaCl was added to final concentrations of 25 mM and 0.9 % 
(w/v) respectively in 1 L double-distilled water. 
 
1 M Tris pH 6.8 (per litre): 
Add 121 g Tris base to 800 ml double-distilled water, adjust the pH to 6.8, and add double 




1 M Tris pH 7.5 (per litre): 
Add 121 g Tris base to 800 ml double-distilled water, adjust the pH to 7.5, and add double 
distilled water to 1 L, then autoclave. 
 
1 M Tris pH 8.0 (per litre): 
Add 121 g Tris base to 800 ml double-distilled water, adjust the pH to 8.0, and add double 
distilled water to 1 L, then autoclave. 
 
1 M Tris pH 8.8 (per litre): 
Add 121 g Tris base to 800 ml double-distilled water, adjust the pH to 8.8, and add double 
distilled water to 1 L, then autoclave. 
 
Trypsin: 
Trypsin is made up by adding 0.5 g trypsin powder to 0.2 g EDTA powder, and making up to 
a total volume of 1 L with PBS buffer. The pH of the solution was adjusted to 7.4 and the 




















Primer sequences of genes amplified with qRT-PCR and the amplicon size. The sequences were designed 
using the NCBI/Primer-BLAST. 
Gene 
Symbol 
Forward Primer ( 5’ – 3’) Reverse Primer ( 5’ – 3’) 
Annealing 
Temperature ( ) 
gapdg GCCTGCTTCACCACCTTC GGCTCTCCAGAACATCATCC 60 
sec63 TTCCAGTTGTTGTGGGCTCTT CAGAAGCTCCAGCCAAAACC 60 
ddost CGGACAAGCCTATCACCCAG TGCCTGTCTGGGAATACCTCT 60 
rrbp1 GGCAGACCTCCTAGTGAAAG GAGTTTTCGCCATCTCCTTGC 58 
llman1 CAGAATCCAAGATGGCGGGA GGAATAGCATTCCCCGCGT 58 
Ire1 GCCTAGTCAGTTCTGCGTCC GCTGGTACTTCCAAAAATCCCG 60 
ssr3 CTCAAGCACAAAGTAGCACAGA GACCACGACCAGGAACAGAG 59 
tram GCGATTCGCAAGAAAAGCAC TTGTTCTTCTGTTGCTGGGAGG 60 
ero1 GGTGCTTCTGCCAGGTTAGTG GTCCCTTCTTCCACACTGGC 60 
vimp GGATGAGGCTAAGAATCTTGTAGA GTAATTACACTGCTCAAGGCTC 57 
sel1l GAAACCAGCTTTGACCGCCA AGCCCCACTTTTCATCTGCT 60 
ubc6 GATCATTACCATGCGCAGCC TCGACCATTAGCCGTTAGGAG 60 
sec61 ATTTCCAGGGCTTCCGAGTG CGAGCTGAGAGCATTTGGGA 60 
grp94 CTGCTCCACGTGGTCTGTTT GATCATCTGAGTCCACCACACC 60 
edem TGTTCACAACAGAGGGACAC CAGGTACACGATTGCAGTTGG 58 
pdiA4 CACCAGAAGTCACGCTTGTGTTGA AGGAGAACGCTTGCTGAGCTCCTT 60 
ask CCCTGGAAACCCTGCATTTTG GAGTCCGAGTTAGTATCACAG 55 
sec24D GAGAAAGGGTTTGACGTGGC CAAAAGAAGTCTGTTCCCGCTC 59 
atf6 ACGGAGTATTTTGTCCGCCT AGCAAAGAGAGCAGAATCCCAA 59 
154 
 
casp4 TGTTCCCTATGGCAGAAGGC TGTCCTGCCATACGTTGCTT 57 
xbp-1s TTACGAGAGAAAACTCATGGCC GGGTCCAAGTTGTCCAGAATGC 55 
grp78/bip GACATCAAGTTCTTGCCGTT CTCATAACATTTAGGCCAGC 50 
ddit3/chop CCAGCAGAGGTCACAAGCAC GGGAATGACCACTCTGTTTC 55 
 
 
 
 
